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1.0 ABSTRACT  
The major objectives of this study were to investigate the antioxidant 
properties of flaxseed lignans secoisolariciresinol (SECO 2) and secoisolariciresinol 
diglycoside (SDG 1) and their major oxidative compounds using 2,2'-azobis(2-
amidinopropane) dihydrochloride (AAPH 47) in an in vitro model of lipid 
peroxidation.  This investigation was facilitated by the structural elucidation of the 
major oxidative compounds and the ability of flaxseed lignans to delay the onset of 
oxidation in two model systems.   
This study showed that SECO 2 oxidation occurs at the aromatic (4-OH) and 
aliphatic (9-OH) hydroxyl groups.  Conversely for SDG 1, only compounds derived 
from the oxidation of aromatic hydroxyl groups were obtained because the 9-OH 
position is glucosylated.   
SECO 2 oxidation with AAPH 47 showed that the intermediate 2a is most 
likely involved in the generation of early-forming (48 and 52) and 2c for the 
formation of late-forming (49, 50 and 51) oxidation compounds.  Compound 48 is 
formed from dimerization of 2a that is converted to 52 and then to 51.  Compound 
50 was formed by the addition of a carbon-centre free radical of AAPH (AP radical) 
to 2c.  Compounds 50 and 51 trap carbon-centered AP radicals supporting SECO 2 
as a chain-breaking antioxidant and AAPH 47 as a proper model for study of SECO 
2 oxidation in vitro.   
  iv
SDG 1 oxidation with AAPH 47 indicated that intermediates 1b and 1c are 
most likely involved for the formation of early forming compounds (55 and 58) and 
1a leads to the late forming compounds (56 and 57).  Compound 55 is a result of 
dimerization.  Compound 56 may be directly formed via intermediate radical 1a by 
adding AP free radicals.  Compound 56 was a stable non-radical compound that 
could trap AP free radicals, thereby supporting SDG 1 as a chain-breaking 
antioxidant.  Hydrogen abstraction from 4-hydroxyl yielded the radical 1a and 
hydroxyl radical addition to 1a yielded 57.  Compound 58 formed from the addition 
of •OH or H2O to 1c.   
This study demonstrated that AAPH 47 produces carbon-centred AP radicals 
upon thermal decomposition and mimics the formation of lipid peroxyl radicals.  
Interaction of carbon-centred AP radicals with SECO 2 and SDG 1 provides a good 
model to study the antioxidant reactions of SECO 2 in vitro.   
The relative antioxidant capacity of the flaxseed lignans versus BHT 17, in 
two model systems, was determined.  The stoichiometric ratio for SECO 2 and SDG 
1 were 1.5 and 1.1-1.2, respectively, compared to BHT 17 (2.0).  The induction time 
by Rancimat analyzer measured inhibition of autoxidation mediated by flaxseed 
lignans SECO, SDG and SDG polymer in comparison with BHT 17.  The induction 
time data demonstrated that SECO 2 protected canola oil better than either SDG 1 or 
SDG polymer 3.   
  v
These results are important for better understanding about the chemistry 
behind flaxseed lignan antioxidant activities.  This study provided useful evidence 
that flaxseed lignans can be used as natural antioxidants.   
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2.0. LITERATURE REVIEW 
2.1. Flaxseed, general description 
Flax (Linum usitatisimum L.) is grown as either an oil crop or as a fibre crop, with 
fibre (linen) derived from the stem of fibre varieties and oil from the seed of linseed 
varieties.1,2  The seed of flax is flat and oval with a pointed tip, and varies in colour from 
dark brown to yellow.3  Depending on the cultivar and growing conditions, flaxseed 
contains 40-50% oil and meal, comprised of 23-34% protein, 4% ash, 5% viscous fibre 
(mucilage) and lignan precursors (9-30 mg per g of defatted meal).4-8  Annual world 
production of flax was 3.06 million tonnes in 1999-2000 and Canada is the world’s 
largest producer of flax (about 38% of total production).9  Flax is currently the second 
most important oilseed crop in Western Canada and is grown primarily in the prairie 
provinces of Saskatchewan (70%), Manitoba (26%), and Alberta (4%).9 
 
2.2. Flaxseed oil   
Flaxseed averages about 41% fat on a dry basis.  It is low in saturated fat (9% of 
total fatty acids), moderate in monounsaturated fat (18%) and rich in polyunsaturated fat 
(73%).10  α-Linolenic acid (ALA, 18:3, ω-3), an essential fatty acid, constitutes 
approximately 59% of the total fatty acids in flaxseed, making it the leading source of 
plant based ω-3 fatty acids.5,11,12  The other polyunsaturated fatty acid in flax is linoleic 
acid (18:2, ω-6), that constitutes about 16% of the total fatty acids.5,11  Flax is the richest 
source of ALA in the North American diet.2  ALA is converted to two major metabolites 
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in vivo, the long-chain ω-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA) after elongation and desaturation.  The major metabolite of linoleic acid is 
arachidonic acid (20:4, ω-6).   
 
2.3. Flaxseed mucilage  
Flaxseed contains both soluble and non-soluble fibre, which accounts for about 
28% of the weight of full-fat flax seeds.  The proportion of soluble to insoluble fibre in 
flaxseed varies between 20:80 and 40:60.13,14  The major insoluble fibre fraction in 
flaxseed consists of cellulose and lignin, and the major soluble fibre fraction are the 
mucilage gums.2,15  Mucilage gums are a type of polysaccharide that becomes viscous 
when mixed with water or other fluids.  These fibre fractions in flax can be classified as 
either dietary fibre or functional fibre.  The classification depends on whether they are 
found intact in flax or are extracted from flax, purified and added to foods and other 
products.  Thus, whole flax seeds and ground flax are sources of dietary fibre, while 
mucilage gums extracted from flax seeds and added to laxatives and cough syrups are a 
functional fibre.2 
 
2.4. Flaxseed lignans  
Lignans are diphenolic compounds of higher plants formed by the coupling of two 
coniferyl alcohol residues that are present in the plant cell wall.16-21  In 1956, Bakke and 
Klosterman22 isolated SDG 1 (Figure 2.1) from a fat free extract of linseed meal with a 
3% yield.  SDG 1 was found to be very soluble in water and alcohol.  The same group 
isolated SECO 2 [2,3-di-(methoxy-4-hydroxybenzyl) butane-1,4-diol] (Figure 2.1) 
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by acid hydrolysis of SDG 1.22  SECO 2 is the aglycone (non-sugar) portion of SDG 
1.  Both SDG 1 and SECO 2 have a UV absorption maximum at 280 nm, which is 
characteristic for lignans.  Flax also contains small amounts of the lignans 
matairesinol (MAT) (11µg/g of full fat flaxseed), pinoresinol, pinoresinol 
diglucoside, isolariciresinol and a diastereomer of SDG 1.23-26   
SECO 2 is the major lignan present in flaxseed, which is found as the 
conjugate diglycoside SDG 1.27  Early studies demonstrated that SDG 1 was part of 
a larger complex.22  An oligomer 3 (Figure 2.2) of SDG 1, which is ester-linked via 
3-hydroxy-3-methylglutaric acid (HMGA) 4, has been identified.16,24,28  A straight-
chain oligomeric structure composed of five SDG 1 residues interconnected by four 
HMGA 4 residues (molecular weight ca. 4000 Da) was also reported.29  SDG 1 may 
comprise greater than 35% (by weight or mole%) of the polymer.29,30  Among foods, 
flaxseed is the richest source of SDG 1 (7 mg/g or 3.7 mg SECO 2/g), which 
contains 75-800 times more SDG 1 than any other foods (Table 2.1).23,31  Variation 
in the flaxseed lignan concentrations depends on the variety, location and year.31  
Whole seed and ground flax typically contain between 0.7 and 1.9% SDG 1,  
which is approximately 77–209 mg SDG 1/tbsp of whole seed or 56–152 mg SDG 
1/tbsp of ground flax.13  Flax oil containing added lignans has been available for 
several years.  One such product contains 0.1% SDG 1 or about 14 mg SDG 1/tbsp 
flax oil.13 
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Figure 2.1. Structure of SDG 1 and SECO 2 (adapted from Muir and Westcott,
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Table 2.1. Lignan content of various foods (adapted from Morris, 2003).13 
 
Food group/food Seco 2 
µg/g 
Seeds 
    Ground flax 
 
3700.0 
    Pumpkin 213.7 
    Sunflower seeds 6.1 
Cereals and grains 
    Rye meal, whole grain   
 
0.5 
    Oatmeal 0.1 
Legumes 
    Peanut  
 
3.3 
    Soybean 2.7 
Vegetables 
    Broccoli  
 
4.1 
    Carrots 1.9 
    Garlic  3.8 
Berries 
    Blackberry 
 
37.1 
    Cranberry 15.1 
    Strawberry 12.1 
    Red currant 1.6 
 
 
 
2.4.1. Properties of SECO 2 and SDG 1 
Some basic physical properties of SDG 1 and SECO 2 in flaxseed are 
summarized in Table 2.2.  SDG 1 and SECO 2 have been previously characterized 
by 1H and 13C nuclear magnetic resonance (NMR) and electrospray-mass-
spectrometry (ES-MS).22,33 
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Table 2.2. Some properties of SDG 1 and SECO 2 in flaxseed.22,27,33,34 
Compound Formula *Molecular 
ion (m/z) 
[M+H]+ 
Melting 
point (°C) 
**Optical 
activity [α]D 
(R,R)-SDG 1 C32H46O16 687.7 118.0 -2.0° 
(R,R)-SECO 2 C20H26O6 363.3 114.0 +37.0° 
  *MW was measured using ES-MS (+ve ion mode).  
  **Ethanol was used for SECO 2 and water was used for SDG 1. 
 
 
2.4.1.1. Optical rotation of SECO 2 and SDG 1  
Stereoselectivity plays an important role in the late stage of phenylpropanoid 
metabolites (e.g., coniferyl alcohol) 5.  Naturally occurring lignans are often not 
racemic, but most are found in an optically active form (unlike lignins).35,36  The 
enantiomer present can vary from one plant species to another.  For example, in 
Forsythia suspense only (+) pinoresinol 6 was present, whereas in Forsythia 
intermedia, only (-) SECO 8 and (-) matairesinol 9 were reported (Figure 2.3).35,37  
In flax, SECO 2 is present essentially only as the (+) form 222,27 and hydrolysis (10% 
HCl, 100°C) of purified SDG 1 gives enantiomerically pure (+) SECO 2 (Figure 
2.4).22,27  Studies on the biosynthetic routes to the formation of SECO 2 in flaxseed 
coupled with enantiomeric separation with chiral HPLC showed that the absolute 
configuration of (+) SDG 1 can mainly occur in the form of SDG 1 (R,R); however, 
some flax species showed (+) SDG 1 in the form of (S,S) configuration.16,36  The 
absolute configuration of (-) SECO 2 has been determined via X-ray crystallography 
and NMR analysis using chiral shift reagents.38 
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One problem in the literature regarding optical activity of lignans has been the 
reporting of a wide range of [α]D for the same lignan in different plants.  For 
example, the optical activity of SECO 2 has been reported as +37.0° (flaxseed),  
-7.0° (Salvia plebeia seed), and -30.8° (Fitzroya cupressoides).22,39,40  Values of [α]D 
= -35°, melting point 123°C has been reported for (-) SECO 8 (R,R)38 and [α]D = 
+37°, melting point of 114°C has been reported for (+) SECO 2.36 
 
2.5. Mammalian lignans  
2.5.1. Conversion of plant lignans to mammalian lignans 
Studies in which flaxseed was fed to rats, monkeys, or humans have found 
that the urinary excretion of the lignans enterodiol (END) 12 and enterolactone 
(ENL) 13 are significantly increased in urine.41-48  Excretion of END 12 and ENL 13 
increased 3-to 285-times after flaxseed consumption (5-10 g daily for six weeks) in 
the urine of 18 healthy young women, 31 healthy postmenopausal women and six 
healthy young men.49-51 
The first mammalian lignans, END 12 (MW = 302) and ENL 13 (MW = 
298) were identified in humans and animals in 1980.18  Mammalian lignans are 
formed in the human body in the gastrointestinal (GI) tract, where GI bacteria 
hydrolyze the sugar moiety of SDG 1 to release SECO 2.6,8,27,28,52  This is followed 
by dehydroxylation and demethylation by colonic microflora to give the mammalian 
lignan END 12 (Figure 2.5).  END 12 is presumed to be oxidized by the GI 
microbial flora to give ENL 13.  The ENL 13 may also be formed directly from 
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matairesinol 14 although this is likely to be a minor metabolic route if other lignans 
are present in the diet.8,18,48,53-55  The mammalian lignans differ from plant lignans in 
that mammalian lignans have hydroxyl groups at the 3' position while plant lignans 
have their oxygenated substituents at the 3' and 4' positions.32,52,56  A scheme 
outlining the proposed biosynthetic pathway of END 12 & ENL 13 from the 
flaxseed lignans SECO 2 and SDG 1 is shown in Figure 2.5.  Concentrations of 
mammalian lignans in urine are typically greater than in plasma, thus most analytical 
methods target the measurement of urinary lignan levels (sections 2.7 and 2.8 for 
details).32 
2.5.2. Role of gut flora in the oxidation of plant lignans to
 mammalian lignans 
Incubation of flaxseed by bacteria present in stools, at a concentration of 103-
104 bacteria/g of stool resulted in the formation of END 12 and ENL 13.53  This 
study showed that plant lignans are converted into END 12 and ENL 13 and the 
conversion is not reversible, thus END 12 and ENL 13 cannot convert to plant 
lignans in vivo.  Furthermore, incubation of flaxseed in a human faecal bacterial 
culture at 103-104 bacteria/g converted END 12 to ENL 13 but sterile faecal cultures 
could not.18  These results suggest that human gut floras are responsible for the 
conversion of plant lignans to mammalian lignans.  A time course study of the 
metabolism of SDG 1 by human faecal cultures shows initial demethylation (Figure 
2.6), occurs prior (20-30h) to dehydroxylation (48h).57  Urinary excretion of END 12 
and ENL 13 has been used as an index of plant lignan intake.58 
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2.6. Hepatic metabolism of mammalian lignans 
2.6.1. Phase I metabolism 
Studies of the hepatic metabolism of the mammalian lignans END 12 and 
ENL 13 in rat, pig, and human liver microsomes found a series of mono-
hydroxylated derivatives of END 12 and ENL 13.59  These metabolites have also 
been found in the bile and urine of rats receiving oral doses of END 12, ENL 13 or 
flaxseed.32  A total of six aromatic mono-hydroxylated metabolites of ENL 13 and 
the 3 corresponding metabolites of END 12 were detected (Figure 2.7–2.8) with 
hydroxylation occurring either ortho or para to the aromatic hydroxyl groups.59,60  A 
series of aliphatic mono-hydroxylated metabolites were also detected.  Only the 
aromatic hydroxylated metabolites were found in human (female and male) urine, 
after 5 days of flaxseed (25 g/day) consumption.61  The biological significance of 
these metabolites remains to be established.61  
 
2.6.2. Phase 2 metabolism 
Mammalian lignans are found in urine as the glucuronide and sulfate 
conjugates.62  Once generated in the colon, END 12 and ENL 13 are absorbed and 
transported to the liver where they are conjugated mainly with glucuronic acid or 
sulfate.21,27,58,62-64  The conjugated lignans are then excreted back into the digestive 
tract via the bile.   
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A portion reaches the kidney and eventually is excreted in the urine as 
conjugates.58  Conjugated lignans are reabsorbed from the intestine and the portion 
which escapes reabsorption becomes deconjugated during passage through the 
intestine by the action of bacterial β-glucuronidase and is excreted in the faeces in 
the unconjugated form.24,62  Therefore, lignans extracted in bile and urine are mainly 
conjugated glucuronides62,66 whereas the faeces contain the unconjugated forms of 
the lignans.67  This enterohepatic circulation pathway of plant lignans is outlined 
schematically in Figure 2.9.   
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Figure 2.9. The enterohepatic circulation of plant lignans, their colonic and
 liver metabolites in man (adapted from Setchell et al., 1982).64   
   
 
2.7. Flaxseed lignan uptake and urinary levels 
Urinary END 12 and ENL 13 has been found in relatively large amounts (10-
1000 times more than endogenous estrogens) in humans.68-70  Mammalian lignan 
production, based on urinary lignan excretion, is linear up to a diet of 5-10% 
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defatted flaxseed or 4.4 µmol SDG 1/day intake in rats, and up to 25 g/day flaxseed 
intake in humans.42  Consumption of 5 or 10 g of ground flaxseed by post-
menopausal women significantly increased urinary excretion of END 12 by 1,009 
and 2,867 nmol/day, respectively.51  Urinary excretion of ENL 13 increased by 
21,242 and 52,826 nmol/day, and total lignans increased (END 12 + ENL 13 + 
matairesinol (MAT) 14) by 24,333 and 60,640 nmol/day, respectively.51  Excretion 
of MAT 14 was not significantly altered by flaxseed consumption.  In human urine, 
ENL 13, END 12, and MAT 14 were mainly excreted as mono-glucuronides (73-
94%), with lesser amounts of monosulfates, sulfoglucuronides, diglucuronides and 
disulfates.66,62   
Approximately one third of the mammalian lignans are excreted via the 
faecal route, while concentrations of the plant lignans in faeces and in urine are 
usually negligible.68,71,72  In most studies, the urinary excretion of ENL 13 ranged 
from 1.1 to 4.2 µmol/24 h.68-70,72-74  Excretion of END 12 was reported to be 
approximately 10 % of the excretion of ENL 13.69,70  It was observed that when rats 
were treated with radiolabelled SDG 1 (3H-SDG 1), most of the radioactivity was 
excreted by 48 hours (feces = 60%, urine = 28-30%).58   
 
2.8. Flaxseed lignan uptake and plasma levels 
The plasma levels of END 12 and ENL 13 in rats fed 1.5 mg/day SDG 1 was 
estimated to be 1 µmol/L.75  The plasma level of lignans in humans fed 1.5 
µmol/kg/body wt SDG 1 was also estimated to be 1 µmol/L.76  One study on nine 
  17
healthy young women who supplemented their diets with 5, 15, or 25 g raw or 25 g 
processed flaxseed (in muffins or bread) for 8 days, showed that the concentrations 
of END 12 (12 nmol/L) were doubled compared with ENL 13 (6 nmol/L).43  The 
conversion rate of END 12 to ENL 13 was very similar at the beginning and end of 
the study, suggesting that microflora were able to metabolize only a certain amount 
of plant lignans to ENL 13.43  
  
2.9. Flaxseed health benefits 
Flaxseed consumption exhibits potential health benefits that include reducing 
the risk of cardiovascular disease, cancer and diabetes.6,16,18,48,52,67,73,77-91  Whole 
flaxseed (2 tbs) contains a number of potentially beneficial components (Table 2.3).  
Most of the health benefits are associated with ALA, lignans and mucilage fibre, 
which will be discussed in this thesis. 
Table 2.3. Nutritional profile of whole flaxseed (2 tbs ≅ 15 g of flaxseed).11,92 
 
Alpha linolenic acid (Omega-3) 1,710 mg
Linoleic acid (Omega-6)    480 mg
Oleic acid (Omega-9) 540 mg
Lignin fibre 1,003 mg
Mucilage fibre 200.6 mg
Lignan 13.6 mg
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2.9.1. ALA in flaxseed - health benefits 
α-Linolenic acid in flaxseed can reduce the risk of cardiovascular disease 
(CVD), osteoporosis, rheumatoid arthritis and cancer.92-96  In most studies flaxseed 
oil or whole flaxseed was used as the source of dietary ALA to show the effect of 
ALA on humans and animals. 
 
2.9.1.1. ALA: Animal studies 
A 10% flax oil supplement fed to mice reduced the growth of mammary 
tumor cells.97-99  ALA may also have beneficial effects in hypertension.  Rats on oil-
rich diets supplemented with flaxseed oil at 40% of energy, showed lower blood 
pressure on average than control100 and Golden Syrian hamsters fed 7.5-22% whole 
flaxseed in their diet for 120 days showed reduced plasma cholesterol and elevated 
high-density lipoprotein-cholesterol (HDL-C) levels.101   
The effect of flaxseed lignans and alpha-linolenic acid, on growth and 
metastasis of human breast cancer in a mouse model has been studied.  Mice 
injected with human breast cancer cells and supplemented with whole flaxseed 
(10%) showed a significant reduction in tumor growth rate and reduction in total 
incidence of metastasis (45%).102   
 
2.9.1.2. ALA: Human studies 
The Multiple Risk Factor Intervention Trial (MRFIT) showed that increased 
ALA intake over eight years correlated with up to a 50% lower risk of death from 
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coronary heart diseases (CHD).103  Clinical studies have shown that flaxseed oil 
supplements may lower plasma cholesterol in hypercholesterolemic men.10,11,104  
One study showed that the consumption of a flaxseed oil (60 mL) supplement for six 
weeks increased EPA levels in plasma triglycerides.105  A decrease in blood platelet 
aggregation was also observed, suggesting ALA in flaxseed may alter platelet 
aggregation.105  Alterations in platelet composition and function were observed in 
healthy young men consuming a low fat diet supplemented with flaxseed oil (40 g) 
versus sunflowerseed oil.106  The EPA level was more than doubled in the group 
taking flaxseed oil but was unchanged in the sunflowerseed group.106  Thromboxane 
B2 concentration decreased 30% in immune cells of 28 healthy men consuming 1.75 
tbsp of flax oil daily for four weeks.107  Dietary flaxseed oil (14 g/d) has also shown 
90% inhibition of pro-inflammatory cytokine production in patients with rheumatoid 
arthritis.108 
ALA in flaxseed oil (10 g/day) as supplements or in the diet of early 
postmenopausal women decreased levels of inflammatory bone resorbing cytokines 
and slowed the rate of bone loss, while increasing calcium absorption, bone calcium, 
and bone density, suggesting a possible protective effect against osteoporosis.93   
Ground flaxseed (50g/day) consumed over 4 weeks increased the average 
daily ALA plasma levels by about 10 times in healthy adults.109  Consumption of 50 
g of ground flaxseed daily for four weeks lead to reductions in serum total 
cholesterol (6-9%) and low density lipoprotein-cholesterol (LDL-C) (9-18%) in 
studies of healthy young adults,10,109 men and women with moderately high levels of 
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blood cholesterol110 and postmenopausal women.111,112  Triglyceride levels were not 
affected by diets containing ground flax and high-density lipoprotein-cholesterol 
(HDL-C) increased by 18% in only one study.11  
Apolipoprotein B (apo B) decreased by 6% in hyperlipidemic women and 
men consuming partially defatted flax in their diets113 and by 19% when eight men 
with normal blood lipid levels consumed flax oil.114  Serum apo B concentrations 
decreased 7.5% in 25 postmenopausal women who ate 40 g of ground flax daily for 
three months.112 
 
2.9.1.3. Mechanism of action 
ALA is a precursor of EPA and DHA, alters the fatty acid composition of 
cell membranes, inhibits the release of pro-inflammatory eicosanoids,107 affects 
membrane fluidity and elasticity92,93 and decreases apo B levels, the major protein in 
LDL-C and very-low-density lipoproteins (VLDL).92,93  Because ALA can interfere 
with the metabolism and biological actions of the ω-6 fatty acids, ALA may block 
the actions of platelet-activating factor (PAF), the formation of arachidonic acid and 
the formation of potent eicosanoids.92,93  This may occur as a result of decreased 
prostaglandin levels or decreased cytokine production.115  
 
2.9.2. Mucilage - health benefits 
Mucilage or soluble fibre in flaxseed may also lower serum total cholesterol 
and LDL-cholesterol in the same way as other soluble fibres in the diet113,116 and it 
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has been suggested that the lipid-lowering effects of flax are the result of the 
mucilage gums.92,93,113  Diets containing 50 g carbohydrate from flaxseed or 25g 
flaxseed mucilage decreased blood glucose by 27%.10  In a study of 29 men and 
women with high blood cholesterol who ate muffins (4/day) made with wheat bran 
or with partially defatted flax (less than 10% fat) for three weeks, total cholesterol 
decreased by 5% and LDL cholesterol decreased by 8% on the partially defatted flax 
diet.13  These study findings suggested the role for flax mucilage gums in lowering 
blood lipids is due to more than ALA.113 
 
2.9.3. Flaxseed lignans – health benefits   
While lignans are found in many plants, flaxseed is the richest source of 
SDG 1 (0.7 and 1.9% in ground flax).13,86  SECO 2 and SDG 1 may possess 
chemopreventive properties in animals and humans6,16,18,48,52,67,73,77-91 including the 
potential to prevent hormone sensitive cancers (e.g. breast, prostate and colon 
cancer), hypercholesterolemic atherosclerosis and diabetes.21,27,63,78,87,88,91,117-119  A 
study of urinary lignan ENL 13 and END 12 excretion, an indicator of dietary lignan 
intake, was found to be 50% lower in women with breast cancer suggesting that 
flaxseed could have chemopreventive properties.69  This observation lead to a series 
of in vitro, animal, and human experiments to obtain a better understanding of the 
role of flaxseed and its lignans on different types of cancer.21,27,63,78,87,88,91,117  
Because flaxseed lignans are the richest source of precursors for the mammalian 
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lignans END 12 and ENL 13, most studies use whole defatted flaxseed or SDG 1 to 
assess the role of the mammalian lignans. 
 
2.9.3.1. Animal studies 
The beneficial effects of flaxseed supplementation in breast cancer,77,82,120,121 
colon cancer,82,88 skin cancer122 and lupus nephritis123 have been demonstrated in 
rats and mice.123  Feeding Inbred mice with 5% flaxseed flour supplement in a high-
fat diet at the promotional stage of tumorigenesis, (7,12-dimethylbenz[a]anthracene-
mediated) produced a 66% reduction in tumour size.82,98  The number and size of 
mammary tumours significantly decreased compared with the control values in 
Inbred mice fed for two weeks with SDG 1 at 73, 147 or 293 µmol/kg.99  Plasma 
insulin-like growth factor I (IGF-I) levels in rats, which are associated with 
increased breast cancer risk, are reduced by dietary supplementation of flaxseed  or 
SDG 1 in a rat breast cancer model.84  
Studies in Sprague-Dawley rats suggest that SDG 1 has an inhibitory effect 
on the early stages of tumor development in mammary tissue, whereas flax oil and 
ground flax primarily effect established mammary tumors at a late stage of tumor 
development.77,82,124,125  A study of colon cancer in Sprague-Dawley rats treated with 
full fat or defatted flaxseed, observed a 50% reduction in tumour number and an 
increase in urinary lignan excretion and cecal β-glucuronidase activity.88,125   
A mouse study on lung metastasis of melanoma cells compared the effects of 
defatted flaxseed diets (2.5, 5, 10%) vs. SDG 1 (73, 147, 293 µM SDG 1/kg diet) 
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and showed similar reductions in lung tumors.88  A diet supplemented with 5% 
flaxseed inhibits the growth and development of prostate cancer in a transgenic 
mouse model.126  Male New Zealand (NZ) rabbits fed a diet containing SDG 1 (15 
mg/kg body weight) for eight weeks, showed a slowed development of 
hypercholesterolemic atherosclerosis, 35% reduction in LDL, and 64% reduction in 
LDL/HDL.127  Furthermore, dietary flaxseed (7.5 g/kg daily, orally) containing 2-
3% α-linolenic acid reduced hypercholesterolemic arteriosclerosis in rabbits by 
46%, suggesting the reduction in arteriosclerosis was not due to ALA but may be 
due to the lignan component of the flaxseed.128  It was also reported that milled 
flaxseed low in ALA protects against the same cardiovascular risks as extracted 
flaxseed oil, but also reduces serum LDL cholesterol, suggesting that the lignans 
may be responsible for the additional health benefits of flaxseed.113,127,129     
 SDG 1 in drinking water (22 mg/kg body weight) has been shown to cause a 
71% decrease in the development of type 1 diabetes in diabetic prone rats119 and a 
75% reduction in type 2 diabetes in Zucker diabetic fatty (ZDF) female rats (40 
mg/kg body weight).130 
 
2.9.3.2. Human studies 
A study in postmenopausal women showed that the excretion of the 
mammalian lignans increased 3.0 to 285.0 times after flaxseed consumption (5.0-
25.0 g/day).50  Several epidemiological studies have indicated a correlation between 
a high level of urinary lignans and a low incidence of cancer, particularly hormone-  
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dependent cancers, such as breast and prostate cancer.44,63,66,90,131  Case-control 
studies of pre- and post-menopausal women with newly diagnosed early breast 
cancer showed that there is a 64% reduction in breast-cancer risk among women 
with high levels of urinary ENL 13.51,89,118   Postmenopausal breast cancer patients 
or omnivores at high risk for breast cancer have 50% lower urinary excretion of 
END 12 and ENL 1368,120 than those at low risk (vegetarians).81,120 
Most human studies use whole or milled flaxseed incorporated into baked 
products such as breads, muffins, cookies, or breakfast cereals.  For example, 
women with newly diagnosed breast tumors who ate a daily muffin containing 25 g 
of ground flax experienced significant reductions in breast cancer cell proliferation 
and tumor growth compared with women who ate whole-wheat muffins.  It has also 
been observed that postmenopausal women fed flaxseed experienced a reduction in 
hot flashes.132   
Several lignans and the isoflavonoids were found to compete with estradiol 
15 for binding to the rat uterine type II estrogen binding site (i.e., bioflavonoid 
receptor).133  Studies examining the effects of flaxseed consumption on urinary 
estrogen metabolite excretion in postmenopausal women found that ground flaxseed 
consumption (0, 5 or 10 g/day) increased urinary concentrations of 2-hydroxyestrone 
and the 2/16 α-hydroxyestrone ratio in postmenopausal women as compared with 
the control group.50  Unlike 2-hydroxyestrone, the 16-α-hydroxyestrone metabolite 
of estradiol 15 induces genotoxic DNA damage and aberrant hyperproliferation 
similar to that induced by chemical carcinogens.134  Flaxseed consumption (25 g 
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ground flaxseed) also increased urinary concentrations of 2-hydroxyestrone, and the 
2/16 -hydroxyestrone ratio to a greater extent than soy consumption (25 g soy flour) 
in postmenopausal women.135  
In a preliminary clinical study, 25 men with prostate cancer consumed 
ground flaxseed (30 g/d) for 4 weeks as part of a low-fat diet.136  Prostate cancer cell 
proliferation decreased and apoptotic death of cancer cells increased in patients 
using ground flaxseed as compared to the control group.  The mammalian lignans 
END 12 and ENL 13 may be partly responsible for this effect.136,137 
 
2.9.3.3. In vitro studies 
Cell culture studies using human MCF-7 estrogen-dependent breast cancer 
cells showed that low concentrations (0.1-10 µM) of ENL 13 induced DNA 
synthesis (as a marker of cell growth) by 150-235%.138  However, ENL 13 at high 
concentrations (20-90 µM) resulted in a 50% inhibition of DNA synthesis.138  It has 
been observed that END 12 and ENL 13 not only significantly stimulates sex 
hormone binding globulin (SHBG) production in Hep-G2 cells (human 
hepatocarcinoma cells) in culture, but also suppresses Hep-G2 proliferation.138,134   
 The inductive or inhibitory effects of the mammalian lignans may also be 
dependent on the presence of a stronger estrogen or antiestrogen.85,139  In the 
presence of estradiol 15, high concentrations of ENL 13 and END 12 are more 
antiestrogenic on estrogen receptor positive breast cancer cells, while at low 
concentration, they are more estrogenic.85,138  Estradiol 15 has proliferative effects 
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on estrogen dependent cancer cells and, some antiestrogens may inhibit this effect.85  
Estradiol 15 (1 nmol/L) and ENL 13 (0.5-2 µmol/L) separately stimulated the 
proliferation of MCF-7 cells, but their combination always resulted in lower or no 
stimulation.85  Concentrations of ENL 13 above 10 µmol/L significantly inhibited 
the growth of the cells suggesting a toxic effect.  Chen et al., (2003)140 determined 
that END 12, ENL 13, and tamoxifen (TAM) 16, alone or in combination, can 
inhibit metastasis in breast cancer cells.140,141    
An in vitro study also showed that END 12 and ENL 13 significantly 
inhibited the growth of three human prostate cancer cell lines.137 
 
2.9.3.4. Correlation between in vitro production and in vivo excretion of 
lignans  
A study was performed to determine whether SDG 1 can account for all the 
lignan production from flaxseed and if a relationship between in vitro production 
and in vivo urinary excretion existed.42  Rats were fed a high fat diet without/with 
2.5, 5 or 10 g/100 g ground flaxseed or 1.1, 2.2 or 4.4 µM SDG 1/day (equivalent to 
levels in the respective flaxseed diets) for 4 wk.42  This study showed that lignan 
production was dose-related since urinary lignan excretion increased linearly with 
doses from 0-5 g/100 g flaxseed and 0.0-2.2 µM SDG.  A similar trend was seen in 
vitro (using human faecal inoculums) for SDG 1, resulting in a high correlation 
between in vitro production and in vivo excretion of lignans.42  Theoretical urinary 
END 12 and ENL 13 from the SDG 1 present in flaxseed correlated with the actual 
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excretion in flaxseed-fed animals.  However, urinary END 12 and ENL 13 of SDG 
1-fed rats was only 20% of levels of flaxseed-fed rats, indicating the presence of 
other precursors or incomplete conversion of SDG 1 to END 12 and ENL 13.42   
 
2.10. Lignan- mechanism of effect 
In vitro studies and in vivo studies suggest that flaxseed lignans may have 
both non-hormonal (i.e. antioxidant) and hormonal (i.e. weak 
esterogenic/antiesterogenic) effects51,52,58,68-70,73,78,85,88-91,131,142-147 making them 
strong candidates for a role as natural cancer protective compounds.58,73,133,147,148  
Epidemiological investigations support this hypothesis, because the highest levels of 
these compounds are found in food in countries or regions with low cancer 
incidence.73,79,90,148 
 
2.10.1. Non-hormonal mechanisms 
2.10.1.1. Antioxidant activity 
Natural antioxidants can be classified as primary (chain-breaking) 
antioxidants, which can react directly with lipid radicals and convert them into stable 
products, or as secondary (preventive) antioxidants, which can lower the rate of 
oxidation by different mechanisms.149  Primary antioxidants most often act by 
donating a hydrogen atom, while secondary antioxidants may act by binding metal 
ions able to catalyse oxidative processes, by scavenging oxygen, by absorbing UV 
radiation, by inhibiting enzymes or by decomposing hydroperoxides.150  It is known 
  28
that different natural phenolic compounds function as both primary and secondary 
antioxidants by different mechanisms.  Monitoring of either the decrease of the 
radical or the antioxidant, or the formation of products can be used for assessing the 
antioxidant activity.149   
The antioxidant activities of SDG 1 was lower than END 12 and ENL 13 in 
both lipid and aqueous in vitro model systems.151  The antioxidant activity was 
monitored by hydroxyl and peroxyl radical scavenging activity of SDG 1, END 12  
and ENL 13 using a lipid emulsion system and inhibition of deoxyribose.151  In this 
study, the deoxyribose assay was used to evaluate the non site-specific and site-
specific Fenton reactant-induced •OH scavenging activity.151  The degree of  
oxidation of Fe2+ to Fe3+ (in Fenton reaction) by peroxyl radicals measured by 
ammonium thiocyanate assay.151      
The antioxidant activity of 15 different major lignans found in knotwood 
extracts including hydroxymatairesinol, secoisolariciresinol 2, nortrachelogenin, 
pinoresinol, and lariciresinol was studied.152  The radical scavenging capacity was 
measured by monitoring the scavenging of the free radical 2,2-diphenyl-1-
picrylhydrazyl (DPPH) and ABAP (2,2-azobis(2-methylpropionamidine) 
dihydrochloride.  Reaction products were identified by GC-MS, LC-MS and NMR 
spectroscopy.  Dimerisation of the two aromatic moieties was the major radical 
termination reaction.152  This study found the reactions with DPPH resulted in more 
unidentified polymeric material than the corresponding reactions with ABAP.  The 
formation of adducts was a predominant reaction in the experiments with ABAP.  
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Instead, polymerisation seems to be the dominating termination reaction with DPPH.  
Lignans with catechol (3,4-dihydroxyphenyl) moieties (e.g. dimethyl matairesinol) 
exhibited the highest radical scavenging capacity, while the corresponding guaiacyl 
(3-methoxy-4-hydroxyphenyl) lignans (e.g SECO 2) showed a slightly weaker 
scavenging capacity.152  In addition, the butanediol structure was found to enhance 
the activity, whereas a higher degree of oxidation at the benzylic positions decreased 
the activity.  Additionally, the readily available lignans (−)-secoisolariciresinol 8, a 
mixture of hydroxymatairesinol epimers and (−)-matairesinol 9 were studied in more 
detail, including kinetic measurements and identification of oxidation products in the 
reactions with DPPH and ABAP.  Table 2.4, shows the radical scavenging capacity 
(EC50) of lignans and reference compounds.  
Table 2.4. Radical scavenging capacity (EC50) of lignans and reference 
compounds, in order of radical scavenging capacity.  DPPH/AH = 
stoichiometric factor at EC50.152  
 
    Compound DPPH/AH 
Matairesinol 2.9 
Hydroxymatairesinol 2.6 
Secoisolariciresinol 4.5 
7-OH-Secoisolariciresinol 3.1 
Nortrachelogenin 2.3 
Pinoresinol 2.3 
Lariciresinol 2.3 
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Beneficial effects of SDG in cancer and lupus nephritis showed that these 
beneficial effects could be due to the ability of SDG to scavenge •OH radicals.153   
•OH was generated by photolysis of H2O2 (1.25 - 10.0 µmol/mL) with UV light and 
was trapped with salicylic acid which is hydroxylated to produce •OH-adduct 
products 2,3-dihydroxybenzoic acid (DHBA) and 2,5 DHBA.  SDG showed that it 
has the ability to scavenge •OH (using HPLC).  SDG (25-2000 µg/mL) showed a 
concentration-dependent decrease in the formation of 2,3-DHBA and 2,5-DHBA.  
The decrease in •OH-adduct products was due to the scavenging of •OH and not by 
scavenging of formed 2,3-DHBA and 2,5-DHBA.  This study suggested that SDG 
scavenges •OH and therefore has an antioxidant activity.153   
 The antioxidant activity of SECO 2, SDG 1, END 12 and ENL 13 have also 
been suggested to contribute in reduction of hypercholesterolemic, atherosclerosis 
and diabetes.119,154  The antioxidant activity of SECO 2, END 12, and ENL 13 was 
investigated by Prasad,154 using chemiluminescence (CL) of zymosan-activated 
polymorphonuclear leukocytes (PMNL).  This study demonstrated that SDG 1, 
SECO 2, END 12, ENL 13, and vitamin E, at a concentration of 2.5 mg/mL, 
produced a reduction of zymosan-activated PMNL by 23.8%, 91.2%, 94.2%, 81.6% 
and 18.7%, respectively.154  The antioxidant activity was highest with SECO 2 and 
END 12 and lowest with vitamin E.  The relative antioxidant potency of SECO 2, 
END 12, ENL 13, and SDG 1 was 4.9, 5.0, 4.3, and 1.3 respectively, as compared to 
vitamin E.154  This study suggested SECO 2, END 12 and ENL 13 are respectively 
3.82, 3.95, and 3.43 more potent than SDG 1.154  Activation of PMNL is known to 
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generate oxygen free radicals.  Oxygen free radical producing activity of PMNL was 
monitored by measuring luminol-dependent CL.  The reduction of PMNL, therefore, 
reflects the antioxidant activity of the compounds studied.154  Zymosan is a 
polysaccharide that is capable of stimulating inflammatory cytokine production and 
PMNL.  Zymosan may serve as a model for the study of innate immune 
responses.155   
Other plant derived lignan compounds such as sesamin and sesamolin (the 
major sesame seed lignans) and a series of related dibenzocyclooctene lignans from 
the fruit of Schisandra chinensis including schisandrin B have been demonstrated to 
exhibit antioxidant activity both in vitro and in vivo.  For example, sesame lignans 
enhance antioxidant activity of vitamin E in lipid peroxidation systems.156  Sesamol 
containing a free phenolic group inhibited lipid peroxidation in both the systems 
whereas sesamin and sesamolin having methylenedioxy groups were effective only 
in the microsomal system.156  Since detoxifying enzymes are localized in 
microsomes, the inhibitory effects of sesamin and sesamolin observed in the 
microsomal system may be attributed to their metabolites.  The inhibitory effects of 
lignans were lower than tocopherols and BHT.156 
 
2.10.1.2. Hormonal mechanisms  
Several mechanisms have been reported for hormonal actions of mammalian 
lignans which are described in this section. 
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 The estrogens (in women) and testosterone (in men) are steroid hormones 
made from cholesterol by the sex organs.  The mammalian lignans are believed to 
work by binding to estrogen receptors on cell membranes.68,147,157  The bound 
mammalian lignans affect the receptors’ actions within the cell.  They can act as 
either estrogen agonists or antagonists.  Estrogen antagonists oppose the actions of 
endogenous estrogens.  When blood levels of the endogenous estrogens are high (as 
in premenopausal women) the lignans can bind to the estrogen receptor and block 
the actions of endogenous estrogens.  In this case, they act as antagonists.  After 
menopause, the levels of endogenous estrogens in the blood decrease naturally 
because the ovaries release less natural estrogens.  In this case, the lignans act like 
weak estrogens.52,58,135   
 END 12 and ENL 13 may bind to estrogen receptors on SHBG, thus 
blocking the binding of estrogen and testosterone.68,133,158  As SHBG is found in 
breast cancer cells, the binding of mammalian lignans to SHBG may interfere with 
cancer processes that are controlled by estrogen.133  ENL 13 and END 12 may 
compete with hormones for binding to SHBG.133,159,160  ENL 13 was reported to be 
10 times weaker than estradiol 15 at stimulating SHBG and its in vivo concentration 
was found to be 100–10,000 times greater than estradiol 15.  Thus, ENL 13 might 
have a greater contribution to physiological regulation of SHBG than estradiol 15.120  
Increased binding of lignans to SHBG may help the transport of lignans to target 
tissues.78,159,161  Lignans may inhibit cell proliferation.85,90,144,147,162-164  Human 
estrogen synthetase (aromatase) is responsible for the conversion of androgen to 
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estrogen.146,52  ENL 13 is a moderate or weak inhibitor of aromatase and this lignan 
binds to or near the substrate binding region of the enzyme active site.  This may 
lower the amount of available estrogen and increase the risk of breast cancer.  The 
inhibition is competitive with respect to testosterone, the lignan affinity is 1/75-
1/300 that of these natural substrates.146   
 ENL 13 is rapidly conjugated to its monosulfate.61,62  It is suggested that one 
possible mechanism by which ENL 13 may affect the growth of estrogen sensitive 
cells is by competition of ENL 13 and its sulfate with the estrogens for sulfokinases 
and sulfatases involved in estrogen metabolism in the cells.85  ENL 13 at low 
concentrations (1-10 µM) has a stimulatory effect on DNA synthesis and estrogen 
dependent breast cancer cells (MCF-7), whereas at high concentrations (30-33 µM) 
has inhibitory effects on these cells.85  The stimulatory effects of mammalian lignans 
were found to be 103-106 times weaker than the endogenous estradiol 15, the most 
potent estrogen produced in women.83,139 
 Prostate cancer, like breast cancer, is hormone-sensitive, and in the early 
stages of development, tumour growth is influenced by the sex hormone testosterone 
and its active metabolite, 16 α-dihydrotestosterone.165  The chemical structures of 
flaxseed lignans are similar to estradiol 15 (regarding the distance between the two –
OH groups) and tamoxifen 16 (Figure 2.10), a breast cancer drug, suggesting that 
they may have weak estrogenic/antiestrogenic properties.52,144,145,162 
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Figure 2.10. Chemical structure of estradiol 15, tamoxifen 16 and SECO 2, 
adapted from Lumsden, et al., 1989.145 
  
Decreased plasma IGF-I and epithelial growth factor receptor concentrations may be 
related, in part, to lower breast cancer risk.84  IGF-I is a protein hormone similar in 
molecular structure to insulin.  Flaxseed may inhibit human breast cancer growth 
and metastasis by downregulation of IGF-I and epithelial growth factor receptor 
expression.102 
  
 
2.11. Free radicals-physiology 
 Free radicals are highly reactive substances formed in the body's cells as a 
result of metabolic processes.166,167  In 1954 Gerschman et al., first proposed the 
theory of free radical formation.168-170  A free radical is a molecule with one or more 
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unpaired electrons in its outer orbital.171  Many of these molecular species are 
oxygen (and sometimes nitrogen) centered.  Oxygen free radicals and its non-radical 
products are associated with reactive oxygen species.172,173   
Free radicals are highly reactive, unstable molecules that react rapidly with 
adjacent molecules via a variety of reactions including: hydrogen abstraction 
(capturing), electron donation and electron sharing.171  For example, the process of 
capturing an electron involves reacting with a donor molecule, which loses an 
electron and is said to have been oxidized.174  The oxidized donor molecule then has 
the capacity to oxidize other molecules and, thus, sets up a chain reaction (self-
propagation reactions).  Although free radicals play an essential role in the body, 
they also can react with DNA, protein or lipids in the cell membrane and cause 
damage.175 
 
2.11.1. Reactive oxygen species-sources 
Reactive oxygen species (ROS) are found intracellularly and extracellularly 
and may be produced endogenously or arise from exogenous sourses, i.e. taken in 
from the environment.176,177  Important sources of endogenous free radicals include 
prooxidative enzyme systems (e.g. lipoxygenase), drugs and their metabolites, 
pollutants, and other chemicals and toxins.178,179  While some of these are directly 
toxic, many others generate free radical fluxes via the very metabolic processes that 
the body uses to detoxify them.  External sources such as sunlight and other forms of 
radiation can generate endogenous ROS, which can lead to a number of 
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diseases.178,180  ROS can also be formed in food through lipid oxidation and 
photosensitizers exposed to light.181   
 
2.11.2. Reactive oxygen species-classification 
Reactive oxygen species are constantly being generated in the body, as a 
result of the normal metabolic processes.182  Mitochondria, which consume more 
than 90% of the oxygen in aerobic living organisms, are the main source of ROS and 
free radicals.  Approximately 1% to 5% of the oxygen consumed by mitochondria is 
reduced and converted to these reactive oxygen species.183,184  ROS can be classified 
into oxygen-centered radicals such as superoxide anion (O2• − ), hydroxyl radical 
(OH• ), alkoxyl radical (RO• ), peroxyl radical (ROO• ) and oxygen-centered non-
radical derivatives such as hydrogen peroxide (H2O2) and singlet oxygen (1O2).  
Other common reactive species are nitrogen species such as nitric oxide (NO• ), 
nitric dioxide (NO2• ), and peroxynitrite (OONO – ).185-189  
 ROS cause lipid oxidation, protein oxidation, DNA strand breaks, and 
modulation of gene expression.185,189-192  ROS are involved in  many diseases such 
as atherosclerosis, cancer, stroke, asthma, arthritis and other age related 
diseases.172,193-196  Some of the biological damage caused by ROS in the human body 
is outlined in Figure 2.11.   
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Figure 2.11. Biological damage caused by ROS in human body 
 (Lee et al., 2004).197 
 
Because antioxidant defense in the human body is not completely efficient, 
increased free radical formation may produce a continuous level of oxidative 
damage.170,172,178,184,186,187,190,191,193,196,198-201  Oxidative stress refers to a severe 
disturbance in the prooxidant-antioxidant balance in favor of the prooxidant, leading 
to potential damage.177  The basic mechanisms of free radical formation are 
reviewed in the following sections. 
2.11.3. Enzymatic formation of ROS 
Lipoxygenases (LOXs), are found in plants and animals.  LOXs are large 
monomeric protein with non-heme iron cofactor containing dioxygenases 
[cyclooxygenases (COX-1, COX-2)] catalyzing the oxidation of the polyunsaturated 
fatty acids (PUFA) forming hydroperoxides.176,177,179,202  Substrates for LOXs in 
plants are linoleic acid (18:2) and linolenic acid (18:3) and in animals is arachidonic 
acid (20:4).202  Because arachidonic acid either is not present in higher plants or is a 
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minor constituent of cellular lipids, plant LOXs are classified into 9- and 13-LOXs 
with respect to their positional specificity of linoleic acid.177,179  In mammals, LOXs 
are classified into 5-, 8-, 12- and 15-LOX with respect to their positional specificity 
of arachidonic acid.202  In mammals, lipoxygenase needs free forms of PUFA, which 
are not present in healthy tissue.  PUFA (e.g. arachidonic acid) can be released from 
glycerides by membrane bound phospholipase.203  Free PUFA are oxidized to form 
lipid hydroperoxides.176,177,179  Lipoxygenase with Fe2+ ion exists in the inactivated 
status.  Once Fe2+ is oxidized to Fe3+, lipoxygenase can convert PUFA into 
hydroperoxides.179  Lipoxygenase has been identified within atherosclerotic lesions, 
which suggests that this enzyme may be involved in the in vivo formation of lipid 
oxidation.204 
 
2.12. Reactive oxygen species-mechanism 
2.12.1. Superoxide anion (O2-•) 
Superoxide anion and hydrogen peroxide are the main reactive oxygen 
species causing the oxidation of cells and tissues.180,205  Superoxide anion itself is 
not a strong oxidant.  Superoxide anion reacts with protons in water solution to form 
hydrogen peroxide (equations 1-3), which can serve as a substrate for the generation 
of hydroxyl radicals and singlet oxygen.172,174,180,193 
 2 O2- + 2H+ → H2O2 + O2 k~0    (equation 1) 
HO2• + O2-• + H+ → H2O2 + O2  k~108 M-1 s-1   (equation 2) 
2HO2•  → H2O2 + O2  k~106 M-1 s-1   (equation 3) 
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The superoxide anion can react with nitric oxide (NO·) and form 
peroxynitrite (ONOO •  ).  The conjugate acid of peroxynitrite, peroxynitrous acid, 
can further decompose to generate hydroxyl radical and nitric dioxide (equation 
4).185,204 
ONO2 + H+ → ONO2H → •OH + NO2   (equation 4) 
Superoxide can reduce Fe3+ to Fe2+.  The last two reactions are known as Haber-
Weiss reaction (equations 5-6).  
Haber-Weiss O2-• + Fe3+ → O2 + Fe2+   (equation 5) 
H2O2 + O2-•    → O2 + OH- + •OH   (equation 6) 
 
2.12.2. Hydroxyl radical (•OH) 
Hydroxyl radical is a highly reactive free radical (diffusion rate-limited) that 
can react with most living organisms.197,206  Hydroxyl radicals react with lipids, 
polypeptides, proteins, and DNA.175,206  Hydroxyl radical is highly electrophilic and 
can abstract electrons from proteins and polyunsaturated fatty acids206-208 resulting in 
the formation of carbon centered free radicals (R•) (equation 7).  The carbon-
centered free radical can undergo further reactions, such as reaction with oxygen, to 
give peroxyl radical (ROO•) and alkoxy radical (RO•) (equation 8-10).207  
RH + •OH → R• + H2O     (equation 7) 
RO• + O2 → ROO•                (equation 8) 
ROOH + Fe3+ → ROO• + Fe2+ + H+        (equation 9) 
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ROOH + Fe2+ → RO• + -OH + Fe3+   (equation 10) 
 
Hydroxyl radicals can damage cell membranes and lipoproteins (the particles 
carrying cholesterol and triglycerides in the blood stream) by lipid peroxidation.  
Lipid peroxidation occurs by a radical chain reaction, i.e. once started, it spreads 
rapidly and affects a great number of lipid molecules.170,198,200,209  For example, 
linoleic acids are mainly located in glycerolipids and phopholipids of cell 
membranes; therefore, cell membranes are easily oxidized and lose their 
functionality.  Proteins may also be damaged by ROS, leading to structural changes 
and loss of enzyme activity.  Oxidative damage to DNA also can cause DNA 
mutation, single strand breaks and chromosomal shortening.189,195  
 
2.12.3. Hydrogen peroxide (H2O2) 
Hydrogen peroxide can be generated through a dismutation reaction from 
superoxide anion by superoxide dismutase.207  Monomeric oxidases located in the 
outer mitochondrial membrane such as amino acid oxidase and xanthine oxidase 
also produce H2O2 from superoxide anion.185,210  Hydrogen peroxide is highly 
diffusible and crosses the plasma membrane easily.  Once generated H2O2 is 
metabolized by catalase or glutathione peroxidase to generate water and 
oxygen.185,210  Although H2O2 is the least reactive molecule among reactive oxygen 
species it is very damaging because it can be converted to hydroxyl radical.175  In the 
presence of metals such as Fe2+ or Cu2+, H2O2 can generate hydroxyl radical through 
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Fenton type reactions185,210 in which Fe2+ is oxidized to Fe3+ and H2O2 is converted 
to •OH and OH-
 
(equation 11). 
Fenton   H2O2 + Fe2+ → -OH + •OH + Fe3+  (equation 11)    
  
2.12.4. Singlet oxygen 
Singlet oxygen is a nonradical oxygen species.  Singlet oxygen can be 
generated from H2O2 during interaction with hypochlorite (OCl-) in cells and tissues 
(equation 12).175,180  It can stimulate formation of nitric oxide (NO) and nitric 
dioxide (ONOO) (equation 13-15).  Singlet oxygen is a mild toxin for mammalian 
tissue in comparison with other reactive oxygen species.180  However, singlet 
oxygen has been known to be associated with oxidation of PUFA to initiate lipid 
peroxidation.179,207   
O2-• + O2-• + 2H+ → H2O2 + 1O2    (equation 12) 
    
-OCl + H2O2 → H2O +Cl- + 1O2    (equation 13) 
         
ONOO- + H2O2  → NO2 + H2O + 1O2    (equation 14) 
 
O2-• +H2O2  → -OH + •OH + 1O2     (equation 15) 
 
 
2.12.5. Peroxyl and alkoxyl radicals 
Peroxyl radicals (ROO•) are formed by a direct reaction of oxygen with alkyl 
radicals (R•), for example, the reaction between lipid radicals and oxygen.197,211  
Decomposition of alkyl peroxides (ROOH) also results in peroxyl (ROO•) and 
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alkoxyl (RO•) radicals.184,185,193,208,212  Peroxyl and alkoxyl radicals are good 
oxidizing agents which are involved in the propagation stage of lipid peroxidation.   
2.13. Reactive nitrogen species (RNS) 
2.13.1. Nitric oxide and nitric dioxide 
Nitric oxide (NO•) is formed in vivo from L-arginine by Nitric oxide 
synthase.181  Nitric oxide itself is not a very reactive free radical, but overproduction 
of NO can lead to protein oxidation in ischemia/reperfusion and neurodegenerative 
and chronic inflammatory diseases.201,208,213  Nitric dioxide (NO2•) is formed from 
the reaction of peroxyl radical and NO, polluted air and smoking.214 
 
2.13.2. Peroxynitrite 
Peroxynitrite can be generated by the reaction of NO• and superoxide anion 
(equation 16).  Peroxynitrite is a cytotoxic species and causes tissue injury and 
oxidizes LDL.194,215,216  Peroxynitrite (OONO–) can cause direct protein oxidation 
and DNA base oxidation.204 
O2-• + NO• → ONOO-      (equation 16) 
 
2.14. Protein oxidation  
 Proteins are highly susceptible to oxidative damage.  Modification of 
proteins is mainly initiated by hydroxyl radicals, leading to the oxidation of amino 
acid side chains (where sulfur-containing amino acids are found) and protein 
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fragmentation.217,218  Malonaldehyde from lipid oxidation can react with protein 
amino groups to form adducts.217,219  Peroxynitrite (ONOO–) can oxidize essential –
SH groups on proteins.219  Protein oxidation alters signal transduction mechanisms, 
transport systems, and enzyme activities, and can lead to atherosclerosis and 
ischemia reperfusion injury.220  Aging is associated at least partly with oxidative 
modification of proteins.217  
 
2.14.1. DNA strand breaks  
Mitochondrial DNA is susceptible to oxidative damage because of the lack of 
protective protein and close proximity to the reactive oxygen species-producing 
systems.183  Oxidative damage of DNA leads to mutagenesis and carcinogenesis.183  
DNA can undergo oxidative damage at both the nucleic bases (the individual 
molecules that make up the genetic code) and at the sugars that link the bases.221  
Oxidative damage of DNA results in degradation of the bases, breaking of the DNA 
strands by oxidation of the sugar linkages, or cross-linking of DNA to protein (a 
form of damage particularly difficult for the cell to repair).  Although all cells have 
some capability of repairing oxidative damage to proteins and DNA, excess damage 
can cause mutations or cell death.172,173 
 
2.14.2. Nucleic acid oxidation  
Nucleic acids are pentose-phosphate polymers that can undergo reactions 
with hydroxyl radical.221  The base modifications in DNA nucleic acids may be 
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responsible for genetic defects produced by oxidative stress.  Among the four DNA 
bases, guanine has the lowest oxidation potential and is most easily oxidized.221  
Recently, 8-hydroxy guanosine has generated considerable interest as a biomarker of 
oxidative stress that can be used to estimate DNA damage in humans.222  
Urinary level of modified bases is a useful means of assessing the amount of 
DNA damage in an animal.  Products such as 8-hydroxy guanosine, thymidine 
glycol, and uric acid are used for these estimates.221  Formation of 8-oxoguanine 
induces Guanine:Cytidine to Thymine:Adenine transversions at the DNA replication 
stage, an important process in carcinogenesis and tumor development.221-222  DNA 
damage has also been estimated by chain breaks and base modifications in cultured 
cells under oxidative stress.  An important metabolic effect of DNA damage is the 
rapid induction of polyadenosine diphosphate ribose synthesis (ADP-ribosylation) in 
nuclei, resulting in extensive depletion of cellular NADH.221  ADP-ribosylation has 
been associated with repair of damaged DNA. 
 
2.15. Lipid Peroxidation in humans  
Lipid peroxidation is a self-propagation reaction that leads to generation of 
lipid radicals and lipid peroxides.173  Cell membranes are phospholipid bilayers and 
proteins, which are the direct targets of lipid oxidation.172,173  As lipid oxidation of 
cell membranes increases, the polarity of lipid-phase and formation of protein 
oligomers increase but molecular mobility of lipids, number of SH groups, and 
resistance to thermodenaturation decrease.172,173   
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During lipid oxidation, malonaldehyde (product of oxidation) can react with 
the free amino group of proteins, phospholipids, and nucleic acids damaging their 
structures and functions.179,185,204,218  Increased levels of lipid oxidation products are 
associated with diabetes and atherosclerosis.173,216  Oxidation of  low-density LDL 
has been reported to be involved in the development of atherosclerosis and 
cardiovascular disease.170,172,216  Oxidized cholesterol or fatty acid moieties in 
plasma LDL can lead to the development of atherosclerosis.173 
 
2.15.1. Lipid Peroxidation in foods  
Lipid peroxidation can cause rancidity of food products such as fats and oils, 
which affects odor, taste and nutritional value of these products.223,224  The main 
purpose of using antioxidants in foods is to delay, retard, or prevent the autoxidation 
process and thus to extend the shelf life of foodstuffs and to minimize nutritional 
losses.223  
Lipid peroxidation (Figure 2.12) involves hydrogen abstraction to form a 
lipid radical (L•) (equation 17), which can react with oxygen to form a lipid peroxyl 
radical (equation 18).  The peroxyl radical propagates the chain reaction by 
abstracting hydrogen from another lipid (equation 19), usually the rate-limiting step 
in lipid peroxidation.224  Ideally, antioxidants work by blocking the propagation step 
(equation 3) through hydrogen atom donation.  Antioxidants can also interfere with 
the oxidation process by chelating catalytic metals and acting as free radical 
scavengers.166 
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  R• + LH → RH + L•           (equation 17) 
L• + O2 → LOO•           (equation 18) 
LOO• + LH  → LOOH + L•     (equation 19) 
 
Figure 2.12. Lipid peroxidation steps (adapted from Shahidi and Wanasundara).224 
 
2.15.2. Antioxidants in food systems-important factors for measuring 
antioxidant effectiveness  
The activities of antioxidants depend not only on their structural features 
(e.g. activities towards peroxyl and other active species), but also on many other 
factors, such as concentration, temperature, light, type of substrate, physical state of 
the system, as well as on microcomponents acting as pro-oxidants or synergists. 225  
Several important factors that may affect the results of antioxidant studies in lipid 
systems are the initial concentration of primary autoxidation products, such as 
hydroperoxides of the lipid and free fatty acids.  Primary oxidation products may 
reduce both the efficiency of the antioxidants and the time for radical-mediated 
consumption of antioxidant.149  Free fatty acids may demonstrate a pro-oxidant 
effect and should be minimized.  Other lipid microcomponents, such as metals, fatty 
alcohols and mono- and diacylglycerols, have been also shown to decrease the 
effectiveness of phenolic antioxidants.149   
Temperatures at which antioxidant activity may be required range from 180–
200°C for deep frying oils, to about 5°C for products such as margarine or 
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mayonnaise that are stored in the fridge.225  Besides the processing and storage 
temperatures to which these products are exposed, the accompanying constituents 
including water, proteins, carbohydrates, vitamins, minerals and other food 
components vary, and the physical structure of the food also varies.  This can cause 
big changes in the activity of the antioxidant in different food systems.149  
Antioxidants are normally less effective at elevated temperatures than at ambient 
temperature.  Therefore, it can be difficult to predict antioxidant effects at low 
temperatures from measurements at elevated temperatures. 
Antioxidants that are heat stable have the property referred to as ‘carry-
through’.225  Antioxidants are divided into two categories, preventive antioxidants 
and chain-breaking antioxidants.226  The preventive antioxidants (e.g. glutathione 
peroxidase and catalase) deactivate the active species (e.g. H2O2) without further 
generation of free radicals and, thereby, reduce the rate of chain initiation.226  Chain-
breaking antioxidants have the ability to scavenge chain-propagating oxygen 
radicals to produce stable, non-radical products and suppress lipid peroxidation.226  
Therefore, the antioxidant capacity, n, shows how many chains may be terminated 
by one molecule of antioxidant.226,227  BHT 17 traps peroxyl radicals to produce a 
stable phenoxyl radical or to form stable non-radical products.197,228  Niki et al. 
(1985)228 demonstrated that chain-breaking antioxidants, such as vitamin E, can 
scavenge the chain-propagating oxygen radicals generated from 2,2'-azobis(2,4-
dimethylvaleronitrile) (AMVN) and suppress the peroxidation of liposomal 
membranes in aqueous dispersions.226  Lee et al. (2004)197 reported that cysteine and 
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glutathione could also act as chain-breaking antioxidants by scavenging oxygen-
centered radicals and suppressing the oxidation of lipids.197   
 The antioxidant properties of naturally-occurring catechols have been studied 
extensively so that many stoichiometric ratios or antioxidant capacities for these 
catechols have been determined.  When inhibition of the oxidation of cumene in 
methyl linoleate is measured, several catechols demonstrate impressive antioxidant 
capacities such as quercetin (2.6), (-)-epigallocatechin (2.2), catechin (1.7) and 
methylgallate (2.3).227   
There are several important factors that must be considered when attempting 
to measure or assess the antioxidant effectiveness of a compound in foods. 
1) Food model system  
One of the major factors affecting the activity of antioxidants that scavenge free 
radicals in foods is their partitioning behavior in lipids and water.  It is commonly 
observed that a non-polar antioxidant such as (α-tocopherol) is relatively ineffective 
in oil but is strongly effective in an oil-in-water emulsion.  In contrast, a polar 
antioxidant such as ascorbic acid or trolox (a water-soluble derivative of α-
tocopherol) is more effective in an oil than in an emulsion.  This phenomenon has 
been described as the polar paradox.225 
Antioxidant are most effective when they are at or near the physical location of the 
oxidative reactions.149  The increased antioxidant ability of the polar antioxidant in 
the bulk oil phase is the result of a preference of the antioxidant for the oil surface, 
where the majority of autoxidation would be expected to occur.  An emulsion 
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consists of two immiscible liquids, with one liquid being dispersed as small diameter 
(0.1-100 mm) spherical droplets in the other liquid.  Food emulsions can exist as oil-
in-water emulsions (e.g. milk) where oil is dispersed in water or water-in-oil 
emulsions (e.g. mayonnaise) where water is dispersed in oil.149  An emulsion can be 
considered to consist of three regions: the interior of the droplets, the continuous 
phase, and the interfacial membrane.  The interfacial membrane consists of a narrow 
region surrounding each emulsion droplet that consists of a mixture of oil, water, 
and emulsifier molecules.149  Nonpolar molecules are mainly located in the oil phase 
and polar molecules are mainly located in the aqueous phase and at the interface.  
The precise molecular environment of a molecule may have a significant effect on 
its chemical reactivity.  The nature of the emulsion droplet interfacial membrane and 
the physical location of antioxidants in emulsions are critical to antioxidant 
effectiveness.  Therefore it is important that an appropriate system is chosen for the 
antioxidant of interest. 
2) Effective analytical techniques  
It is frequently useful to have antioxidant assays that are capable of 
measuring both primary (e.g., hydroperoxides, conjugated dienes) and secondary 
oxidation (carbonyls, volatile compounds) products.229  In some cases antioxidants 
(e.g., tocopherols) can increase primary lipid oxidation products by donating 
hydrogen to a peroxyl radical to form a lipid hydroperoxide while simultaneously 
decreasing formation of low molecular weight volatile secondary oxidation 
products.  Other compounds can decrease lipid hydroperoxides (e.g., oxidizing 
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agents such transition metals) while increasing the secondary lipid oxidation 
products that cause rancidity.229  For example, if only lipid hydroperoxides are 
measured to evaluate an antioxidant, an extract of biological material high in iron 
could appear to be antioxidative because lipid hydroperoxides are being decomposed 
into the volatile oxidation products that cause rancidity and would never 
accumulate.149  It is also possible that nucleophilic compounds can form complexes 
with aldehydes.  Thus, if measuring only a single aldehyde as an index of lipid 
oxidation, certain compounds could appear to be antioxidative because they could 
complex that aldehyde, thereby causing its decrease, while not affecting other 
volatile lipid oxidation components that can affect rancidity.149 
In vitro assays that measure free radical scavenging activity assays such as 
the ferric reducing/antioxidant power (FRAP), Trolox-equivalent antioxidant 
activity (TEAC) and oxygen radical absorbant capacity (ORAC) are performed in 
the absence of lipids.149,229  This means that the impact of antioxidant partitioning is 
not evaluated thus leading to lack of correlation between the results of in vitro 
assays and antioxidant performance in foods.  In order to accurately evaluate the 
potential of antioxidants in foods, models must be developed that have the chemical, 
physical and environmental (e.g. pH and ionic strength) conditions expected in food 
products.149,229  Since these factors are not consistent throughout all food systems, 
individual models must be developed.230  Some researchers have recommended 
using more than one assay for measuring antioxidants in foods so that results can be 
compared more easily and accurately.149,229  Assays for measuring antioxidant 
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activity in food systems may be divided into (a) assays based on primary oxidation 
products and (b) assays based on secondary oxidation products.  Use of a 
combination of these assays frequently provides more information regarding the 
potential of the compound as a food preservative. 
a) Assays based on primary oxidation products 
The peroxide value (PV) method (e.g. ammonium thiocyanate assay) can 
determine the oxidative stability of unsaturated oil.230,231  Peroxide value 
measurements however, are unable to detect any deterioration such as measuring off 
flavour in foods.149   
Assays to measure the ability of an antioxidant to inhibit lipid oxidation 
under accelerated conditions (e.g. rancimat method) have the advantage of being 
able to simulate a long induction period in a short time.232  These accelerated test 
systems mainly include lipids by increasing temperature.150,232  The Rancimat 
method measures the amount of volatile hydroperoxides as primary oxidation 
products.230  This method suffers from possible changes in the mechanism of 
oxidation and stability of the antioxidant at elevated temperature. 
During lipid oxidation, unconjugated fatty acids can be converted to 
conjugated fatty acids (conjugated dienes).  Therefore, methods have been 
developed to measure conjugated dienes.230  These methods artificially induce 
autoxidation of linoleic acid or LDL by either Cu(II) or an azo initiator (e.g. AAPH 
or AMVN).  The progress of autoxidation is monitored by measuring UV 
absorbance at 234 nm for the formation of conjugated diene peroxides from linoleic 
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acid oxidation.230   This method is suitable provided that decomposition of the 
primary conjugated diene products does not interfere. 
b) Assays based on secondary oxidation products 
A portion of the lipid hydroperoxides that form in the early stages of lipid 
oxidation are broken down to form the low molecular weight volatile compounds 
(secondary products) that impart rancidity.  Various low molecular weight 
aldehydes, alkenals, and nonvolatile precursors of these substances react with 2-
thiobarbituric acid, resulting in chromogens, termed thiobarbituric acid reactive 
substances (TBARS), that can be determined after acid extraction.  Another method 
for determining secondary oxidation products is to measure volatile oxidation 
products, typically by headspace analysis using a gas chromatography (GC) 
technique.229 Good correlations have been observed between TBARS and headspace 
volatiles (e.g., hexanal, pentanal) in determination of muscle tissue oxidation.225,229   
A number of assays exist which measure the ability of an antioxidant to 
scavenge free radicals.  Assays for radical scavenging ability that are commonly 
used include: measuring the reduction of stable radicals (DPPH radicals), measuring 
the ability to scavenge radicals generated using azo-initiators (AAPH, AMVN and 
ABTS), and scavenging of hydroxyl radical generated by the Fenton reaction based 
radical assay (FRBR assay) or one of several other methods.150,230,233  
Some general considerations that should be observed for all food products 
during antioxidant activity measurements are listed as follows: 
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1. Avoid high oxidation temperatures (>60°C) during storage studies.  High 
temperatures can cause rapid decomposition of hydroperoxides, decomposition or 
volatility of antioxidants, and a decrease of oxygen solubility. 
2. Ensure that the starting lipid does not contain high levels of oxidation products 
(e.g.  transition metals hexanal, free fatty acids, lipid hydroperoxides).225 
3. When possible, use analytical techniques to measure both primary and secondary 
oxidation products.149 
4. The fatty acid composition, degree of unsaturation and position of double bonds 
for the sample should be known.229  
5. The use of  pure compounds will allow a better evaluation and understanding of 
how the compound functions alone and in combination with other food 
components.229 
6. When antioxidant activity in emulsions is evaluated, it is important to utilize 
emulsion systems similar to those found in the food of interest. 
7. Use the same molar concentration of tested components (e.g., phenolics) as the 
reference compound (e.g BHT, BHA) which are in the range that would be used in 
the food product.225 
8. Use a food lipid with a consistent source (e.g. sampling from one batch) of natural 
endogenous antioxidants or pro-oxidants for all analyses to minimize variation.149   
9. pH can affect oxidative reactions by influencing pro-oxidant (e.g., iron solubility 
increases with decreasing pH) and antioxidant (the pH can alter the charge of 
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antioxidants, which can affect solubility and chelation capacity) activity.  The pH of 
oxidation models should therefore be similar to the food of interest. 229 
10. Standardize time and conditions to determine if the antioxidant is effective.  
Appropriate ways to express antioxidant effectiveness include: a difference in 
induction period, percent inhibition of compound formation at a set time, rate of 
compound formation or decomposition, IC50 (antioxidant concentration to achieve 
50% inhibition), or percent loss or retention of antioxidant.225 
 
2.15.3. Synthetic antioxidants in foods 
The antioxidant activity of phenolic compounds such as butylated hydroxy 
toluene (BHT) 17 and butylated hydroxy anisole (BHA), tertiary butylhydroquinone 
(TBHQ), and esters of gallic acid, e.g. propyl gallate (PG), have been well 
studied.224  Synthetic phenolic antioxidants are usually used at the level of 0.02 % of 
the fat or oil content of the food.225  The disadvantages of gallates is their heat 
sensitivity and their tendency to form dark precipitates with iron ions.  Some 
antioxidants, such as BHA and BHT, are used in combination with resulting 
synergistic effects.   
In general, phenolic antioxidants such as BHT 17 and BHA appear to trap 
peroxyl radicals via a two step process: 1) a peroxyl radical abstracts a hydrogen 
atom from the hydroxyl group, producing a stable phenoxyl radical; 2) the phenoxyl 
radical reacts with another peroxyl radical to form stable non-radical products 
(Figure 2.13).  
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Figure 2.13. Formation of stable non-radical products using antioxidant BHT 17
 (adapted from Shahidi and Wanasundara).224 
 
2.16. Enzymic detoxification of xenobiotics in the body  
 The enzymic detoxification of xenobiotics has been classified mainly into 
Phase I and Phase II detoxification.  Phases I and II involve the conversion of 
lipophilic, non-polar xenobiotics into more water-soluble molecules, which can then 
be eliminated more easily from the cell.  Phase I processes are catalysed mainly by 
the cytochrome P-450 (CYP450) system.234  This family of microsomal proteins is 
responsible for a range of reactions, of which oxidation appears to be the most 
important.235  The major CYP450 enzymes involved in metabolism of drugs or 
exogenous toxins are the CYP3A4, CYP1A1, CYP1A2, CYP2D6, CYP2C and 
CYP2E1 enzymes.236  
Phase II conjugation reactions generally follow Phase I metabolism, resulting 
in a xenobiotic that has been transformed into a water-soluble compound that can be 
excreted through urine or bile.236  Several types of conjugation reactions are present 
in the body, including glucuronidation, sulfation, and glutathione and amino acid 
conjugation.181,234  These reactions require cofactors, which must be provided 
through dietary sources.  Quantitatively, conjugation to glutathione (GSH), which is 
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catalysed by the Glutathione S-transferases (GSTs), is the major phase II reaction in 
many species.237  GSTs also can catalyse the reduction of hydroperoxides, resulting 
in the formation of oxidized glutathione (GSSG).237  Some of important 
detoxification enzymes in the body are explained in the following sections. 
 
2.16.1. Superoxide dismutase (SOD) 
SOD is present in cell cytoplasm (copper-zinc enzyme) and in mitochondria 
(manganese enzyme) in order to maintain a low concentration of superoxide 
anion.178,234  It catalyzes the dismutation of superoxide anion into oxygen and 
hydrogen peroxide according to the following reaction (equation 20): 
2O2-• + 2H+ → H2O2 + O2     (equation 20) 
2.16.2. Catalase 
Catalase is a heme protein that catalyses the detoxification of hydrogen 
peroxide (equation 21).172  Catalase provides a protective role that is similar to that 
of glutathione peroxidase because both are important means of removing hydrogen 
peroxide.205   
    Catalase 
2H2O2 → 2H2O + O2    (equation 21) 
 
2.16.3. Glutathione peroxidase (GPx) 
Glutathione peroxidase (GPx) is a cytoplasmic and mitochondrial 
enzyme that is important for detoxifying peroxides in the cell.234  The GPx 
enzymes catalyze the reduction of H2O2 to water and organic peroxides (R-O-O-
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H) to the corresponding stable alcohols (R-O-H) using glutathione (GSH) as a 
reducing source (equation 22).234 
ROOH + 2GSH →  ROH + GSSG + H2O   (equation 22) 
 
2.16.4. Glutathione (GSH) 
Glutathione (GSH, γ-glutamylcysteinylglycine), the primary non-protein 
sulfhydryl enzyme in aerobic organisms, is synthesized in most cells.210  The 
tripeptide is formed by the combination of glutamic acid and cysteine, catalyzed by 
γ-glutamylcysteinyl synthetase.  Glycine is then added by glutathione synthetase to 
form GSH.210  The sulfur atom in cysteine is able to partially ionize at neutral pH, 
i.e., the pH found in normal cells.  This produces a different reactivity than the 
chemistry associated with a sulfhydryl group.  Therefore in the case of glutathione 
there are two forms that differ only in the presence or absence of the proton on the 
cysteine moiety of the peptide (equation 23).210  The anionic form of glutathione is a 
strong nucleophile.  Since there is very little of the anion at pH=7, cells have 
developed a family of enzymes called glutathione S-transferases that make 
glutathione a more reactive nucleophile.181,234  
GSH  → GS- + H+     (equation 23) 
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2.16.5. Glutathione S-transferases (GSTs) 
GSTs are a large group of multifunctional proteins that catalyse the 
conjugation of GSH to various electrophilic substrates.210  GSTs appear to play an 
important role in protecting cells against oxidative damage by: 1) binding 
glutathione in such a way that the sulfur is induced to ionize more completely, and 
2) binding a second molecule close by so that a reaction can be facilitated.181,234  
This reaction is necessary to detoxify xenobiotic materials such as toxins, drugs, and 
other foreign compounds.210 
 
2.16.6. Glutathione reductase 
The flavoprotein, glutathione reductase, uses the reducing power for the 
pentose phosphate pathway (NADPH) to keep the glutathione pool in a cell in a very 
reduced state (equation 24).210  Cells contain at least 100 reduced glutathione 
molecules for every molecule of glutathione disulfide.182   
GSSG + NADPH → 2GSH + NADP+ + H+    (equation 24)  
The net result of this cycle is to use NADPH to reduce hydrogen peroxide to water, a 
process that requires two electrons.182  Other reductases can also catalyze reactions 
that reduce lipid peroxides, i.e., LOOH, instead of hydrogen peroxide (equation 25).  
LOOH + 2GSH → GSSG + LOH          (equation 25) 
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2.17. Non-enzymic detoxification of xenobiotics in the body  
2.17.1. Tocopherols 
Tocopherols (i.e.Vit E) are natural constituents of biological membranes.  
Antioxidant mechanisms of tocopherols include the transfer of a hydrogen atom 
from the 6–hydroxyl group on the chroman ring, and scavenging of singlet oxygen 
and other reactive species.215,228  Tocopherols are regenerated in the presence of 
ascorbic acids.215,228  Tocopherols can protect PUFA within the membrane and LDL, 
and inhibit smooth muscle cell proliferation.238,239  Tocopherol has been associated 
with the reduction of heart disease, delay of Alzheimer’s disease, and prevention of 
cancer.238  Tocopherols have beneficial effects in cardiovascular diseases both by 
inhibiting LDL oxidation and by down-regulating hydroxy-methylglutaric CoA 
reductase (HMG-CoA reductase), a key enzyme of the mevalonate pathway.238,239 
 
2.17.2. Ascorbic acid 
The antioxidant mechanisms of ascorbic acid are based on hydrogen 
atom donation to lipid radicals, quenching of singlet oxygen, and removal of 
molecular oxygen.240  Ascorbic acids help to regenerate tocopherols by donating a 
hydrogen atom to a tocopheroxyl radical.  Ascorbic acid and tocopherol 
supplementation can substantially reduce oxidative damage.240 
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2.18. Plant-derived antioxidants  
2.18.1. Flavonoids 
Flavonoids 18 (Figure 2.14) are polyphenolic compounds that are abundant 
in fruits, vegetables, red wine, tea and chocolate.195,241-243  They display a multitude 
of biological effects in vitro and in vivo after consumption of flavonoid-containing 
foods.  Epidemiologic studies show that increased consumption of flavonoids 
reduces the risk of cardiovascular disease and certain types of cancer.148,244,148,244  
Flavonoids may exhibit antioxidant, antimutagenic, and free-radical scavenging 
activities.245  Moderate consumption of red wine, which contains a high content of 
polyphenols, is associated with a low risk of coronary heart disease.246,247  
Consumption of soy and soy products are related to biological effects, including 
anticarcinogenic, antiatherosclerotic, and antihemolytic effects.245,247  The daily 
average consumption of flavonoids as 1 gram showed higher antioxidant activity 
than ascorbic acid and α-tocopherol.247 
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Figure 2.14. Structure of flavonoid 18 (adapted from Lee et al., 2004).197  
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Flavonoids 18 generally consist of two benzene rings (rings A and B) linked 
by an oxygen-containing heterocycle (ring C) (Figure 14).197  There are six classes 
of flavonoids including: flavanones, flavones, flavonols (catechins and 
proanthocyanidins), isoflavonoids, anthocyanins, and flavans, which vary in 
structure.  The antioxidant properties of flavonoids have been well studied and are 
structure-dependent with the major contributing factor being the catechol structure at 
ring B (two adjacent hydroxyl groups at 3′,4′-positions) (Figure 2.14).  Hydroxyl 
substituents on the flavonoid ring increase the antioxidant activity, while 
substitution by methoxy groups decrease this activity.248,249  Many of the techniques 
used to study flavonoid antioxidant properties are relevant to the study of lignan 
antioxidant properties.  Understanding the antioxidant properties of flavonoids may 
provide some insight into the antioxidant properties of lignans. 
 
2.18.3. Flavonol 
2.18.3.1. Quercetin 
The catechol 19 (Figure 2.15) containing flavonoid structures [quercetin 20, 
catechin 26 and (-)-Epicatechin 28] are well known to be H-donating antioxidants.  
In Figure 2.16, the structure of quercetin 20 and the mechanism of hydrogen 
donation during oxidation of quercetin are depicted.  Interestingly, the hydroxy 
groups on the chromane-like flavonoid of quercetin 20 do not appear to participate 
directly in oxidation.  Instead, it is the hydroxy groups of the catechol moiety, the B 
ring, that donate or accept hydrogens.250-252  In vitro incubation of quercetin in 
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normal human plasma and in vivo study of rats fed with a quercetin-enriched diet 
showed that quercetin is extensively bound to plasma proteins.253 
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Figure 2.15. Structure of catechol 19.197 
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Figure 2.16.  Oxidation of quercetin 20.197 
 
2.18.3.2. Catechins 
Flavanols 29 (Figure 2.17) exist in both the monomer form (catechins) and 
the polymer form (proanthocyanidins).197,248  Green tea and chocolate are by far the 
richest sources of catechin 26 contaning food.197,248   Catechins are also present in 
red wine.197,248  In contrast to other classes of flavonoids, flavanols are not 
glycosylated in foods.197,248 
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Figure 2.17. Structure of flavonol 29 (adapted from Lee et al., 2004).197 
Catechins have antioxidant and inhibitory activity against tumors.242,244,254  
The green tea catechins make up approximately 30% of the dry weight of green tea 
leaves.  Black tea contains fewer monomer flavanols, which are oxidized during 
fermentation of tea leaves to the major pigments that are more complex condensed 
polyphenols known as theaflavins (dimers) and thearubigins (polymers).242,244,254 
Epidemiologic studies suggest that both green tea and black tea consumption 
may reduce the risk of cardiovascular diseases.242  In vitro studies showed that the 
antioxidant activity of catechins at 40 µM were comparable to the commercial 
antioxidants BHT 17 and vitamin E at 10 µM.255  They also are capable of 
preventing DNA oxidation particularly in the presence of transition metal ions.256  
Methylation of tea catechins also may protect human fibroblasts from oxidative-
stress-induced cell death.257  Catechins have the ability to induce apoptosis cancer 
cells.258  Catechins have been shown to inhibit COX enzymes in vitro, which a 
modulation of the inflammatory process.258  
There are four major catechins in tea: (-)-Epigallocatechin (EGC) 27, (-)-
Epicatechin (EC) 28, (-)-Epigallocatechin-3-gallate (EGCG) 29, and (-)-Epicatechin-
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3-gallate (ECG) 30.242,259  Of the catechins, EGCG is the most abundant one in green 
tea leaves (Figure 2.18).   
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Figure 2.18. Chemical structure of tea polyphenols.197  
  
O-methylation may be one of the major metabolic pathways for catechin 
metabolism in mammals.244,259  Figure 2.19 illustrates formation of tea catechin 
metabolites.  Most of these compounds exist in the glucuronide and sulfate 
conjugated forms.244,259  
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Figure 2.19. Structures of (-)-Epicatechin 28 metabolites: 31 3′-O-methyl (-) 
 Epicatechin; 32 4′-O-methyl-(-)-Epicatechin; 33 (-)-Epicatechin-5- 
 O-glucuronide; 34 3′-O-methyl-(-)-Epicatechin-5-O-glucuronide;  
 35 (-) Epicatechin- O-quinone.197  
 
Dimer formation occurs following oxidation of epicatechin 28 (Figure 2.20).  
A remarkable feature of dimers of this kind is that they contain the same number of 
active OH groups on a monomer unit basis as the original compound.227   
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Figure 2.20. Formation of dimers from Epicatechin 28.227 
 
The infuence of methylation of the catechol 19 group on the antioxidant 
activity of epicatechin, in the form of 3′-O-methyl epicatechin 31, was determined 
using the TEAC assay.227  Such assays are designed for antioxidant capacity of 
antioxidants through their hydrogen-donating abilities.  The TEAC values of 
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epicatechin and 3′-O-methyl epicatechin (relative to Trolox) were 4.8 and 1.8, 
respectively, indicating that the H-donating ability is greatly reduced on methylation 
of the B-ring.227,197 
The partitioning of polyphenols and their metabolites between aqueous and 
lipid phases is largely in favor of the aqueous phase because of their hydrophilicity.   
Partitioning of polyphenols for binding to albumin was 99% (up to 15 µmol/L), 
whereas binding to VLDL was not significant (<0.5%).253  3′-O-methyl epicatechin 
31 would be expected to enter cells more freely than epicatechin 28 itself due to its 
higher lipophilicity.227  It was suggested that health benefits of flavonoids such as 
epicatechin 28 is not only due to the native compound but also by the ability of their 
metabolites to interact with cell-signalling cascades, to infuence the cell at a 
transcriptional level and to down-regulate pathways leading to cell death.257,259 
 
2.18.3.3. Proanthocyanins 
Proanthocyanidins, which are also known as condensed tannins, are dimers, 
oligomers, and polymers of of catechins.148  They are made up of EC 28 or EGCG 
29 that are known as procyanidins 36 or prodelphinidins, respectively.148,197  Figure 
2.21 illustrates the trimeric form of anthocyanidins.   
In France, coronary heart disease mortality is low despite a high intake of 
saturated fats and relatively high plasma cholesterol levels; this is called the “French 
paradox.”148,197  High consumption of wine was found to be related with the French 
paradox.197,260  Tannins and proanthocyanins are the major polyphenols found in 
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wine.260  Other phenolic compounds in wine are p–coumaric, cinnamic, caffeic, 
gentisitc, ferulic, and vanillic acids.197 
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Figure 2.21. Chemical structure of procyanidins 36.148,197 
 
2.18.4. Mechanism of action  
In general, mechanisms of flavonoid antioxidant action can include (1) 
suppressing reactive oxygen and nitrogen species formation either by inhibition of 
enzymes or chelating trace elements involved in free radical production; (2) 
scavenging reactive oxygen and nitrogen species; and (3) upregulating or protecting 
antioxidant defences.148,226,248  For example, catechins inhibit the enzymes 
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responsible for superoxide anion production, such as xanthine oxidase and protein 
kinase C.148,226,248   
It is believed that antioxidant mechanisms of green tea catechin compounds 
are based on hydrogen donating abilities and chelating metal ions, which may 
initiate lipid oxidation.226  After donating a hydrogen atom, these phenolic 
compounds become resonance-stabilized radicals, which do not easily participate in 
other radical reactions.  Antioxidant activities of flavonoids are influenced by 
hydroxylation and the presence of sugar moieties.247  Flavonoids are effective 
hydroxyl radical and peroxyl radical scavengers.   
As free radical scavengers, flavonoids inhibit lipid peroxidation, promote 
vascular relaxation and help prevent atherosclerosis.197  Both animals and humans 
have shown that increasing polyphenol intake can protect LDL cholesterol from 
becoming oxidized (a key step in developing atherosclerosis), lower blood pressure 
in hypertensive subjects, reduce the tendency of the blood to clot and elevate total 
antioxidant capacity of the blood.197 
One of the antioxidant properties of green tea catechins is their ability to 
inhibit oxidation of linoleic acid (an ω-6 fatty acid) from sources such as margarine, 
safflower oil and corn oil.197  Excess linoleic acid, most likely in the peroxidized 
form, can activate various pro-inflammatory enzymes, which are involved in 
promoting inflammation and tumor growth.197  When polyunsaturated cooking oils 
are heated, carcinogenic peroxides can result.  It was discovered that catechins act 
synergistically with α-tocopherol (Vitamin E) to protect against oxidative damage by 
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oxidized linoleic acid before this fatty acid is incorporated into cell 
membranes.148,197 
Catechins have the ability to inhibit peroxynitrite free radicals.248  
Peroxynitrite destroys proteins, as well as endogenous antioxidants such as 
glutathione and Vitamin E.  Green tea catechins are more effective than Trolox in 
protecting critical amino acids such as tyrosine and the amino acids of 
apolipoprotein B in LDL cholesterol against nitration damage by the peroxynitrite 
radical.227,261  Epicatechin in green tea appears to be metabolized to an anthocyanin-
like compound that is also an antioxidant, offering particularly long-lasting 
protection. 
A comparison of the antioxidant properties of simple catechins in green tea 
versus the complex polymeric polyphenols in black tea found that in lipids the 
simple catechins were more effective, while in aqueous conditions the polymers had 
more activity, but glycosylation decreased the antioxidant properties.241  
Tea catechins play an important role in the inhibition of DNA damage.254  
Tea catechins enhanced the urinary excretion of hydroxylated metabolites via 
glucuronidation, therefore, it may lower the formation of DNA adducts.262  UDP-
glucuronosyltransferases (UGTs) are increased by green and black tea intake, a 
detoxification pathway for carcinogen heterocyclic arylamines formed during the 
cooking of meat, poultry and fish.262 
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2.18.5. Isoflavones 
2.18.5.1 Genistein 
 Soybeans contain significantly levels of isoflavone 37 (Figure 2.22) levels 
including genistein 38 and daidzein 39 (Figure 2.23), and their glycosides.197  
Antioxidant activities of isoflavones 37, especially genistein 38, were reported in 
vivo and in vitro, in simple lipid system such as liposomes, and in more complex 
system such as lipoproteins.197,247  Addition of purified forms of isoflavones 
inhibited copper-dependent LDL oxidation.  Oral intake of the isoflavone genistein 
is associated with decreased LDL and plasma lipid oxidation.148 
In an oxidation model induced by UVB irradiation, Genistein 38 
substantially inhibited a series of oxidative events, including H2O2 production, lipid 
peroxidation, and 8-hydroxy-2-deoxyguanosine formation, an important process in 
carcinogenesis and tumor development.63,263,264  Genistein was also studied in a LDL 
oxidation model initiated by copper and peroxy radicals and was found to inhibit 
LDL oxidation.197,263,265-267 
In vitro oxidation of genistein with AMVN-derived peroxyl radicals yielded 
a hydroxylated derivative of genistein 38 and stable adducts of 4′-oxogenistein with 
AMVN.265  This adduct formation occurred on the B-ring of the molecule.  In Figure 
2.24, genistein 38 oxidation products are illustrated.   
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Figure 2.22. Structure of isoflavone 37 (adapted from Lee et al., 2004).197 
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           Figure 2.23. Structure of genistein 38 and daidzein 39 (adapted from Arora 
et al., 2000).265 
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Figure 2.24. Structure of genistein 38 and its oxidation products including: 
hydroxylated metabolite 40 and 4′-oxogenistein 41 and 4 with 
AMVN adduct (adapted from Arora, et al., 2000).265
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2.18.6. Isoflavones-Mechanism of action 
The observed health protective actions of soybean isoflavones are mediated 
by a wide range of mechanisms of which antioxidant activity is probably the most 
important.265  Although genistein and daidzein have the same B-ring structure 
(Figure 2.23), because genistein 38 has one more hydroxyl group than daidzein 39 
on the AC-ring, genistein 38 might have higher free radical scavenging capacity than 
daidzein 39.248   
The cholesterol oxidation model results indicated that isoflavone aglycones 
might have higher antioxidant activities than their glycosides.226  This would not be 
important in vivo since most of the glycosides would be cleaved to form aglycones 
by intestinal microorganisms during their absorption in the GI system but could have 
significance in cholesterol containing foods.248   
Isoflavones chemopreventive action may arise from their promotion of 
endogenous antioxidant enzymes, such as catalase, superoxide dismutase, 
glutathione peroxidase and glutathione reductase.197  Isoflavones could act at either 
the transcription level or the protein level to influence the activities of endogenous 
antioxidant enzymes, but the specific mechanism has not been identified.197   
 
2.18.7. Anthocyanidin 
Anthocyanidins 43 (Figure 2.25) are major pigments of flowers and fruits 
that exist in glycoside forms (anthocyanins) in plants.242  They impart a pink, red, 
blue, or purple color in plants.242  They are highly unstable and degradation is 
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prevented by glycosylation, generally with a glucose at position 3, and esterification 
with various organic acids (citric and malic acids) and phenolic acids.242  Cyanidin 
such as cyanidin 3-galactoside in the skin of fruits is the most common 
anthocyanidin in foods.  Oral administration of red wine polyphenol decreased blood 
pressure in rats.242  Moderate red wine consumption may protect against 
cardiovascular and coronary artery disease.242,268   
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Figure 2.25. Structure of anthocyanidin 43 (adapted from Lee et al., 2004).197 
 
2.18.8. Flavanones 
In human foods, flavanones 44 (Figure 2.26) are found in tomatoes and 
certain aromatic plants such as mint, but they are high in citrus fruit.242  Flavanones 
are generally glycosylated by a disaccharide at position 7.  The aglycones forms are 
naringenin in grapefruit, hesperetin in oranges, and eriodictyol in lemons.  
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Figure 2.26. Structure of flavanone 44 (adapted from Lee et al., 2004).197 
2.18.9. Flavone 
Flavones 45 (Figure 2.27) are much less common than flavonols in fruit and 
vegetables.  The only important edible sources of flavones identified to date are 
parsley and celery apigenin.248  The skin of citrus fruit contains polymethoxylated 
flavones, which can be found in tangeretin and essential oil of mandarin.  These 
polymethoxylated flavones are the most hydrophobic flavonoids.248 
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Figure 2.27. Structure of flavone 45 (adapted from Lee et al., 2004).197 
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2.18.10. Flavan 
The oligomeric proanthocyanidins are flavan 46 (Figure 2.28), usually in the 
form of flavan-3-ol oligomers, which give anthocyanidins by cleavage of a C–C 
bond under strongly acidic conditions.242  The oligomeric proanthocyanidins usually 
are generated from a flavan-4-ol or a flavan-3,4.   
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Figure 2.28. Structure of flavan 46 (adapted from Lee et al., 2004).197 
 
2.19. Potential applications of natural antioxidants in foods 
The potential applications for natural antioxidants in foods is growing as 
consumers become more aware of their potential health benefits.269  Thus, the 
market for natural antioxidants has been pushed food makers to source natural 
preservatives (e.g. rosemary).  Little information is available about natural 
antioxidant as food preservatives and some important factors regarding this are listed 
as follows: 
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1) Many natural antioxidants can support structure/function claims but few, if 
any, can support health claims.270 
2) The Generally Recognized as Safe (GRAS) regulatory level of approved 
antioxidants is not high enough to protect product life through manufacturing and 
distribution.271 
3) Natural antioxidants are more expensive (10 or 20 times) than synthesized 
antioxidants on a mass scale.269 
4) They need an FDA approved standard.271 
It’s taken decades for vitamins C and E to ingrain themselves into the 
consumer interests.270  Vitamin E and vitamin C are widely used in oil and oil-based 
foods.  Unlike some of the synthetics, vitamin E can withstand high-heat 
processes.271  Recently, rosemary is also labelled, mainly in meat and meat-based 
foods as natural antioxidant.  Food industries intend to provide natural powerful 
grades for new food applications in order to replace the synthetic antioxidants 
available in the market.270  Danisco was the first company that declare the content of 
rosemary (500-1000 PPM) in their meat products description.271 
Based on Codex regulation for food antioxidant, BHA, BHT and propyl 
gallate can be added to raw meat (e.g. beef patties) or cooked meat (e.g. cooked 
meatballs) at 0.01% of the fat content.  They can also be used at 0.02% in 
combination.272  This allows levels of BHA and BHT only up to 200 ppm based on 
the food’s fat content.271,272  A rosemary extract at 1000 ppm, is able to exceed the 
stability that you would get in a poultry fat at 200 PPM of BHA or BHT.271,272  For 
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example, rosemary extract is added at 500 to 1000 ppm in precooked and frozen 
chicken patties.270  The advantage of rosemary extracts is that it is more thermally 
stable than most synthetics.269,273  In addition to the antioxidative functionality, 
rosemary extract also has some antimicrobial activity (to kill gram-positive 
pathogens like Listeria monocytogenes).271   
The natural antioxidant markets will be increased as consumers become 
more educated about the importance of antioxidants in maintaining and enhancing 
the quality of life.  However, more research that can point specifically to the safety 
and efficacy of each antioxidant will be needed to make this happen. 
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2.20. Hypothesis and Objectives 
1) The antioxidant stoichiometry of the flaxseed lignans SDG 1 and SECO 2 
can be determined in an in vitro lipid peroxidation system. 
2) The flaxseed lignans SDG 1, SECO 2 and SDG Polymer 3 can prevent 
autoxidation in a bulk oil model.  
3) The AAPH 47-mediated antioxidant reactions of the flaxseed lignans SDG 1 
and SECO 2 can be determined in vitro. 
Flaxseed lignans are known to have a number of health benefits, including 
decreased tumor growth, reduction of serum cholesterol levels and decreased 
formation of breast, prostate and colon cancers.  It is believed that these health 
benefits of SECO 2 and SDG 1 may be attributed to their antioxidant properties, 
estrogenic properties, some other mechanism or some combination of all of these. 
There is a growing interest in finding alternative antioxidant food 
preservatives.  These include natural products that have the potential to provide 
health benefits such as the reduction of tumor growth and the lowering of serum 
cholesterol levels.6,124,127,151,274  Antioxidant food preservatives such as BHT 17 are 
commonly used to minimize autoxidation of oil-based food products.223,275  Some 
concerns regarding potential liver toxicity from chronic use of these compounds 
have been expressed.276  Flaxseed lignans have potential advantages over BHT 17 in 
that they are natural antioxidants with no known toxicity and thus may also have 
potential health benefits associated with their consumption.129,153,277  Little is known 
about SDG 1 and SECO 2 antioxidant mechanism in vitro.   
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The principal objectives of this study were: 
1) Determine the antioxidant stoichiometric ratio for SECO 2 and SDG 
1 in liposomes; 
2) Determine the ability of SECO 2 and SDG 1 to act as a preservative 
in food; 
3) Determine the products of SECO 2 and SDG 1 antioxidant reactions, 
using a peroxyl radical system to model lipid peroxidation in vitro.   
 
Specific aim for objective (1) was: 
- Determine the antioxidant stoichiometric ratio for SECO 2 and SDG 1 in a 
liposomal suspension using BHT 17 as a standard. 
specific aim for objective (2) was:  
- Determine the ability of SECO 2 and SDG 1 to prevent lipid peroxidation 
in vegetable oils using BHT 17 as a standard.  
Specific aims for Objectives (3) were:  
- Oxidize flaxseed lignans using an in vitro model of lipid peroxidation, 2,2′ 
Azobis-(2-Amidopropane) (AAPH 47); 
- Isolate & purify SECO 2 and SDG 1 oxidation products (using analytical 
HPLC, semi-prep HPLC, and prep-HPLC); 
- Determine structure of oxidation products (using ES-MS and NMR)  
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3.0. MATERIALS & METHODS  
3.1. Materials and solvents 
SECO 2, SDG 1 and SDG polymer 3 were a kind gift from Agriculture & 
Agri-Food Canada, Saskatoon Research Centre.  SECO 2 and SDG 1 were ≥ 99% 
pure by high performance liquid chromatography (HPLC) and are present as the 
(R,R) (+)-enantiomer as determined by optical rotation using a Jasco P-1010 
polarimeter (Glass cell, length:100mm) (Jasco Corp. Tokyo, Japan).  The optical 
rotation was determined to be:  SECO 2 [α]22D = + 35 (c 0.20, CH3OH) and SDG 1 
[α]22D = + 0.02 (c 0.20, CH3OH).  2,2'-azobis(2-amidinopropane) dihydrochloride 
(AAPH) was obtained from Polyscience Inc. (Warrington, PA).  Hydrogen peroxide 
(H2O2, 1%), ammonium thiocyanate and ferrous chloride were obtained from Sigma 
Chem. Co. (St. Louis, MO).  Canola oil (Canola Harvest®) manufactured by Canbra 
Foods Ltd. (Lethbridge, AB), was purchased from a commercial source (Casco) in 
Saskatoon.  The oil was %100 pure and free of added antioxidants or preservatives.  
BHT 17 was purched from Sigma (St Louis, MO, USA) and 1,2-Dilinoleoyl-sn-
Glycero-3-phosphocholine (DLPC) was from Avanti polar-lipids Inc. (Alabaster, 
AL).  All reagents were HPLC grade.  Water was purified using a Millipore super Q 
water system with one carbon cartridge followed by two ion exchange cartridges 
(Millipore, USA). 
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3.2. Experimental 1: Stoichiometry ratio of SECO 2 and SDG 1  
3.2.1. Stoichiometry (n-value) measurement 
Antioxidant stoichiometry was measured using a modification of the method 
of Liebler and Burr (1995).278  A liposomal oxidation mixture was prepared using 
BHT 17, AAPH 47 and DLPC.  The stoichiometric ratio of SECO 2 and SDG 1 was 
measured by comparison of the lag time for conjugated diene formation (at 240 nm), 
using UV/VIS spectrophotometer (Agilent 8453, Canada with Agilent Chem Station 
software) in the presence of SECO 2 and SDG 1, versus the lag time for conjugated 
diene formation in the presence of a standard antioxidant (BHT 17).  The 
stoichiometric ratio (n) of radical trapping was calculated using a kinetic equation 
(equation 26) described by Liebler and Burr (1995)278 where Ri (mM min-1) is the 
rate of chain initiation, [ArOH] is the concentration of the antioxidant, and τ is the 
length of induction time (min). 
n = Ri τ/[ArOH]   (equation 26) 
 
The azo compound AAPH 47 was used to generate peroxyl radicals at a 
constant rate for each antioxidant.  The oxidizable substrate used was DLPC (in 
chloroform) liposomes.  Substrate oxidation was monitored by measuring the 
formation of conjugated diene at 240 nm, using a spectrophotometer.  BHT 17 was 
used as the antioxidant standard to determine Ri values for autoxidation initiated at 
50°C by AAPH 47 peroxyl radicals in Tris-HCl buffer solution containing DLPC 
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liposomes.  The Ri values then were used to estimate stoichiometric ratio (n) for 
each antioxidant.   
Liposomes were prepared following a modification of Azuma et al (1999).275  
Briefly, BHT 17 (in hexane) at two different concentrations (0.53 mM and 0.80 
mM) was added to a screw-capped wide mouth 5mL vial, and the hexane evaporated 
under nitrogen while rotating the vial.  In the same vial, 5 mg DLPC (in chloroform, 
from one batch) was added and the chloroform evaporated under nitrogen (by 
rotating the vial) to obtain a thin layer of DLPC film.  Tris-HCl buffer (0.6 mL), pH 
7.0 was added and the mixture was vortexed for 1 min, resulting in a multilamellar 
dispersion.  The suspension was then transferred to a new screw-capped 1.5 mL 
HPLC vial with a septum on top and diluted with 800 µL of pre-warmed (50°C) 
Tris-HCl buffer, pH 7.0.  The lipid peroxidation reaction was initiated by adding 200 
µL of AAPH 47 (0.2 mM in water) solution to a final volume of 1.5 mL to minimize 
head space oxidation.  The vial was sampled through the septum via syringe to 
minimize the introduction of air to the system.  Oxidations were carried out at 50°C 
in the dark; a control reaction was performed in the absence of BHT 17.   
Conjugated diene formation was measured by removing 30 µL aliquots, 
which were dissolved in 970 µL methanol to a final volume of 1.0 mL.  These 
aliquots were removed at 2 min intervals for 20 min and 5 min intervals until 30 
min.  Absorbance was measured at 240 nm using methanol as a blank.  SECO 2 and 
SDG 1 were analyzed at two different concentrations (0.53 and 0.80 mM).  Due to 
incomplete dissolution of SECO 2 and SDG 1 in hexane, the procedure was 
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modified slightly.  In a vial, 5 mg DLPC in chloroform was added and the 
chloroform evaporated under nitrogen.  To this vial was added a solution of SDG 1 
or SECO 2 dissolved in Tris-HCl buffer (0.6 mL).  Other oxidation reaction 
parameters were the same to those for BHT 17.  For each analysis, three individual 
samples were prepared in duplicate and analyzed using EXCEL program.  Errors 
were expressed as standard deviation of the mean. 
 
3.2.2. Analytical HPLC 
The BHT 17:AAPH 47 oxidation product formation was measured using an 
Alliance HPLC (Waters Inc., Milford, MA) on a symmetry C18 reverse phase 
column (3x150 mm, 5mm, Waters Inc.).  Mobile phase consisted of 0.05% TFA in 
H2O (solvent A) and 0.05% TFA in ACN (solvent B).  A gradient elution was 
performed (Table 3.1) with a flow rate was 0.4 mL/min.  Peaks were detected using 
a 996 UV-Vis PDA detector (Waters Inc.) with full spectral scans (200-400 nm). 
 
Table 3.1. HPLC gradient for stoichiometry ratio. 
 
 
 
 
 
 
Time (min) %H2O %ACN 
1-2 98 2 
3-5 60 40 
6-10 98 2 
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3.3. Experimental 2: Rancidity test 
3.3.1. Induction time (h) measurement 
Rancidity test was measured using a modification of the method of Martinez-
Tome et al., 2001.279  A pilot study compared SECO 2 to BHT 17 by weight (mg) 
per 100 g oil (10 mg/100 g oil = 100 mg/kg).  For follow-up study, SECO 2, SDG 1 
and BHT 17 were treated with three different concentrations (0.04, 0.06 and 0.08 
mM) of antioxidant or control (absence of antioxidant); SDG polymer 3 was treated 
by weight (10, 20, 30 mg/100 g oil).  Samples were stored at room temperature 
(23°C) in sealed glass containers in the dark to prevent oxidation and were analyzed 
at 30 day intervals over 120 days using a Rancimat Analyzer (model 743, Metrohm 
Ltd. Herisau Switzerland).  Data are the mean of at least two replications, using 
EXCEL program for statistical analysis.  The Rancimat method,280,281 has been 
developed as an automated version of the active oxygen method (AOM)282 for the 
determination of the induction time of fats and oils.  In this method the oil is heated 
and highly volatile organic acids (mainly formic acid) are produced by autoxidation 
of the oil.280  These are transferred by the stream of air into a measuring vessel 
containing deionised water, whose conductivity is continually being measured.  The 
time required for a change in conductivity (Delta Kappa uS/cm) is called the 
induction time (IT).280  Plotting conductivity against time produces oxidation curves, 
whose point of inflection is known as the induction time (h), which is automatically 
recorded by the Rancimat.280  The inflection point is the point at which all of the 
antioxidant is consumed and unimpeded lipid peroxidation occurs.  IT provides an 
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estimate of the oxidative stability of the oil being measured.  For each analysis, 3 g 
of each sample in duplicate were removed, added to measuring vessel and subjected 
to oxidation (110 + 2°C) by the air stream (flow of 20 L/h). 
 
3.4. Experimental 3: Determination of oxidation compounds of
 SECO 2 and SDG 1 
3.4.1. SECO 2 and SDG 1 oxidation by AAPH 47  
SECO 2 or SDG 1 oxidation was performed based on modifications of 
literature method.278  Briefly, SECO 2 or SDG 1 (0.01 mol L-1) dissolved in 
MeOH/H2O (50/50%, v/v) was incubated with AAPH (0.1 mol L-1) also dissolved in 
MeOH/H2O (50/50%, v/v), in 10 mL screw-capped test tubes with septum at 60°C.  
Aliquots (20 µL) were removed through the septum via syringe (to minimize the 
introduction of air to the system) at 5.0 min intervals for 1h and 30.0 min intervals to 
the end of the reaction.  The oxidation reaction was monitored using analytical 
HPLC for 6 h to optimize the reaction time, 5 h for SECO 2 and 4 h for SDG 1 was 
enough to form sufficient levels of oxidation products.  Each aliquot was analyzed 
by HPLC as described in section 3.4.2.  The reactions with SECO 2 and SDG 1 were 
scaled up in order to collect enough quantity of each oxidation product for further 
purification and structural determination, using semi-prep HPLC and prep-HPLC 
followed by LC-MS and NMR.  SECO 2 (0.01 mol L-1) was dissolved in 
MeOH/H2O (50/50%, v/v) and incubated with AAPH 47 (0.1 mol L-1) in a solution 
of MeOH/H2O (50/50%, v/v), under atmospheric oxygen, using a 1000 mL glass 
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bottle.  This mixture was heated in the dark at 60°C for 5h, using a shaking water 
bath.  SDG 1 (0.01 mol L-1) was dissolved in MeOH/H2O (50/50%, v/v) and 
incubated with AAPH 47 (0.1 mol L-1) in a solution of MeOH/H2O (50/50%, v/v), 
under atmospheric oxygen, using a 1000 mL glass bottle.  This mixture was heated 
in the dark at 60°C for 4h, using a shaking water bath.  AAPH 47 in the absence of 
SECO 2 or SDG 1 was used as control. 
 
3.4.2. Isolation and purification 
3.4.2.1. Analytical HPLC 
Oxidation products of SECO 2/SDG 1 were separated using an Alliance 
HPLC (Waters Inc., Milford, MA) on a symmetry C18 reverse phase (RP) column 
(3x150 mm, 5mm, Waters Inc.).  Mobile phase consisted of 0.05% trifluoroacetic 
acid (TFA) in H2O (solvent A) and 0.05% TFA in acetonitrile (ACN) (solvent B).  A 
gradient elution was performed (Table 3.2) with a flow rate at 0.4 mL/min.  Peaks 
were detected using a 996 UV-Vis photodiode array (PDA) detector (Waters Inc.) 
with full spectral scans (200-400 nm). 
Table 3.2. Analytical HPLC gradient for SECO 2 (a) and SDG 1 (b) oxidation 
products. 
(a)      (b) 
 Time (min) %H2O %ACN 
1-10 90 10 
30 60 40 
40 40 60 
50-55 90 10 
Time (min) %H2O %ACN 
1-5 90 10 
20 60 40 
30 90 10 
35 90 10 
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3.4.2.2. Preparative HPLC  
Separations were performed on a C18 (Prep Nova-Pak, Waters Inc.), 6µm, 
25x10 cm RP column with a flow rate of 20 mL/min; other parameters were similar 
to analytical HPLC with the exception of using methanol instead of ACN.  In prep-
HPLC, 23 fractions of SECO 2 oxidation products were collected; fractions 2-6 and 
17-22 were enriched with the compounds of interest.  Since these fractions were still 
not pure, they were combined and subsequently purified using semi-prep HPLC.  To 
isolate SDG 1 oxidation products only semi-prep HPLC was used.  
 
3.4.2.3. Semipreparative HPLC 
Separations were performed on a C18, 5µm, 300x10 mm RP column with a 
flow rate of 3.0 mL/min.  A gradient method, which was used for SECO 2 and SDG 
1 oxidation products, is shown in (Table 3.3-3.4); other parameters were similar to 
the analytical HPLC protocol. 
 
Table 3.3. Semi-prep HPLC gradient for SECO 2 oxidation products. 
 
 
 
 
 
 
Time (min) %H2O %ACN 
1-10 80 20 
50-55 60 40 
56-60 20 80 
61-65 80 20 
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For SECO 2, 120 fractions were collected using a fraction collector.  The fractions 
containing compounds of interest are listed:   
Compound 48 (RT = 25.6), obtained from preparative fractions 61-65;  
Compound 49 (RT = 26.7), obtained from preparative fractions 66-69;  
Compound 50 (RT = 18.6), obtained from preparative fractions 24-30;  
Compound 51 (RT = 19.6), obtained from preparative fractions 35-37;  
Compound 52 (RT = 28.9), obtained from preparative fraction 22; 
Compound 53 (RT = 10.7) and 54 (RT = 11.4), obtained from preparative 
fractions 2-6. 
 
Table 3.4. Semi-prep HPLC gradient for SDG 1 oxidation products. 
 
 
 
 
 
For SDG 1, 120 fractions were collected using a fraction collector.  The fractions 
containing compounds of interest are listed:    
Compound 55 (RT = 14.3), obtained from preparative fractions 72-73;  
Compound 56 (RT = 12.9), obtained from preparative fractions 64-65;  
Compound 57 (RT = 12.1), obtained from preparative fractions 62-63;  
Compound 58 (RT = 17.0), obtained from preparative fractions 84-92 
Time (min) %H2O %ACN 
1-10 95 5 
60-65 60 40 
66-72 5 95 
73-75 95 5 
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 3.5. Identification of oxidation compounds 
3.5.1. LC-MS analysis 
LC-MS were determined using a Quattro-LC (Micromass UK Limited, 
Manchester, UK) equipped with ES-MS (±) sources (Micromass) using ACN as 
mobile phase.  LC analysis was performed applying the same gradient as analytical 
HPLC except 0.05% formic acid was used instead of 0.05% TFA. 
 
3.5.2. NMR analysis 
The NMR data was obtained on a Bruker AVANCE DPX-500 spectrometer 
(PBI in Saskatoon, SK) operating at 500 MHz and 125 MHz for proton and carbon, 
respectively.  Deuterated methanol (CD3OD) was used as solvent.  Residual signals 
from CD3OD (3.30 ppm and 49.0 ppm for proton and carbon-13) served as internal 
standard.  Programs for 2-D experiments were available from a software package 
(XWINNMR) provided by Bruker.  COSY, HMQC and HMBC experiments were 
performed with gradient pulses.  The Distortionless Enhancement by Polarization 
Transfer (DEPT) experiment together with 2-dimentional-NMR (2D-NMR) 
experiments including: Correlation Spectroscopy (COSY), Heteronuclear Multiple 
Quantum Correlation (HMQC), Heteronuclear Multiple Bond Correlation (HMBC) 
and Nuclear Overhauser Effect Spectroscopy (NOESY) experiments were 
performed with gradient pulses.   
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3.6. Extinction coefficient 
Extinction coefficients of samples (in methanol) were obtained from the 
following equation: 
   ε = A/CL    (equation 27) 
Where ε is extinction coefficient (L mole-1 cm-1), A is maximum absorption (at 280 
nm), C is concentration (mole), L is path length of cell which was 1cm.  For each 
analysis five individual samples with five replications were used using EXCEL 
(Microsoft Office, Office 10) program for statistical analysis. 
 
3.7. Peroxide Value test  
An ammonium thiocyanate assay was used based on a modification of the 
method of Asamari, 1996.283  The assay was conducted by adding 2.5 mL of 75% 
ethanol, 0.05 mL of ammonium thiocyanate solution (30%w/v in H2O), and 0.05 mL 
of ferrous chloride (0.1%w/v in H2O) to 100 µL of sample in ethanol.  In a 3 mL test 
tube, the mixed solution was incubated at room temperature (23°C) in the dark for 3 
min.  The absorbance of the reaction mixture was measured at 500 nm against 75% 
ethanol as a blank.  Peroxide concentrations were determined according to the 
equation obtained from the standard curve of H2O2.  To obtain the standard curve, 
H2O2 at concentrations ranging from 5-40 µg/mL were added to the reaction mixture 
in a reference cell.  In the reference cell, previously added 2.5 mL 75% ethanol, 0.05 
mL of ammonium thiocyanate solution (30%w/v in H2O), and 0.05 mL of ferrous 
chloride to a final volume of 3 mL.  Peroxides were calculated from the ratio of 
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concentration of each sample to reference.  Results are an average of four individual 
readings (from four separate tubes) at 500 nm, using UV/VIS spectrophotometer 
(Agilent 8453, Canada) with Agilent Chem Station software.  EXCEL program was 
used for statistical analysis.  
 
  94
 
 
4.0. RESULTS 
4.1. Antioxidant capacity of flaxseed lignans in liposomal and
 vegetable oil systems 
4.1.1. Stoichiometry ratio determination 
The stoichiometric ratio (n) for peroxyl radical trapping is calculated from 
equation 24 (section 3.2.1 for details).  BHT 17 (n = 2) was used as a standard for 
antioxidant activity to determine an Ri value for AAPH 47-mediated lipid 
peroxidation of DLPC liposomes at 50°C (Table 4.1).278  An n of 2.0 ± 0.01 was 
confirmed for BHT 17 by analyzing products of the BHT 17/AAPH 47/DLPC 
reaction.  The Ri value was used to calculate n for each antioxidant (Table 4.1-4.2).  
In addition, under these conditions n = 1.75 was determined for α-tocopherol 
(personal communication, Brian Fahlman).  In the presence of antioxidant, lag time 
was determined from the intercept of two lines representing the delay prior to the 
onset of lipid peroxidation and the oxidation phase, when the antioxidant had been 
consumed (BHT 17, SECO 2 or SDG 1).  This is demonstrated in Figure 4.20, 
where the line representing delay (y = 0.002X + 0.2108) and the line representing 
the onset of lipid peroxidation (y = 0.012X + 0.0041) in the presence of 0.8 mM 
BHT 17 are shown.   
Plots of absorption (240 nm) vs time (min) for oxidations of Blank, BHT 17, 
SECO 2 and SDG 1 in liposomes are depicted in Figure 4.1-4.2 and described as 
follows: 
  95
y = 0.0425x + 0.2784
R2 = 0.9924
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
0 5 10 15 20 25
Time (min)
A
B
S 
(2
40
 n
m
)
 
Figure 4.1. Mean (±SD) graphs of determination of antioxidant-mediated lag 
time (min)AAPH 47-mediated peroxidation of DLPC liposomes 
(pH 7.4, 50°C), n=3.  
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Blank: There was no delay time (induction time) for blank since it did not contain 
any antioxidant (Figure 4.1).  Therefore, a plot of absorption (240 nm) vs time (min) 
for a control was linear for conjugated diene formation over 20 min. 
BHT 17: delayed AAPH 47-induced lipid autoxidation by 15.3 min (0.53 mM) and 
17.2 min (0.80 mM) (Figure 4.2).   
SECO 2: delayed AAPH 47-induced lipid autoxidation by 11.7 min (0.53 mM) and 
13.4 min (0.80 mM) (Figure 4.3)  
SDS 1: delayed AAPH 47-induced lipid autoxidation by 8.5 min (0.53 mM) and 
10.5 min (0.80 mM) (Figure 4.4).   
The stoichiometric ratios for SECO 2 was 1.5± 0.15 and for SDG 1 was 1.1-
1.2 ± 0.09 (Table 4.2).  These results indicate that both SECO 2 and SDG 1 are less 
potent antioxidants than BHT 17, although SECO 2 is superior to SDG 1.   
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Figure 4.2. Mean (±SD) graphs of determination of antioxidant-mediated lag 
 time (min) at pH 7.4, 50°C, at 0.53 and 0.8 mM for BHT 17 (n=3). 
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Figure 4.3. Mean (±SD) graphs of determination of antioxidant-mediated lag 
 time (min) at pH 7.4, 50°C, at 0.53 and 0.8 mM for SECO 2 (n=3). 
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Figure 4.4. Mean (±SD) graphs of determination of antioxidant-mediated lag 
 time (min) at pH 7.4, 50°C, at 0.53 and 0.8 mM for SDG 1 (n=3). 
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Table 4.1. Mean (±SD) rate of AAPH 47-induced lipid peroxidation of DLPC 
at pH 7.4, 50°C calculated in the presence of BHT 17 (n = 3).  
 
sample 
at 50°C 
Lag time 
(min) 
Ri value 
(mM min-1) n 
  BHT 17 
  (0.53 mM) 
 
15.3 ± 0.01 0.07 ± 0.01 2.0 ± 0.01 
  BHT 17 
  (0.80 mM) 17.2 ± 0.04 0.09 ± 0.01 2.0 ± 0.01 
 
 
Table 4.2. Mean (±SD) stoichiometric ratio (n) for SECO 2 and SDG 1 at 
50°C (n=3). 
 
sample 
at 50°C 
Lag time 
(min) 
Ri value 
(mM min-1) n 
  SECO 2 
  (0.53 mM)    11.7 ± 0.10 0.07 ± 0.01         1.5 ± 0.10 
  SECO 2  
  (0.80 mM)    13.4 ± 0.10 0.09 ± 0.01         1.5 ± 0.20 
  SDG 1 
  (0.53 mM)      8.5 ± 0.03 0.07 ± 0.01 1.1 ± 0.15 
  SDG 1  
  (0.80 mM) 10.5 ± 0.05 0.09 ± 0.01 1.2 ± 0.03 
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4.1.2. Antioxidant activity of flaxseed lignans in vegetable oil 
Antioxidant activity of flaxseed lignans was accomplished by measuring the 
induction time for autoxidation of canola oil in the absence or presence of an 
antioxidant.  A pilot study compared SECO 2 to BHT 17 by weight (mg) per 100 g 
oil (10 mg/100 g oil = 100 mg/kg) (Table 4.3a-4.3b) at two different temperatures 
(110ºC and 120ºC).  Induction times at time = 0.0 was the same for control, BHT 17 
and SECO 2 at all amounts.  Induction time decreased vs storage time for control, 
whereas longer induction times were observed for all amounts of both BHT 17 and 
SECO 2 treated oils.  At both temperatures, protection against autoxidation was 
weight dependent as induction times changed the most over time for 10 mg of BHT 
17 and SECO 2 and both produced similar induction times at all amounts.   
A follow-up study was carried out which compared the ability of BHT 17 
and flaxseed lignans to protect against autoxidation in our model system on a per 
mole basis.  The influence of BHT 17, SECO 2 and SDG 1 on induction time was 
measured using 0.04, 0.06 and 0.08 mmole/ 100 g oil.  In addition, SDG 1 polymer, 
whose structure consists of SDG 1 units liked via HMGA moieties, was included in 
this study.30   
The results shown in Table 4.4 indicate that induction time increased over 
time for control and all antioxidants.  In addition, each antioxidant produced 
amount-dependent increase in induction time as compared to control.  At all 
amounts, SECO 2 was comparable to BHT 17 in its ability to maintain induction 
time at all time points.   
  
 
Table 4.3a. Induction time (hours) vs storage time (days) at 110ºC for 10, 20 and 30 mg antioxidant/100 g oil. 
 
Induction time (h) 
Storage Time 
(days) 
Control
 
SECO 2 
(10 mg) 
SECO 2 
(20 mg) 
SECO 2 
(30 mg) 
BHT 17 
(10 mg) 
BHT 17 
(20 mg) 
BHT 17 
(30 mg) 
0 11.29 11.26 11.28 11.25 11.33 11.29 11.36 
30 10.38 10.68 10.98 11.13 10.61 11.05 11.17 
60 9.93 10.19 10.44 10.98 10.22 10.86 11.11 
90 8.62 9.77 10.21 10.62 9.92 10.50 10.82 
120 7.09 9.01 9.16 10.03 9.05 9.44 10.27 
 
 
 
 
  
 
Table 4.3b. Induction time (hours) vs storage time (days) at 120ºC for 10, 20 and 30 mg antioxidant/100 g oil. 
Induction time (h) 
Storage Time 
(days) 
Control
 
SECO 2 
(10 mg) 
SECO 2 
(20 mg) 
SECO 2 
(30 mg) 
BHT 17 
(10 mg) 
BHT 17 
(20 mg) 
BHT 17 
(30 mg) 
0 5.66 5.65 5.66 5.66 5.66 5.65 5.67 
30 4.91 5.07 5.18 5.30 5.18 5.31 5.35 
60 4.58 4.70 4.87 5.17 4.98 5.06 5.21 
90 4.02 4.63 4.68 4.97 4.67 4.78 5.09 
120 2.83 3.98 4.15 4.32 4.20 4.44 4.66 
 
  
Table 4.4. Induction time (hours) vs storage time (days) at 110ºC of BHT 17, SECO 2 and SDG 1 at 0.04, 0.06 and 0.08 
mmol/100 g oil.  SDG polymer 3 was 10, 20, 30 mg/100 g oil. 
 
Storage Time 
(days) 
Control 
 
SECO 2 
(0.04mM) 
SECO 2 
(0.06mM) 
SECO 2 
(0.08mM) 
BHT 17 
(0.04mM) 
BHT 17 
(0.06mM) 
BHT 17 
(0.08mM) 
0 11.43 11.45 11.60 11.61 11.45 11.60 11.63 
30 10.06 11.12 11.46 11.27 11.22 11.40 11.59 
60 8.90 10.52 10.93 11.16 10.72 11.16 11.51 
90 7.74 9.93 10.42 10.65 10.14 10.68 11.07 
120 6.76 9.37 9.95 10.23 9.46 10.39 10.65 
Storage Time 
(days) 
Control 
 
SDG 1 
(0.04mM) 
SDG 1 
(0.06mM) 
SDG 1 
(0.08mM) 
SDG polymer 3  
(10 mg) 
SDG polymer 3 
(20 mg) 
SDG polymer 3 
(30 mg) 
0 11.43 10.96 11.25 11.35 11.41 11.50 11.50 
30 10.06 10.63 10.84 11.10 10.82 11.02 11.24 
60 8.90 10.00 10.70 10.78 10.31 10.60 10.91 
90 7.74 9.36 10.36 10.17 9.70 10.19 10.58 
120 6.76 8.86  9.25 9.80 9.10 9.70 10.18 
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Most notably at 120 days the lowest amount used (0.04 mmol/100g oil) of 
BHT 17 and SECO 2 display almost identical induction times (9.46 h, 9.37 h 
respectively).  In contrast, at all amounts and time points, SDG 1 did not maintain 
induction time to the same extent as SECO 2 and BHT 17 (Table 4.4).  SDG 1 
polymer however, produced amount-dependent increases in induction time as 
compared to control, which were greater than that afforded by SDG 1 and 
comparable to that seen with SECO 2 (Table 4.4).   
 
4.1.3. Consistency between two model systems  
Both model systems showed that as an antioxidant, SECO 2 provides better 
protection than SDG 1.  The IT ratio from the stoichiometric ratio (calculated from 
Table 4.1-4.2) were close with the IT ratio from Rancimat experiments (calculated 
from Table 4.4, values at 120 days).  Calculated IT ratios between two model 
systems are shown in Table 4.5. 
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Table 4.5. Calculated stoichiometric ratio (n-value) and calculated protection 
factor (PF) value from rancimat. 
 
Antioxidant n-value 
Stoichiometric ratio 
PF 
Rancimat 
SECO 1.5 1.5 
SDG 1.2 1.3 
SDG polymer nd 1.4 
BHT 2.0 1.6 
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4.2. Time-course of an AAPH 47-mediated oxidation of SECO 2 
Oxidation over time of SECO 2 (0.01 mol L-1) with AAPH 47 (0.1 mol L-1) 
produced five major dominant UV-detectable peaks (200-400 nm) (Table 4.6).  As 
SECO 2 was oxidized by AAPH 47, two compounds 50 and 51, more polar than 
SECO 2, and three compounds 48, 49 and 52, less polar than SECO 2, were 
generated (Table 4.6). 
Time course of the oxidation indicated a time dependent formation of 
oxidation products where compounds 48 and 52 are formed early in the reaction and 
decomposed after 90 minutes (Figure 4.6a).  Meanwhile, compounds 49, 50, and 51 
were formed later (Figure 4.6a).  Compound 52 formed at the initial stage of the 
oxidation reaction, then declined after 120 min.  Compound 51 was formed after 90 
min and gradually increased to the end of the reaction.  Among all of the oxidation 
compounds, compound 50 was the major compound of the oxidation reaction, which 
formed after 30 min, increased to a maximum level up to 240 min, then started to 
decrease after this time (Figure 4.6b).  Compound 48 formed early, increased to a 
maximum level at 90 min and then decreased after this time.  Compound 49 was 
detected after 120 min and gradually increased until the end of the reaction.  Control 
reactions were performed in the absence of AAPH 47 or SECO 2.  
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Table 4.6. Oxidation compounds of SECO 2 (0.01 mol L-1) in the presence of 
AAPH 47 (0.1mol L-1) for 5 h at 60°C. 
 
Compound Trivial name RTa (min) MWb 
 
UV absorbance 
maxima (nm) 
Compound 2 SECO 21.4 362.4 205.7, 279.8, 224.7 sh 
 
Compound 48 9,9″-SECO dimer 25.6 722.6 205.7, 279.8, 223.8 sh 
 
Compound 49 5,5″-SECO dimer 26.7 722.6 205.7, 279.8, 224.7 sh 
 
Compound 50 4-AP-SECO 18.6 446.6 202.2, 258.5, 223.3 sh 
 
Compound 51 4-AP, 9,9″-peroxide-
SECO 
19.6 478.6 202.2, 265.6, 223.3 sh 
 
Compound 52 9,9″-peroxide-SECO 28.9 394.2 202.2, 279.8, 226.6 sh 
 
Compound 53 methylene AAPH 10.7 _ 198.7, 294.0 
Compound 54 methyl AAPH 11.4 _ 202, 294.0 
 
aRT, retention time 
bMW, molecular weight, calculated from mass spectral data 
sh shoulder 
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Figure 4.6a*. Oxidation of SECO 2 (0.01 mol L-1) by AAPH 47 (0.1mol L-1) for 5 h at 60°C. 
*4.6a shows non-expanded peak areas of oxidation compounds. 
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Figure 4.6b*. Oxidation of SECO 2 (0.01 mol L-1) by AAPH 47 (0.1mol L-1) for 5 h at 60°C. 
*For simplicity, 4.6b shows expanded peak areas of oxidation compounds. 
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In the absence of AAPH 47, no oxidation products were observed from SECO 2.  In 
the absence of SECO 2, AAPH 47 was converted to two major oxidation 
compounds, 53 and 54 (Figure 4.6a).  
 
4.3. Product yield of an AAPH 47-mediated oxidation of SECO 2 
SECO 2 (0.01 mol L-1) was oxidized by AAPH 47 (0.1mol L-1) to produce 
five major oxidation compounds 48 to 54 for a total of 1217 mg (Table 4.7).  The 
oxidation reaction formed some minor compounds (Table 4.7).  270 mg of SECO 2 
were recovered after the reaction was terminated at 5 hours.  Overall, 138 mg of 
SECO 2-containing oxidation reaction materials were lost during purification.  The 
UV-detectable profile by HPLC for oxidation of SECO 2 by AAPH 47 is illustrated 
in Figure 4.7. 
 
4.4. Structural determination  
4.4.1. SECO 2 
The results from the 1H- and 13C-NMR for SECO 2 are shown in Table 4.8 
and are similar to those obtained from previous studies.24,284,285  The 1H NMR 
spectrum exhibited an ABC (three spin-coupled systems) for the aromatic protons 
and the methoxy singlet at δ 3.66 (Table 4.8).  The presence of a total number of 10  
hydrogen atoms indicated that SECO 2 has an axis of symmetry.  The mass spectra 
confirmed a pseudo-molecular ion peak at m/z 361.4 [M-H]- and m/z 363.4 [M-H]+. 
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Table 4.7. Yield of oxidation compounds from SECO 2 (0.01 mol L-1) by 
AAPH 47 (0.1mol L-1) for 5 h at 60°C. 
 
Oxidation compound Yield (mg) Yield (%) 
Major compounds   
Compound 48 225 11 
Compound 49 310 15 
Compound 50 224 10 
Compound 51 112 5 
Compound 52 175 8 
Total major compounds   1217 49 
Total minor compounds 875 35 
Unoxidized SECO 270 10.5 
Overall loss 138 5.5 
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Figure 4.7. HPLC chromatogram from oxidation of SECO 2 (0.01 mol L-1) by AAPH 47 (0.1mol L-1) at 60°C  
 after 5 h, λmax at 280 nm.   
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The DEPT experiment together with 2D-NMR experiment including: COSY, 
HMQC, HMBC and NOESY experiments confirmed the presence of two 
methylenes, three methines, one methyl and three quaternary carbons for a total of 
nine signals (Table 4.8).  From the chemical shifts, the quaternary carbons may be 
attributed to the tri-substituted aromatic ring.  The distinction between C-3/3′ and C-
4/4′ was achieved from the 3J (C,H) coupling of C-3/3′ with the methoxy protons.  In 
addition, COSY and HMQC spectra verified an ABC spin system, together with an 
isolated methoxy group that corresponds to the protons of the methylenes and/or 
methines of C-9, C-8, C-7 and the aromatic system.   
 
4.4.2. SECO 2 oxidation compounds 
4.4.2.1. Identification of compound 48 (9, 9”-SECO dimer) 
Compound 48 (RT=25.6 min) showed pseudo-molecular ions (m/z 721.6 [M-
H]-, 723.6 [M+H]+), reflective of a dimerization of SECO 2 (Figure 4.8).  The 
molecular formula of 48 was calculated to be C40H50O12.  The 13C NMR spectrum 
displayed signals for 20 carbon atoms suggesting that compound 48 may have an 
axis of symmetry (Table 4.9).  Chemical shifts of the aliphatic moieties and that of 
one of the aromatic rings showed some similarity to those of the corresponding 
carbons in SECO 2.  However, 13C NMR indicated that distinguishable differences 
were observed for C-9 (74.4), C-8 (47.6) and C-7 (39.9) compared to 62.1, 44.1 and 
36.0 for the same carbons in SECO 2.  This is reflective of two sub-structures linked 
via -OH moieties on the aliphatic part of the molecule. 
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Table 4.8. 1H- (500 MHz) and 13C-NMR (125 MHz) data of SECO 2 in 
CD3OD. 
 
SECO 2 
Position δC       δH (multiplicity, J Hz) HMBC 
1/1′ 133.9           - 5, 9a/9b, 8/5′, 9′a/9′b, 8′ 
2/2′ 115.8           6.52 (d, 2.0) 6, 7a/7b/6′, 7′a/7′b 
3/3′ 148.8           - 5, 2, OCH3/5′, 2′, OCH3 
4/4′ 145.5           - 5, 2, 6/5′, 2′, 6′ 
5/5′ 113.4           6.59 (d, 8.0) - 
6/6′ 122.7           6.47 (dd, 8.0) 7a/7b, 2 
7a/7′a 36.0           2.48 (dd, 7.8, 13.8) 2, 6, 8, 9a/9b 
7b/7′b 36.0           2.59 (dd, 6.9, 13.8) 2′, 6′, 8′, 9′a/9′b 
8/8′ 44.1           1.83 (br t, 6.1) 9a/9b, 7a/7b/9′a/9′b, 7′a/7′b 
9a/9′a 62.1           3.54 (dd, 5.0, 11.0) 8, 7a/7b, 9b/9′b 
9b/9′b 62.1           3.49 (dd 4.9, 11.1) 8′, 7′a/7′b, 9a/9′a 
OCH3 56.2           3.66 (s) - 
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Figure 4.8. Proposed structure for compound 48. 
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Figure 4.9. Proposed structure for compound 49. 
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Table 4.9. 1H- (500 MHz) and 13C-NMR (125 MHz) data of 48 and 49 in 
CD3OD. 
 
Compound 48 49 
Position δC           δH (multiplicity, J Hz) δC           δH (multiplicity, J Hz) 
1,1″ 133.6           - 133.8           - 
2,2″ 115.5           6.54 (d, 1.5) 115.9           6.60 (d, 1.5) 
3,3″ 149.3           - 149.3           - 
4,4″ 145.4           - 146.7           - 
5,5″ 113.2           6.58 (d, 8.0) 127.0           - 
6,6″ 122.6           6.48 (d, 1.5) 123.2           6.54 (d, 1.5) 
7,7″ 39.9           2.62 (m) 36.2           2.60 (m) 
8,8″ 47.6           2.20 (t, 6.1) 44.0           1.95 (brt, 6.1) 
9,9″ 74.4           3.65 (m, 4.5, 10.5) 62.1           3.60 (m, 4.5, 10.5) 
3, 3″-OCH3 56.5           3.77 (s) 56.4           3.77 (s) 
1′, 1″′ 133.9 - 133.4           - 
2′,2″′ 115.8           6.54 (d, 1.5) 115.8           6.54 (d, 1.5) 
3′,3″′ 148.8           - 148.8           - 
4′,4″′ 145.4           - 145.4           - 
5′,5″′ 113.1           6.58 (d, 8.0) 113.3           6.59 (d, 8.0) 
6′,6″′ 122.5           6.47 (dd, 1.5, 8.0) 122.7           6.47 (dd, 1.5, 8.0) 
7′,7″′ 36.0           2.62 (m) 36.0           2.58 (m) 
8′,8″′ 44.6           1.83 (brt, 6.1) 44.1           1.95 (brt, 6.1) 
9′,9″′ 62.2           3.61 (m, 4.7, 10.8) 62.1           3.60 (m, 4.5, 10.5) 
3′, 3″′-OCH3 56.4           3.69 (s) 56.2           3.66 (s) 
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The 1H NMR spectrum of 48 showed an ABC system [6.54 (dd, 1.5, 8.0), 6.58 (d, 
1.5), and 6.48 (d, 8.0)] for the aromatic rings (Table 4.9).  From the HMBC 
spectrum, correlation peaks through H-8 (δ 2.20) to C-1, C-7, C-7′, C-8′, C-9, C-9′ 
established that a dimer was linked between 9-OH to C-9′′ (Table 4.9).  A downfield 
shift of the C-8 protons (δ 2.20) adjacent to the peroxyl linkage compared to the C-8 
protons (δ 1.95) near the unsubstituted alcohols (SECO H-8: δ 1.83) suggest that the 
peroxy link may have caused the molecule to twist to avoid congestion.  In doing so, 
the C-8 proton appears to be in a new shielding environment. 
 
4.4.2.2. Identification of compound 49 (5,5”-SECO dimer) 
Compound 49 (RT=26.7 min) showed pseudo-molecular ions (m/z 721 [M-
H]-, 723 [M+H]+), reflective of another dimer with a molecular formula of 
C40H50O12 (Figure 4.9).  The 13C NMR data indicate that compound 49 is a 
symmetric molecule (Table 4.9).  Distinguishable differences in NMR data were 
observed for C-4 (146.7) and C-5 (127.0) compared to 145.5 and 113.4 for the same 
carbons in SECO 2.  All other chemical shifts of the aliphatic and aromatic moieties 
were very similar to those of the corresponding carbons in SECO 2 (Table 4.8).   
These chemical shifts indicated that these two sub-structures are linked via aromatic 
rings.  The 1H NMR spectrum of 49 has an ABC system [6.54 (dd, 1.5, 8.0), 6.59 (d, 
1.5), and 6.47 (d, 8.0)] and an AB [δ 6.60 and 6.54 (each d, 1.5)] system for 
aromatic rings (Table 4.9). 
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 In the HMBC spectrum, correlation peaks observed between H-6/H-6″ (δ 
6.54) to C-1/C-1″, C-4/C-4″, C-5/C-5″ and C-7/C-7″ established a connection from 
C-5 to C-5″ for dimerization.  In addition, COSY and HMQC spectra of compound 
49 verified an ABC spin system, together with an isolated methoxy group, that 
corresponds to the protons of the methylenes of C-9,  C-8 and methines of C-7.  The 
two dimers 48 and 49 would predict to have n-value=1 due to the loss of one 
hydrogen form SECO 2 molecule that undergoes dimerization (section 5.6 for 
details).   
 
4.4.2.3. Identification of compound 50 (4-AP-SECO) 
Compound 50 (RT=18.6 min) produced pseudo-molecular ions (445 [M-H]- 
and 447 [M+H]+), reflective of the addition of one AP radical to the SECO 2 
molecule (Figure 4.10).  The molecular formula of 50 was then calculated to be C24 
H34 O6N2.  Unlike SECO 2, the 13C NMR spectrum showed that 50 did not possess 
an axis of symmetry by displaying signals for 23 carbon atoms (Table 4.10).  Signals 
from an AP moiety were found at δ 176.6, 80.1, and 28.1.  A large methyl singlet 
was observed at δ 1.56 plus two close, but distinguishable ABC systems for 
aromatic protons. 
In the HMBC spectrum, no cross-correlation was observed between SECO 2 
and the AP moieties thereby suggesting that AP was linked at the 4-OH or 9-OH 
because the AP carbon chemical shift at δ 80.1 (s) is indicative of linkage to oxygen.  
The changes observed from the chemical shift of C-1 (140.8), C-3 (154.1), C-4 
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(140.8), C-5 (125.1) and C-6 (124.6) in 50, compared to 133.9, 148.8, 145.5, and 
113.4 for the same carbons in SECO 2, could be due to the AP moiety on 4-OH 
(Table 4.10).  To confirm this structure, the NOESY spectrum for 50 was obtained.  
In this spectrum, a cross-correlation peak was observed between the AP methyl 
groups at δ 1.56 and the aromatic group at δ 6.91 for H-5 (Table 4.10). 
 
4.4.2.4. Identification of compound 51 (4-AP-9,9”-peroxy-SECO) 
Compound 51 (RT=19.6 min) produced pseudo-molecular ions (477 [M-H]- 
and 479 [M+H]+), reflective of the addition of one AP 47 radical as well as two 
oxygen atoms to the SECO 2 molecule resulting in a molecular formula of 
C24H34N2O8 (Figure 4.11).  The carbon chemical shifts of the aliphatic moiety of 51 
were similar to those of the same carbons in 52 suggesting the presence of the 
peroxide function at C-9 and C-9′ (Table 4.10).  The 13C NMR spectrum also 
showed carbon atoms at δ 28.1, 80.1, and 176.6 for an AP residue (Table 4.10).  As 
in 48, no correlation was observed between the AP and the SECO 2 moieties of 51.  
However, the similarity of their aromatic carbon chemical shifts in both 1H- and 13C-
NMR experiments was strong evidence that the AP in 51 was linked to the 4-OH on 
one of the aromatic rings (Table 4.10).  Compounds 50 and 51 would be predicted to 
have n=2 due to first, losing hydrogen (n=1) from SECO 2 molecule and second, 
trapping AP free radical (n=1) (section 5.6).   
 
  121
4.4.2.5. Identification of compound 52 (9.9”-peroxy-SECO) 
Compound 52 (RT=28.9 min) produced pseudo-molecular ions (393 [M-H]- 
and 395 [M+H]+), reflective of the addition of two oxygen atoms to SECO 2 (Figure 
4.12).  The molecular formula for compound 52 was calculated to be C20H26O8.   
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Figure 4.10. Proposed structure for compound 50. 
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Figure 4.11. Proposed structures for compound 51. 
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Table 4.10. 1H- (500 MHz) and 13C-NMR (125 MHz) data of 50 and 51 in 
CD3OD. 
Compound 50 51 
Position δC δH (multiplicity, J Hz) δC δH (multiplicity, J Hz) 
1 140.8           - 140.8           - 
2 115.1           6.73 (br s)  114.9           6.71 (br s)  
3 154.1           - 154.2           - 
4 140.8           - 141.5           - 
5 125.1           6.91 (d, 8.0) 125.3           6.92 (d, 8.0) 
6 124.6           6.67 (br d, 8.2) 124.5           6.69 (br d, 8.2) 
7 36.2           2.68 (m) 40.0           2.74 (m) 
8 44.5           1.91 (br s) 47.7           2.18 (m) 
9 62.0           3.59 (m) 74.3           3.70 (m) 
3-OCH3 56.2           3.73 (s) 56.2           3.71 (s) 
1′ 133.9           - 133.8           - 
2′ 115.9           6.65 (br s) 115.8           6.66 (br s) 
3′ 148.8           - 148.8           - 
4′ 145.4           - 145.5           - 
5′ 113.5           6.64 (d, 7.9) 113.4           6.65 (d, 7.9) 
6′ 122.6           6.51 (br d, 8.0) 124.7           6.54 (br d, 8.0) 
7′ 36.0           2.63 (m) 40.1           2.73 (m) 
8′ 44.0           1.96 (br s) 47.6           2.18 (m) 
9′ 62.2           3.61 (m, 4.5, 10.5) 74.3           3.75 (m) 
3′-OCH3 56.3           3.69 (s) 56.3           3.70 (s) 
1″ 80.1           - 80.1           - 
2″ 176.6           - 176.6           - 
3″/4″ 28.1           1.56 (s) 28.1           1.56 (s) 
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Figure 4.12. Proposed structure for compound 52. 
 
Table 4.11. 1H- (500 MHz) and 13C-NMR (125 MHz) data of 52 in CD3OD. 
 
52 
Position 
δC δH  (multiplicity, J Hz) HMBC 
1/1′ 133.6           - 5, 9a/9b, 8/5′, 9′a/9′b, 8′ 
2/2′ 115.6           6.64 (d, 2.0) 6, 7a/7b/6′, 7′a/7′b 
3/3′ 148.8           - 5, 2, OCH3/5′, 2′, OCH3 
4/4′ 145.5           - 5, 2, 6/5′, 2′, 6′ 
5/5′ 113.4           6.60 (d, 8.0) - 
6/6′ 124.8           6.65 (dd, 8.0) 7a/7b, 2 
7a/7′a 39.0           2.61 (m) 2, 6, 8, 9a/9b 
7b/7′b 39.0           2.61 (m) 2′, 6′, 8′, 9′a/9′b 
8/8′ 47.7           2.20 (br s) 9a/9b, 7a/7b/9′a/9′b, 7′a/7′b 
9a/9′a 74.3           4.42 (dd, 5.0, 11.0) 8, 7a/7b, 9b/9′b 
9b/9′b 74.3           4.35 (dd, 4.9, 11.1) 8′, 7′a/7′b, 9a/9′a 
OCH3 56.3           3.65 (s) - 
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The 13C NMR data for compound 52 displayed signals for 10 carbon atoms, 
suggesting that the molecule has maintained its symmetry (Table 4.11).  Aromatic 
chemical shifts of SECO 2 and 52 were quite similar (see Table 4.8 for SECO 2 
NMR data).  However, major changes were observed between the aliphatic moieties: 
39.0 (C-7/C-7′), 47.7 (C-8/C-8′), 74.3 (C-9/C-9′) found for 52 compared to 36.0 (C-
7/C-7′), 44.1 (C-8/C-8′), 62.1 (C-9/C-9′) for SECO 2.  These differences indicate 
that 52 have peroxides at both the C-9 and C-9′ positions.  In the 1H NMR and 13C 
spectra from 52, distinguishable changes were observed only for the aliphatic moiety 
(Table 4.11).  In addition, COSY and HMQC spectra of compound 52 verified an 
ABC spin system, together with an isolated methoxy group, that corresponds to the 
protons of the methylenes of C-9, C-8 and methines of C-7 (Table 4.11).  Compound 
52 with peroxide in the structure would be estimated to have n=0 because it does not 
lose any hydrogen or trap any AP free radicals (section 5.6).   
 
4.4.2.6. Identification of compound 53 (methylene-AP) and 54  
 (methyl AP) 
Heating AAPH 47 in the absence of SECO 2 produced two major oxidation 
compounds, 53 (RT=10.7 min) and 54 (RT=11.4 min) (Table 4.6).  The mass of 53 
and 54 were less than 100 and that they were not distinguishable from ES-MS.  
Thus, each structure was characterized by HPLC and NMR analyses (Figure 4.13).   
The 1H NMR and 13C NMR results for compounds 53 and 54 are summarized in 
Table 4.12. 
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Figure 4.13. Proposed structure for compounds 53 and 54. 
  
 
 
Table 4.12. 1H- (500 MHz) and 13C-NMR (125 MHz) data of 53 and 54 in 
CD3OD. 
 
 Compound 53 Compound 54 
Position δC δH (multiplicity, J Hz) δC δH (multiplicity, J Hz) 
1 18.6           1.90 (s, 3.0) 18.5           1.13 (d, 1.0) 
2 120.8           5.36 (s, 1.0) 35.0           2.39 (m, 1.0) 
3 139.1           5.72 (s, 1.0) 180.1           - 
4 170.8           - -           - 
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4.5. Confirmation tests 
4.5.1. Oxidation of compound 48 
Further oxidation of compound 48 (RT=25.6 min) by AAPH 47 showed the 
formation of compounds 52, 51 and SECO 2 from compound 48 (Figure 4.14). 
4.5.2. Peroxide value of products 52 and 51 
The peroxide value test confirmed the presence of a small quantity of 
peroxide (3.33 ug mL-1) in compound 52 and (4.6 ug mL-1) in compound 51, 
according to the equation obtained from standard curve of H2O2 (Figure 4.15).  This 
was equivalent to total of 1.8 ± 0.12 and 1.7 ± 0.09 peroxide equivalents per 
molecule of compound 52 and 51.  Based on the proposed structures, compound 52 
and 51 would be anticipated to have 2 peroxide equivalents per molecule.  
 
4.6. Extinction coefficient (ε) 
An average extinction coefficient for SECO 2 standard at different 
concentrations was 3208 ± 0.035 (L mol-1 cm-1) (Table 4.13).  Compound 48 and 
compound 49 had extinction coefficients of 6413 and 6412 (L mol-1 cm-1) 
respectively, which was double the extinction coefficient of SECO 2 (Table 4.14).  
Compounds 50 and 51, had extinction coefficients of 3694 and 3795 (L mol-1 cm-1) 
respectively, that were also higher than that observed for SECO 2.  Compound 52 
had an extinction coefficient of 3209 (L mol-1 cm-1), which was similar to SECO 2 
(Table 4.14).  Compounds 53 and 54 had ε=586, which was similar to the extinction 
coefficient of AAPH 47 after 5 h at 60°C (ε=586). 
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Figure 4.14a* Oxidation of compound 48 to SECO 2 and compounds 52 and 51 after reaction with  
 AAPH 47 at 60°C for 30 min. 
  *4.14a shows non-expanded peak areas of oxidation compounds. 
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Figure 4.14b*. Oxidation of compound 48 to SECO 2 and compounds 52 and 51 after reaction with  
  AAPH 47 at 60°C for 30 min. 
  *For simplicity, 4.14b shows expanded peak areas of oxidation compounds. 
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Figure 4.15. Mean (±SD) peroxide value for hydrogen peroxide µg mL-1 at 500 
nm, n=4. 
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Table 4.13. Mean (±SD) extinction coefficient (L mol-1 cm-1) for a SECO 2  
standard (in methanol) at different concentrations, at 280 nm (n=5).  
 
SECO 2 
standard 
(mole/L) 
ε (L mole-1 cm-1) 
0.001 3208 ± 0.021  
0.002 3212 ± 0.042 
0.004 3207 ± 0.082 
0.006 3201 ± 0.009 
0.008 3210 ± 0.021 
0.01 3210 ± 0.095 
Average 3208 ± 0.035 
 
Table 4.14. Mean (±SD) extinction coefficients (L mol-1 cm-1) of AAPH 47-
mediated SECO 2 oxidation products (in methanol), at 280 nm 
(n=5).   
 
Compound mole/L ε (L mole-1 cm-1) 
48 0.0030 6413 ± 0.0302 
49 0.0042 6412 ± 0.0460 
50 0.0050 3694 ± 0.0719 
51 0.0023 3795 ± 0.0006 
52 0.0045 3209 ± 0.0515 
53-54 0.012 586 ± 0.00030 
AAPH 47  
(5 h at 60°C) 
0.010 586 ± 0.00075 
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4.7. Time-course of an AAPH 47-mediated oxidation of SDG 1   
For SDG 1, the same oxidation reaction conditions were applied as those 
used for SECO 2.  Oxidation over time of SDG 1 (0.01 mol L-1) by AAPH 47 (0.1 
mol L-1) produced four major compounds 55 to 58.  Compounds, 56 and 57, more 
polar than SDG 1 and compounds 55 and 58 less polar than SDG 1 were generated 
(Table 4.15). 
The time-course indicated that compounds 55 and 58 were formed early and 
decomposed after 50 min while compounds 56 and 57 formed later in the reaction 
(Figure 4.16a).  Control reactions were performed in the absence of AAPH 47 or 
SDG 1.  In the absence of AAPH 47, no oxidation products were observed from 
SDG 1.  In the absence of SECO 2/SDG 1, AAPH 47 formed two major oxidation 
compounds that was discussed earlier (section 4.2). 
The formation of SDG 1 oxidation compounds was time dependent.  
Compound 55 appeared in the early stages of the oxidation reaction, then declined 
after 50 min (Figure 4.16b).  At this time, the formation of compounds 56 and 57 
appeared to increase.  Among all of the oxidation compounds, compound 56 was the 
major compound which, formed after 30 min, increased to the maximum level after 
180 min and then decreased after this time.  Compound 57 formed gradually and 
continued to accumulate until the reaction was terminated at (4 h).  Compound 58 
was the minor compound, detected after 120 min and decreased after 180 min.  
Semi-preparative HPLC, ES-MS and NMR were used to purify, isolate and identify 
these products.  
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Table 4.15. Oxidation compounds of SDG 1 (0.01 mol/L) in the presence of 
AAPH 47 (0.1 mol/L) at 60°C after 4h.  
 
Compound Trivial Name aRT (min) bMW UV-spectrum (nm) 
 
Compound 1 SDG 13.3 686.6 205.7, 279.8, 224.7 sh 
 
Compound 55 5,5″-SDG dimer 14.3 1370 202.3, 280.6, 223.3 sh 
 
Compound 56 4,4″-AP-SDG 12.9 722.6 205.7, 279.8, 223 sh 
 
Compound 57 4,4″-SDG peroxide 12.1 718.4 202.2, 269.1, 351sh 
 
Compound 58 4-SDG-quinone  17.0 702.0 202.2, 276.2, 228.6 sh 
 
aRT, retention time 
bMW, molecular weight, calculated from mass spectral data. 
sh shoulder 
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Figure 4.16a* Time course oxidation of SDG 1 (0.01 mol/L) by AAPH 47 (0.1 mol/L) at 60°C after 4h. 
    *16a shows non-expanded peak areas of oxidation products. 
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Figure 4.16b*. Time course oxidation of SDG 1 (0.01 mol/L) by AAPH 47 (0.1 mol/L) at 60°C after 4h. 
    *16b shows expanded peak areas of oxidation products. 
 
  136
4.8. Product yield of an AAPH 47-mediated oxidation of SDG 1 
SDG 1 was oxidized by AAPH 47 to produce a total of 740 mg of four major 
oxidation compounds 55, 56, 57 and 58 (Table 4.16).  The oxidation reaction also 
formed other minor compounds, which were not identified (Table 4.16).  After the 
4h oxidation reaction 220 mg of SDG 1 was recovered.  Overall, 390 mg of SDG 1-
containing oxidation reaction materials were lost during purification.  The UV-
detectable profile by HPLC for oxidation of SDG 1 by AAPH 47 is illustrated in 
Figure 4.17. 
 
4.9. Structural determination 
4.9.1. SDG 1  
Table 4.17, shows 1H-NMR and 13C-NMR assignments for SDG 1.  These 
data are similar to those reported previously.24,29,285  SDG 1 had RT=13.3 min from 
an HPLC experiment and showed a [M+H]+ peak at m/z=687.6 in ES-MS in positive 
mode corresponding to the molecular formula C32H46O16.  The 1H NMR spectrum 
exhibited an ABC (three spin-coupled systems) for the aromatic protons and the 
methoxy singlet at δ 3.73, a series of resolved multiplets extending from δ 4.24 to 
2.12 for a total of 18 non-exchangeable protons (Table 4.17).  The presence of five 
hydroxyl groups, gives a total of 23 hydrogen atoms, thus confirming that 1 is a 
symmetrical molecule.  The mass spectrum displayed a pseudo-molecular ion peak 
at m/z 687.6 [M+H]+, consistent with the mass of singly protonated SDG 1 
supporting presence of a dimeric glucosylated phenyl propanoid.   
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Table 4.16. Yield of oxidation compounds from SDG 1 (0.01 mol L-1) by AAPH 
47 (0.1mol L-1) for 4 h at 60°C. 
 
Oxidation Product Yield (mg) Yield % 
Compound 55 135.5 9 
Compound 56 305.0 10 
Compound 57 119.4 8 
Compound 58 180.1 10.5 
Total major compounds 740.0 37.5 
Total minor compounds 650.0 32.1 
Unoxidized SDG 1 220.0 11.3 
Overall loss 390.0 19.1 
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Figure 4.17. HPLC chromatogram of oxidation reaction of SDG 1 by AAPH 47 at 60°C after 4 h, λmax at 280 nm.  
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Table 4.17. 1H- (500 MHz) and 13C-NMR (125 MHz) data of SDG 1 in CD3OD. 
 
Position SDG 1 
 δC δH (multiplicity, J Hz)          HMBC 
1/1′ 133.9 - 5, 9a/9b, 8/5′, 9′a/9′b, 8′ 
2/2′ 113.5 6.58 (d, 2.0) 6, 7a/7b/6′, 7′a/7′b 
3/3′ 148.7 - 5, 2, OCH3/5′, 2′, OCH3 
4/4′ 145.4 - 5, 2, 6/5′, 2′, 6′ 
5/5′ 115.7 6.64 (d, 8.0) - 
6/6′ 122.9 6.56 (dd, 2.0, 8.0) 7a/7b, 2 
7a/7′a 35.6 2.61 (dd, 8.2, 13.7) 2, 6, 8, 9a/9b 
7b/7′b 35.6 2.68 (dd, 6.5, 13.7) 2′, 6′, 8′, 9′a/9′b 
8/8′ 41.2 2.12 (t, 6.0) 9a/9b, 7a/7b/9′a/9′b, 7′a/7′b 
9b/9′b 71.2 3.47 (m, 6.5, 9.8) 9-O-Glc (anomeric), 8, 7a/7b 
9a/9′a 71.2 4.08 (dd, 5.5, 9.8) 9′-O-Glc (anomeric), 8, 7′a/7′b 
OCH3 56.3 3.73 (s) - 
9-O-Glc (anomeric)  104.8 4.24 (d, 7.7) 9a/9b, Glc 
9-O-Glc 62.8-78.2 3.10-3.90 (m) Glc (anomeric), 9a/9b 
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A DEPT experiment together with 2D-NMR experiments including COSY, 
HMQC, and HMBC, confirmed the presence of three methylenes, nine methines, 
one methyl and three quaternary carbons for a total of 16 signals (Table 4.17).  From 
the chemical shift, the quaternary carbons are easily attributed to the tri - substituted 
aromatic ring.  The distinction between C-3/3′ and C-4/4′ was achieved on the basis 
of the 3J (C,H) coupling of the former with the methoxy protons.  In addition, COSY 
and HMQC spectra verified an ABC spin system, together with an isolated methoxy 
group, which corresponds to the protons of the methylenes and/or methines of C-9, 
C-8, C-7, the glucose moiety and the aromatic system.   
For the glucose portion of SDG 1, analysis of COSY spectrum starting from 
the anomeric proton at δ 4.24 assigned by its 1H shift and from HMQC connectivity 
led to present of multiplets in the one dimentional spectrum.  The coupling constants 
unambiguously provided the identification of the carbohydrate residue in the 
structure (Table 4.17).  When NOESY spectra were recorded for SDG 1 to check the 
appearance of cross peaks, meaningful differences in the intensities of NOE 
suggested the existence of preferred conformations of H-9/9′.  These chemical shifts 
were significantly different for the methylene protons of the 9/9′-CH2O.  The 
integrals of the corresponding NOE cross-peaks in the NOESY spectrum clearly 
indicated that the proton with the larger δ (4.08) at H-9a is closer to the anomeric 
proton than H-9b and stereochemical differentiation is then possible: H-9a is pro-R 
and H-9b is pro-S.   
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4.9.2. Identification of compound 55 (5,5”-SDG dimer) 
The ES-MS data for compound 55 (RT=14.5 min) (Table 4.18) displayed a 
pseudo-molecular ion peak at m/z 1371 [M+H]+ in positive mode, which is 
consistent with a dimer of SDG 1 (Figure 4.18).  The molecular formula of 55 was 
then calculated to be C64H90O32.  The 13C NMR (Table 4.18) spectrum displayed 
signals for 32 carbon atoms suggesting that compound 55 was a symmetrical 
molecule (Figure 4.18).  Chemical shifts of the aliphatic and that of one of the 
aromatic ring moieties were very similar to those of the corresponding carbons in 
SDG 1.  Important differences were observed for C-5/5″ (126.9) and C-6/6″ (125.4)  
compared to 115.7 and 122.9 for the same carbons in SDG 1.  This suggested that 
these two SDG 1 molecules were linked via their aromatic rings.  The 1H NMR 
spectrum for 55 showed an ABC system [6.58 (d, 1.5), 6.64 (d, 8), and 6.57 (d, 1.5,  
8.0)] and an AB [δ 6.65 and 6.61 (1H each d, 1.5)] system for aromatic rings (Table 
4.18).  In the HMBC spectrum, correlation peaks observed between H-6/H-6″ (δ 
6.61) to C-1/C-1″, C-4/C-4″, C-5/C-5″ and C-7/C-7″ established a connection from 
C-5 to C-5″ for dimerization (Table 4.18).  In addition, COSY and HMQC spectra of 
compound 55 verified an ABC spin system, together with an isolated methoxy 
group, that corresponds to the protons of the methylenes of C-9, C-8 and methines of 
C-7.  Compound 55 would be predicted to have n=1 due to the loss of one hydrogen 
from SDG 1 that undergoes dimerization (section 5.6).   
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Figure 4.18. Proposed structure for compound 55. 
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Table 4.18. 1H- (500 MHz) and 13C-NMR (125 MHz) data of 55 in CD3OD. 
 Compound 55  
Position δC  δH (multiplicity, J Hz) 
1,1″ 134.0 - 
2,2″ 115.6 6.65 (d, 1.5) 
3,3″ 149.3 - 
4,4″ 146.5 - 
5,5″ 126.9 - 
6,6″ 125.4 6.61 (d, 1.5) 
7,7″ 35.6 2.63 (m) 
8,8″ 41.3 2.10 (br t, 6.1) 
9a, 9a′, 9a′′, 9a′′′  71.2 4.04 (m, 5.5, 9.8) 
9-Clc 62.8-78.2 3.10-3.90 (m) 
9-O Glc (anomeric) 104.7 4.28 (d, 7.7) 
3, 3″-OCH3 56.5 3.73 (s) 
1′, 1″′ 134.0 - 
2′,2″′ 113.6 6.58 (d, 1.5) 
3′,3″′ 148.8 - 
4′,4″′ 145.4 - 
5′,5″′ 115.8 6.64 (d, 8.0) 
6′,6″′ 122.9 6.57 (dd, 1.5, 8.0) 
7′,7″′ 35.5 2.61 (m) 
8′,8″′ 41.3 2.10 (t, 6.1) 
9b, 9b′, 9b′′, 9b′′′ 71.2 3.43 (m, 6.5, 9.8) 
9-Clc 62.8-78.2 3.10-3.90 (m) 
9-O Glc (anomeric) 104.7 4.24 (d, 7.7) 
3′, 3″′-OCH3 56.3 3.71 (s) 
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4.9.3. Identification of compound 56 (4,4”-AP-SDG) 
The ES-MS data of 56 (RT=12.9 min) showed pseudo-molecular ion peaks at 
m/z 772 [M+H]+ and 770 [M-H]- in positive and negative mode (Table 4.19), 
respectively, suggesting the addition of one AP radical to the SDG 1 molecule 
(Figure 4.19).  The molecular formula for 56 was suggested by combined analysis of 
ES-MS, 1D- and 2D-NMR data.  Molecular formula of 56 was then calculated to be 
C36H54O16N2.  The structure of compound 56 is shown in Figure 4.19.  
The 13C NMR spectrum showed that 56 was not a symmetrical molecule by 
displaying signals for 36 carbon atoms (Figure 4.19).  Signals from an AP moiety 
were found at δ 176.5, 80.1, and 28.0.  A large singlet for methyl groups was 
observed at δ 1.51, plus two close but distinguishable ABC systems for the aromatic 
protons.  There was no correlation between SDG 1 and AP moieties in the HMBC 
spectrum suggesting that AP is linked to the aromatic group at the 4-OH position.  
The AP carbon chemical shift at δ 80.1 (s) was an indication of its linkage to oxygen.  
The changes observed from the chemical shift of C-1 (140.7), C-3 (154.0), C-4 
(146.1), and C-5 (124.9) in 56 compared to 133.9, 148.7, 145.4, and 115.7 for the 
same carbons in SDG 1 could be due to an AP moiety on the 4-OH.  Like compound 
50 from SECO 2 oxidation, compounds 56 from SDG 1 oxidation would be predicted 
to have n=2 due to the loss of one hydrogen and trapping an AP radical (section 5.6).   
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Figure 4.19. Proposed structure for compound 56. 
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Table 4.19. 1H- (500 MHz) and 13C-NMR (125 MHz) data of 56 in CD3OD. 
 
 Compound 56  
Position    δC δH (multiplicity, J Hz) Position    δC δH (multiplicity, J Hz) 
1 140.7 - 1′ 133.9 - 
2 114.6 6.73 (brs)  2′ 113.8 6.65 (br s) 
3 154.0 - 3′ 148.6 - 
4 146.1 - 4′ 145.3 - 
5 124.9 6.91 (d, 8.0) 5′ 114.1 6.64 (d, 7.9) 
6 124.8 6.67 (br d, 8.2) 6′ 122.7 6.51 (br d, 8.0) 
7   35.8 2.68 (m) 7′   35.5 2.63 (m) 
8   41.4 1.91 (br s) 8′   41.2 1.96 (br s) 
9   70.7 3.59 (m) 9′   71.0 3.61 (m, 4.5, 10.5) 
3-OCH3   56.0 3.73 (s) 3′-OCH3   56.1 3.69 (s) 
9-O-Glc  104.6  9′-O-Glc 104.4  
9-O-Glc 62.7-78.1  9′-O-Glc 62.7-78.1  
   1″   80.1 - 
   2″ 176.5 - 
   3″/4″   28.0 1.56 (s) 
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4.9.4. Identification of compound 57 (4,4”-SDG-peroxide) 
The 1H- and 13C-NMR data for 57 (RT=12.1 min) were similar to those of 
SDG 1 (RT=13.3 min) displaying signals for only half of the molecule (Table 4.20).  
The difference between 57 and 1 was suggested based on their RT and ES-MS 
results.   
In the ES-MS, the molecular ion peak of 57 (RT=12.1 min) appeared at m/z 
717 [M-H]- in negative mode suggesting addition of two oxygen atoms to SDG 1.  
The molecular formula for 57 was calculated to be C32H46O18.  NMR experiments 
revealed changes in the chemical shifts of, C-2 (114.8), C-3 (149.7), C-4 (149.4) and 
C-5 (117.1) in (57) compared to 113.5, 148.7, 145.4 and 115.7 for the same carbons 
in SDG 1 (Table 4.17).  In addition, 1H NMR spectra verified an ABC spin system, 
together with an isolated methoxy group, which corresponds to the protons of the 
methylenes at C-9 and C-7 and methines of C-8, the glycosidic moiety and the 
aromatic system.  The glucose portion was assigned by its 1H chemical shift and from 
COSY and HMBC correlations.  The coupling constants unambiguously provided the 
identification of the carbohydrate residue in the structure and indicated that the 
glucose moieties were unchanged (Figure 4.20).  Compound 57 would predict to 
have n=0 because it does not lose any protons or trapping any AP free radicals 
(section 5.6).  Compound 55 would be predicted to have n=1 due to the loss of one 
hydrogen from SDG 1 molecule that undergoes dimerization.  Like compound 50 
from SECO 2 oxidation, compounds 56 from SDG 1 oxidation would have n=2 due 
to losing one hydrogen and trapping an AP radical.   
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Figure 4.20. Proposed structure for compound 57. 
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Table 4.20. 1H- (500 MHz) and 13C-NMR (125 MHz) data of 57 in CD3OD. 
 
Position Compound 57 
 δC δH (multiplicity, J Hz) HMBC 
1/1′ 133.9 - 5, 9a/9b, 8/5′, 9′a/9′b, 8′ 
2/2′ 114.8 6.57 (d, 2.0) 6, 7a/7b/6′, 7′a/7′b 
3/3′ 149.7 - 5, 2, OCH3/5′, 2′, OCH3 
4/4′ 149.4 - 5, 2, 6/5′, 2′, 6′ 
5/5′ 117.1 6.63 (d, 8.0) - 
6/6′ 123.1 6.54 (dd, 2.0, 8.0) 7a/7b, 2 
7a/7′a 35.3 2.59 (dd, 8.3, 13.7) 2, 6, 8, 9a/9b 
7b/7′b 35.6 2.66 (dd, 6.5, 13.7) 2′, 6′, 8′, 9′a/9′b 
8/8′ 41.2 2.11 (t, 5.6) 9a/9b, 7a/7b/9′a/9′b, 7′a/7′b 
9a/9′a 71.2 3.46 (m, 6.4, 9.8) 9-O-Glc (anomeric), 8, 7a/7b 
9b/9′b 71.2 4.05 (dd, 5.4, 9.8) 9′-O-Glc (anomeric), 8, 7′a/7′b 
OCH3 56.3 3.71 (s) - 
9-O-Glc  104.7 4.21 (d, 7.7) 9a/9b, Glc 
9-O-Glc 62.8-78.2 3.10-3.90 Glc (anomeric), 9a/9b 
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4.9.5. Identification of compound 58 (4-SDG quinone) 
The ES-MS analysis for compound 58 (RT=17.0) showed the molecular ion 
peak at m/z 701 [M-H-]-, suggesting a molecular formula of C32H46O17 for 58 (Table 
4.15).  The 1H NMR spectra showed an ABC system of aromatic protons [1H δ 6.65 
(d, 2) and 6.91 (d, 10.0) and 6.60 (d, 8.2)].  This was an indication that one of the 
aromatic rings in SDG 1 had been oxidized (Figure 4.21).   
The 13C NMR for compound 58 displayed signals for a carbonyl carbon at δ 
171.0 plus an oxygenated carbon at δ 73.4 (Table 4.21) which are not seen for SDG 1 
(Table 4.17).  DEPT, COSY, HMQC, and HMBC experiments confirmed the 
presence of three methylenes, nine methines, one methyl and three quaternary 
carbons for a total of 16 signals (Figure 4.21).  In addition, 1H NMR and 13C spectras 
verified an isolated methoxy group (Figure 4.21).  Compound 58 would have n=2 
due to first, losing hydrogen for the formation of a double bond (n=1) and, then, the 
addition of hydrogen (n=1) for the formation of a quinone molecule (section 5.6).   
 
4.10. Confirmation tests for compounds 55 and 57   
4.10.1. Oxidation of product 55 
Further oxidation of compound 55 with AAPH 47 showed the formation of 
SDG 1 and then conversion of SDG 1 to compound 56 (Figure 4.22).
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Figure 4.21. Proposed structure for compound 58. 
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Table 4.21. 1H- (500 MHz) and 13C-NMR (125 MHz) data of compound 58 in 
CD3OD. 
 
 Compound 58  
Position δC  δH (multiplicity, J Hz) Position δC δH (multiplicity, J Hz) 
1 73.4 - 1′ 133.9 - 
2 137.6 6.65 (d, 2) 2′ 113.5 6.61 (d, 2.0)  
3 150.5 - 3′ 147.4 - 
4 171.0 - 4′ 146.3 - 
5 127.6 6.91 (d, 10) 5′ 115.4 6.64 (d, 7.9) 
6 129.7 6.60 (br d, 8.2) 6′ 122.9 6.54 (br d, 8.0) 
7   37.6 2.67 (m) 7′   35.6 2.61 (m) 
8   42.2 2.25 (br s) 8′   41.2 2.11 (br s) 
9   71.6 3.59 (m) 9′   71.2 3.61 (m, 4.5, 10.5) 
3-OCH3   56.9 3.74 (s) 3′-OCH3   56.7 3.72 (s) 
9-O-Glc 
(anomeric)  
104.8 4.04 (m) 9′-O-Glc 104.8 4.23 (m) 
9-O-Glc 62.3-78.2 3.11-3.91 9′-O-Glc 62.5-78.2 3.11-3.91 
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4.10.2. Peroxide value of compound 57 
The peroxide value test confirmed the presence of a small quantity of 
peroxide (0.85 µg mL-1) in compound 57 (calculated from Figure 4.15).  This was 
equivalent to a total number of 1.7 ± 0.19 peroxide equivalents per molecule of 
compound 57.  Compound 57 would be anticipated to have 2 peroxide equivalents 
per molecule. 
 
4.11. Extinction coefficient 
Average extinction coefficient (L mol-1 cm-1) of SDG 1 standard was 3204 
(Table 4.22).  In Table 4.23, extinction coefficient (L mol-1 cm-1) of the major AAPH 
47-mediated SDG 1 oxidation compounds is shown.  The extinction coefficient was 
used to estimate the concentration based on the data from the HPLC chromatogram 
(Table 4.23).  For this calculation, the maximum UV-absorption (280 nm) observed 
from HPLC was used.  These results were similar to the calculated concentration 
from mass (Table 4.23).  Compound 55 had an extinction coefficient of 6405 ± 
0.0037 (Table 4.23), which was almost twice the extinction coefficient of SDG 1.  
Compound 56 had an extinction coefficient of 3765 ± 0.0089, which was higher than 
the extinction coefficient of SDG 1.  Compounds 57 and 58 had extinction 
coefficients of 3208 ± 0.0103 and 3209 ± 0.0049, respectively, which were similar to 
the extinction coefficient of SDG 1.   
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Figure 4.22. AAPH 47-mediated oxidation of compound 55 to SDG 1 and 
compound 56 (60°C for 30 min). 
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Table 4.22. Mean (±SD) extinction coefficient (L mol-1 cm-1) of SDG 1 
standard (in methanol) at different concentrations, at 280 nm (n=5).  
 
Conc 
(mole/L) 
Extinction coefficient  
(L mol-1 cm-1) 
0.001 3200 ± 0.0010 
0.002 3206 ± 0.0020 
0.004 3203 ± 0.0040 
0.006 3204 ± 0.0060 
0.008 3203 ± 0.0080 
0.01 3207 ± 0.0100 
Average 3204 ± 0.0052 
 
Table 4.23. Mean (±SD) extinction (L mol-1 cm-1) of SDG 1 oxidation 
compounds with AAPH 47 (in methanol), at 280 nm (n=5). 
 
Compound Conc (mole/L) 
from mass 
Conc (mole/L) from 
HPLC (UV data) 
Extinction coefficient 
(L mol-1 cm-1) 
55 0.000988 0.000956 6405 ± 0.0037  
56 0.003956 0.003553 3765 ± 0.0089 
57 0.001663 0.001610 3208 ± 0.0103 
58 0.002564 0.002279 3209 ± 0.0049 
AAPH 47  
after heat  
0.010000 0.010000 586 ± 0.00030 
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5.0. DISCUSSION 
5.1. SECO and SDG as chain-breaking antioxidants 
The major objectives of this study were to investigate the antioxidant 
properties and major oxidative compounds of SECO 2 and SDG 1 using an AAPH 
47 in vitro model of lipid peroxidation.  This investigation was facilitated by the 
structural elucidation of the major oxidative compounds from the reaction with 
AAPH 47 and the stoichiometric ratio determination of SECO 2 and SDG 1 
compared to BHT 17, as a positive control.  This study relates the results of the 
product study to the relative antioxidant capacity.  Finally, the antioxidant capacity 
was confirmed using two different systems.  In addition, this research confirmed the 
antioxidant activity of flaxseed lignans and provided an insight into the antioxidant 
chemistry.   
Antioxidant food preservatives such as BHT 17 are commonly used to 
minimize autoxidation of oil-based food products,223,275 typically at levels of 75 mg 
kg-1 in foods.279,280  Concern has arisen regarding potential liver toxicity from 
chronic use of these compounds.276  This has lead to a growing interest in finding 
alternative antioxidant food preservatives, specifically natural products that may also 
have the potential to provide additional health benefits.  Flaxseed lignans are natural 
antioxidants with no known toxicity and may have potential health benefits 
associated with their consumption.6,124,127,151,274   
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Based on the chemical structure, SECO 2 is expected to be a more lipophilic 
antioxidant than SDG 1.  The present study demonstrated that in a liposomal system, 
SECO 2 (on a molar basis) has a higher free-radical trapping capacity than does 
SDG 1.  This higher capacity is attributed to the aglycone structure of SECO 2 
(compared to SDG 1, a glycoside) providing greater solubility in liposomes.  A 
similar observation has been previously reported for the flavonoid quercetin which 
was shown to have a higher antioxidant activity than its glycoside, rutin.165,286,287  
SDG 1 has been reported to prevent the development of disease related to oxidative 
stress,119,127,130 these results suggest SECO 2 may also be effective in the prevention 
of oxidative stress by free-radical scavenging and prevention of oxidation.154,288   
The results reported here indicate that flaxseed lignans may be useful as 
natural antioxidant preservatives and might be applicable in this role in vegetable 
oils and other foods.  Both in vitro and in vivo studies on human and animal models 
demonstrate the health benefits of flaxseed lignans, including decreases in breast 
and prostate cancers, delayed onset of diabetes, protection against lupus-induced 
nephritis, bone loss and heart disease.129,277,289  It may also be attractive to include 
flaxseed lignans as a preservative in vegetable oil-based products because of the 
potential to provide additional health benefits as antioxidant or weak 
estrogenic/anti-estrogenic compounds.50,68,133,135,290  The requirement for increased 
amounts of flaxseed lignans for this purpose could also provide a value-added 
economic benefit to flaxseed growers.   
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The conclusions from the data for the in vitro oxidation systems cannot be 
extended directly to the in vivo oxidation system.  The in vivo system involves 
complex processes and feedback mechanisms that cannot be reproduced using in 
vitro experiments.279,280  Many reactions take place competitively in vivo and the 
overall antioxidant activities are determined by a delicate balance of these 
competing reactions.  Nevertheless, the behaviour of antioxidants in vivo are 
unlikely to be understood unless the chemistry and biochemistry of these 
antioxidants for the in vitro systems are elucidated.279,280 
 
5.2. Antioxidant capacity of flaxseed lignans in liposomal and
 vegetable oil systems 
The ability of flaxseed lignans to delay the onset of oxidation in two model 
systems was examined.  These studies demonstrated the potential use of flaxseed 
lignans as naturally-occurring food preservative antioxidants.  First, a peroxyl 
radical-mediated liposomal oxidation system was used to calculate an antioxidant 
stoichiometric value which measured the number of radicals consumed per molecule 
of antioxidant.149,230  Second, the ability of each antioxidant was examined to find 
whether they can inhibit rancidity in a commercially available vegetable oil via 
measurement of lipid oxidation levels using a Rancimat analyzer.279,280 
Dietary antioxidants broadly include radical scavengers, metal chelators, 
oxidative enzyme inhibitors, and antioxidant enzyme cofactors.150,230  A variety of 
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tests have been developed to express antioxidant potency.  These tests can be 
categorized into two groups:  
1) Assays for radical scavenging ability.150,230,233  Some of the commonly used 
methods include: measuring the reduction of stable radicals (DPPH radicals), 291 
measuring the ability to scavenge radicals generated using azo-initiators (AAPH, 
AMVN and ABTS), 292 deoxyribose assay for non site-specific and site-specific 
Fenton reactant-induced ●OH scavenging activity151,231, and scavenging of hydroxyl 
radical generated in the FRBR assay.230  
2) Assays that test the ability to inhibit lipid oxidation under accelerated 
conditions.232  Accelerated test systems mainly include lipids, which rapidly oxidize 
in order to simulate a long induction period in a short time.  To accelerate oxidation, 
an increase in temperature is often used.150,232  Both the stoichiometric ratio and 
Rancimat methods reported here were based on lipid oxidation under thermal 
acceleration.  
 
5.2.1. Stoichiometric ratio 
The purpose of this study was to quantitate the ability of the flaxseed lignans 
to inhibit lipid peroxidation, thus necessitating model systems that mimic lipid 
peroxidation.  The stoichiometric ratio uses liposomes as a mimic of in vivo lipid 
peroxidation.  Thermal decomposition of AAPH 47 induces autoxidation of linoleic 
acid, where phosphatidylcholine and linoleic acid form phospholipid liposomes 
when dispersed in water.230  An antioxidant’s ability to inhibit liposomal lipid 
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peroxidation is given a numerical value, the stoichiometric ratio n.  This method 
relies on calibration with an antioxidant with a known reaction stoichiometry in this 
system.  In this case BHT 17, which reacts with two peroxyl radicals per molecule 
(n=2) was chosen.  It has been generally observed that the kinetics and mechanisms 
for the oxidation of lipids in liposomal membranes are essentially the same as those 
of phospholipids and fatty acids in organic solution.230  Therefore, the liposomal 
system can serve as a good in vitro model for biological membranes.  This study did 
not use an emulsifier as stabilizer since some emulsifiers (e.g. Tween) can increase 
free radical generation which  may produce a pro-oxidant rather than inhibitory 
effect.149,225   
The progress of autoxidation was monitored by the formation of primary 
oxidation products, conjugated dienes (240 nm).150  In the absence of antioxidant 
(blank control), linear formation of conjugated dienes was observed, as described by 
the equation y=0.0425x + 0.2784.  Addition of BHT 17, SECO 2 or SDG 1 resulted 
in inhibition of conjugated diene formation as indicated by a lag phase where limited 
conjugated diene formation occurred.  Since formation of conjugated diene products 
occurs during the chain propagation phase it would be expected that a non-zero level 
of conjugated dienes would be formed if the lignans are indeed quenching chain 
propagation.  When all of the antioxidant was consumed the rate of formation of 
conjugated dienes returned nearly to the levels seen for the blank control.  The 
slopes of the curve (Ri value or rate of oxidation) were inversely proportional to the 
concentration of SECO 2 and SDG 1, which is consistent with values previously 
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reported for the oxidation of vitamin E and β-carotene.278,293  The intersection of 
these two lines (inflection point) defines the lag phase (τ) which can be related to the 
stoichiometric ratio.  Due to the gradual change in slope near the point of 
intersection, there is some uncertainty in determination of an exact inflection point.  
Therefore the selection of data points defining the two lines was biased in favour of 
early and late data points. 
The stoichiometric ratio determination provided valuable information about 
the number of peroxyl radicals consumed per molecule of SECO 2 and SDG 1 as 
compared to the widely used synthetic antioxidant BHT 17.  The contribution of 
aromatic hydroxyl groups in oxidation reactions are well known for phenolic 
antioxidants.279,280  It was anticipated that the n-value for SECO 2 and SDG 1 could 
be estimated from the relationship between n-value and the number of active 
hydroxyl groups in their structures.227  SECO 2 and SDG 1 have an equal number of 
aromatic hydroxyl groups and therefore, they would be expected to scavenge an 
equal number of free radicals, with a maximum stoichiometric ratio of n=4 predicted 
for both.  In this study SECO 2 and SDG 1 were determined to have different 
stoichiometric ratios and both possessed an n<4, less than might be expected from 
the number of their active hydroxyl groups, similar to those found by Roginsky 
(2003)227 for catechol derivatives.  
The stoichiometric ratio (1.5) of SECO 2 indicates that SECO 2 has a higher 
free-radical scavenging capacity than SDG 1 (1.1-1.2).  The stoichiometric ratio 
values well below the ideal value of n=4 suggest that the predicted models for 
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flaxseed lignan antioxidant reactions do not accurately reflect the antioxidant 
process.  The greater antioxidant capacity of SECO 2 is likely due to two 
possibilities, (i) greater solubility in the liposomal system of SECO 2 vs SDG 1, (ii) 
involvement of the two alcoholic hydroxyl groups on SECO 2 that are glycosylated 
in SDG 1 in the antioxidant reactions.  Consistent with these results are studies 
which have indicated that flavonoids and (-)-epicatechin with glycosylated phenolic 
groups show lower antioxidant activities than their aglycones.251,294-296  Isoflavones 
in the aglycone form have higher antioxidant activities than their glycosides and it 
has been suggested that this is the result of increased lipophilicity.226,287  Since the 
number of phenolic hydroxyl groups in the aglycone form of flavonoids, and 
catechins has an effect on their free-radical scavenging capacity, it is likely that the 
diminished antioxidant capacity in those glycosylated systems is the result of 
blocking key hydrogen donating phenol groups, although reduced lipid solubility 
may also play a role.251,294-296   
In the case of SDG 1, the hydroxyl groups which are blocked are alcohols 
rather than phenols and would not be expected to participate in the antioxidant 
reactions, suggesting reduced lipid solubility as a likely explanation.  If the alcohols 
do contribute to the antioxidant reactions it is conceivable that the alcohols on the 
glucose moieties would also contribute to the antioxidant capacity.  This would 
suggest that SDG 1 should have higher antioxidant capacity than SECO 2 which was 
not observed in the present study.  The product studies in section 5.3 will address the 
reactivity of the alcohol groups on SECO 2.  Furthermore, a new proposed 
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antioxidant model for the flaxseed lignans based on the determination of the 
products from AAPH 47 mediated oxidation of SECO 2 and SDG 1 will be 
discussed in section 5.6. 
Antioxidants are divided into two categories, preventive antioxidants and 
chain-breaking antioxidants.226  The preventive antioxidants (e.g. glutathione 
peroxidase and catalase) deactivate the active species (e.g. H2O2) without further 
generation of free radicals and, thereby, reduce the rate of chain initiation.226  Chain-
breaking antioxidants have the ability to scavenge chain-propagating oxygen 
radicals to produce stable, non-radical products and suppress lipid peroxidation.226  
Therefore, the antioxidant capacity, n, shows how many chains may be terminated 
by one molecule of antioxidant.226,227  BHT 17 traps peroxyl radicals to produce a 
stable phenoxyl radical or to form stable non-radical products.197,228  Niki et al. 
(1985)228 demonstrated that chain-breaking antioxidants, such as vitamin E, can 
scavenge the chain-propagating oxygen radicals generated from AMVN and 
suppress the peroxidation of liposomal membranes in aqueous dispersions.226  Lee et 
al. (2004)197 reported that cysteine and glutathione could also act as chain-breaking 
antioxidants by scavenging oxygen-centered radicals and suppressing the oxidation 
of lipids.197   
 Many stoichiometric ratios or antioxidant capacities for naturally-occurring 
catechols have been determined.  Several of these catechols demonstrate impressive 
antioxidant capacities (quercetin (2.6), (-)-epigallocatechin (2.2), catechin (1.7) and 
methylgallate (2.3) calculated from the oxidation of cumene in methyl linoleate227).  
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In spite of their lower apparent antioxidant capacity, SECO 2 and SDG 1 may 
however have an advantage to the catechols.  Flavonoid catechols  are susceptible to 
oxidation to quinones, especially ortho-quinones, which can increase oxidative stress 
or react with biological molecules.165  SECO 2 and SDG 1 cannot form ortho-
quinones.  In conclusion, SECO 2 and SDG 1 demonstrated that they are chain-
breaking antioxidants because they trap AP radicals and do not propagate the chain 
of oxidation reaction.   
 
5.2.2. Rancidity test  
The Rancimat method is one technique that can be used to measure rancidity 
of fats and this data can be used to estimate the effect an antioxidant may have on 
shelf life of a food product.  This technique has the advantage that it measures 
volatile lipid peroxidation products and that it is automated and calculates induction 
time, a measure of antioxidant capacity, through a curve-fitting program.  The goal 
of these experiments was to determine whether the lignans in flaxseed would act as 
preservatives of an oil-based food (canola oil) and which form of lignan, SECO 2, 
SDG 1 or SDG polymer 3, would be the most effective in this system.  Since BHT 
17 was used as a standard in the stoichiometric ratio and is used as a commercial 
food preservative it was decided that the use of BHT 17 in the rancidity study may 
allow comparison with the results from the stoichiometric study.  In addition, BHT 
was used instead of BHA because BHT is more heat resistant than BHA which 
makes it a better model compound for this study design.150 230 
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One goal of this study was to utilize conditions similar to those seen in real 
food systems.149,230  All oil samples were stored in the dark at room temperature as 
hydroperoxide decomposition is more rapid at higher storage temperatures (>60°C) 
and the kinetics of oxidation are not the same as would be observed at lower 
temperatures.225  An initial pilot study was performed using equivalent weights of 
BHT 17 and SECO 2 per 100g oil to determine a sensitivity range for this method.  
The concentrations used were chosen based on a typical BHT 17 level used in food 
preservation of 200 ppm.272  The concentrations of 10, 20 and 30 mg/ 100 g oil 
correspond to 100, 200 and 300 ppm BHT 17, respectively.  In addition, the pilot 
study was carried out at two temperatures, 110ºC and 120ºC.  These temperatures 
are commonly used to model frying temperature.  The results for the pilot study at 
both temperatures show that induction time decreases over time and both 
antioxidants minimize the decrease in induction time in a concentration-dependent 
manner (Table 4.3).  The results at 120ºC show that the rate of decrease in induction 
time is approximately double that at 110ºC over time, as would be predicted by the 
Arrhenius equation for every 10ºC change.280  It was decided to use 110ºC for the 
remainder of the study as the results at this temperature showed greater sensitivity to 
changes in concentration (Table 4.4.).    
Although BHT consistently demonstrates a greater protective effect than the 
lignans, the values were similar.  Since the molecular weight of SECO 2 is 1.6 times 
greater than the molecular weight of BHT 17, this implies that on a per molecule 
basis SECO 17 may be as potent an antioxidant as BHT 17.  To test this observation, 
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the Rancimat study was repeated using mole per 100g oil to compare the antioxidant 
ability on a per molecule basis.  Two additional compounds were tested, SDG 1 and 
SDG polymer 3.  Kamal-Eldin et al. (2001) reported that the SDG polymer 3 
(MW=4000) consists of a straight-chain structure composed of five SDG 1 residues 
interconnected by four HMGA residues.29  It is important to note that other 
phenolics, including cinnamates, are present in the SDG polymer 3 and that these 
may contribute to the antioxidant effects.29  However, many of these cinnamates are 
present as -O- glucosides which limit their potential to act as antioxidants in food 
systems but not in mammalian systems (personal communication with Dr. Muir).  A 
specific wt% can not be assigned to the polymer, although a lower limit of 35 wt% 
SDG 1 in the polymer30 allows an estimate of SDG 1 equivalents such that 10 mg, 
20 mg, or 30 mg/100 g oil correspond to SDG 1 concentrations of 0.0044 mmol, 
0.0087 mmol or 0.0131 mmol/100 g oil, respectively.  
The induction time experiments showed that flaxseed lignans SECO 2, SDG 
1 and SDG polymer 3 can inhibit autoxidation in a vegetable oil (canola) model and 
prolong the shelf-life with similar induction times to that of BHT 17, the positive 
control (Table 4.4).  The ability of the SDG polymer 3 to inhibit autoxidation, at 
least as well as SDG 1, may represent an economic benefit, since SDG polymer 3 
requires fewer processing steps and is less expensive to isolate than SECO 2 or SDG 
1 (personal communication with Drs. Muir and Westcott).  Thus, it may be that SDG 
polymer 3 is the most economically feasible form of flaxseed lignans to use in the 
role of a food preservative.     
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The results observed for the Rancimat study are in agreement  with those 
seen for the stoichiometric ratio results, in which all of the compounds studied were 
antioxidants and were in the order BHT>SECO>SDG.  The glucose moieties on 
SDG 1 are clearly responsible for the difference in activity between SECO 2 and 
SDG 1 as discussed in the previous section, but what remains unclear is whether this 
is the result of solubility or reactivity of the alcohol groups on SECO 2.   
BHT 17 and SECO 2 were dissolved directly in the bulk oil, SDG 1 and 
SDG polymer 3 do not dissolve in oil as well and required a co-solvent (1 mL 
ethanol), therefore co-solvent was used for all of the compounds tested.  However, 
the SDG polymer 3 unexpectedly showed higher antioxidant activity than SDG 1 in 
this canola oil system.  The SDG polymer 3 has been observed to elute after SDG 1 
by reversed-phase HPLC, indicating that the SDG polymer 3 is more lipophilic than 
SDG 1.297    Esterified HMGA residues in the SDG polymer 3 appear to increase the 
lipophilicity of the polymer compared to SDG 1.29,30,298  The observed antioxidant 
activity of the SDG polymer 3 confirms that glucosylated lignans can maintain 
antioxidant activity, which may be enhanced with increased lipophilicity.  What the 
contribution of the HMGA substituent and the trace phenolics present in the polymer 
to antioxidant capacity is unknown and beyond the scope of this study.  Variability 
in the SDG 1 content in the polymer is also a potential problem with the assessment 
of the polymer as a food preservative.  In this study, all of the SDG polymer 3 used 
was derived from a single batch, however without a standardized protocol for 
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polymer isolation, it will be necessary to determine % SDG 1 content accurately for 
any future comparative studies. 
What is also unknown is why SECO 2 does not protect canola oil as well as 
BHT 17.  This may be the result of differences in lipid solubility, or that the 
mechanism of antioxidant activity of SECO 2 differs from that for BHT 17, an idea 
that will be explored further in the discussion of the product study results.   
Another method for expressing results from the Rancimat study is to use a 
protection factor (PF) which is a ratio of IT for each sample versus IT for the blank. 
150,225,299  The n-values and the PF values (Table 4.5) at 120 days for the antioxidants 
tested  allows for a comparison of the results for these two systems.   The PF for 
BHT 17 is lower than the n-value, which may indicate that the Rancimat method is 
less sensitive to minor differences in antioxidant capacity.  This comparison 
illustrates that a similar trend exists for the two systems, although it remains difficult 
to treat these numbers as quantitative.   
For the purpose of cooking and frying oils there are four factors that good 
antioxidants must possess: lipid solubility, heat stability, the presence of active 
hydroxyl groups and the ability to maintain clarity (ie. the compound does not cause 
cloudiness).149  SECO 2 and SDG polymer 3 meet the criteria of lipid solubility and 
active hydroxyl groups, their heat stability and ability to maintain clarity would 
require further investigation.  The results reported in this study can only be used to 
infer the potential use of flaxseed lignans as food preservatives in oil based food 
systems.  The use of the lignans in other food systems such as oil in water emulsions 
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would require experiments carried out in the appropriate systems.  It would also be 
interesting to determine whether a synergistic antioxidant effect is observed for 
SECO 2 and SDG 1 in combination, for which an emulsion may be an appropriate 
model system.  Studies such as these would also require a clear understanding of the 
solubility, stability and partitioning of SECO 2/SDG 1 in oil in water or water in oil 
emulsions. 
In conclusion, the two oxidation model systems demonstrated the potential 
for SECO 2, SDG 1 and SDG polymer 3 to act as antioxidants in oil-based foods.  
First, the stoichiometric ratio in a liposomal system established that this was a 
satisfactory assay to measure the ability of SECO 2 and SDG 1 to inhibit APPH 47-
catalyzed lipid peroxidation.227  The stoichiometric ratio for SECO 2 and SDG 1 
were 1.5 and 1.1-1.2, respectively, compared to BHT 17 (2.0), indicating that both 
SECO 2 and SDG 1 delayed AAPH 47-induced lipid autoxidation likely through a 
combination of peroxyl radical chain termination reactions and by scavenging AP 
radicals.  These results demonstrated that SECO 2 and SDG 1 are less potent 
antioxidants compared to BHT 17, however they have potential advantages over 
BHT 17 in that they are natural antioxidants that have potential health benefits 
associated with their consumption.129,153,277  It should be noted however, that before 
SECO 2 or SDG 1 could be used in this capacity, more in-depth toxicological 
studies are warranted to ensure that prolonged consumption of flaxseed lignans is 
safe.   
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Second, it was determined that the Rancimat was an appropriate analytical 
tool for the measurement of inhibition of autoxidation mediated by flaxseed lignans 
in comparison with BHT 17-mediated inhibition of autoxidation.  Both model 
systems showed that as an antioxidant, SECO 2 provides better protection than SDG 
1.  The observed induction times were consistent with the calculated stoichiometric 
ratio (Table 4.5), and illustrative of two appropriate oxidation models.   
The activities of antioxidants depend not only on their structural features 
(e.g. activities towards peroxyl and other active species), but also on many other 
factors, such as concentration, temperature, light, type of substrate, physical state of 
the system, as well as on microcomponents acting as pro-oxidants or synergists.225  
Several important factors that may affect the results of antioxidant studies in lipid 
systems are the initial concentration of primary autoxidation products, such as 
hydroperoxides in the lipid and free fatty acids.  Primary oxidation products may 
reduce both the efficiency of the antioxidants and the time for radical-mediated 
consumption of antioxidant.149  Free fatty acids may demonstrate a pro-oxidant 
effect and should be minimized.  Other lipid microcomponents, such as metals, fatty 
alcohols and mono- and diacylglycerols, have been also shown to decrease the 
effectiveness of phenolic antioxidants.149  In the present study, attempts were made 
to minimize the contribution of these factors.  DLPC was stored appropriately to 
keep hydroperoxide concentrations low.  Lipids were chosen that should have little 
free fatty acid composition and they were free of endogenous antioxidants.  High 
purity water was used to minimize the presence of metals such as Fe and Cu.  It 
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should be noted however, no attempts were made to determine the background 
levels of these components.  
  
5.3. SECO 2 antioxidant reaction products from AAPH 47-mediated 
oxidation  
A pilot study was carried out to optimize the reaction conditions for AAPH 
47-catalyzed oxidation of SECO 2.  Three different concentrations of AAPH 47 
(0.05, 0.1, 0.2 M) based on literature  methods,300-302 were tested and 0.1 M AAPH 
47 was chosen as this concentration produced sufficient levels of reaction products 
for analysis.  A time course study (up to 72 h) was performed and it was determined 
that >90% of SECO 2 had been consumed by 5 h and sufficient amounts of the 
major oxidation products were observed to allow for isolation and purification.  In 
addition, the oxidation reaction was carried out at two different temperatures (50ºC 
and 60ºC) and 60ºC was chosen as optimal.  AAPH 47 undergoes thermal 
decomposition in solution with the loss of N2 to produce two carbon centred radicals 
(AP).  The AP radical can add O2 to form a peroxyl radical, although carbon centred 
radicals often predominate.  There are two notable limitations to the product study, 
AAPH 47 tends to form carbon-centred radicals as opposed to peroxyl radicals and 
lipid is absent from the reaction system.  AAPH 47 was used due to it’s favourable 
solubility properties that allowed this study to be carried out for both SECO 2 and 
SDG 1 and because unlike AMVN, the products of thermal decomposition do not 
possess a chiral centre.  Although lipid was absent in the product studies to simplify 
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isolation and identification of the potential oxidation products, this model system 
still provides valuable information about the possible antioxidant reactions of SECO 
2.   
  Oxidation of SECO 2 with AAPH 47 indicated that compounds 48 and 52 
were formed rapidly and decomposed after 90 min, whereas compounds 49, 50 and 
51 formed later (section 4.2, Figure 4.6).  It would be expected that the phenolic OH 
would preferentially undergo H-atom abstraction.200  The results reported here, 
however, indicate that the early-forming compounds involved the aliphatic alcohols 
of SECO 2 in the oxidation reaction.  This is surprising given that the O-H bond 
energy of an aliphatic alcohol (104.5 kcal mol-1)303 is greater than for a phenolic  
O-H (72.6 kcal mol-1).225  Several possible reaction pathways leading to the 
formation of 48 and 52 can be envisioned.  One possibility is that the aliphatic 
oxygen-centred radical 2a forms directly from the AP radical mediated H-atom 
abstraction from the SECO 2 aliphatic OH.  A hydrogen-bonding interaction 
between the aliphatic alcohols may lower the pKa of the alcohol, which could 
produce alkoxide ion in low amounts which would be more susceptible to radical 
formation.304  Alternatively, an intramolecular H transfer from the aliphatic alcohol 
to the initially formed phenoxl radical 2c could occur (Figure 5.1).  A third, albeit 
less likely, possibility cannot be ruled out in which an intermolecular H transfer 
from the aliphatic alcohol of one molecule of SECO 2 to the phenoxyl radical 2c of 
another molecule of SECO 2 occurs.  The products derived from the alkoxyl radical 
2a were unexpected and appear to be unique.  It would be beneficial to obtain crystal 
  173
structures of these products as further confirmation of this unexpected pathway, 
however this will require the preparation of further amounts of compounds 48, 51 
and 52 via AAPH 47 catalyzed oxidation of SECO 2.    
The peroxide structure proposed for 52 was probed further by determining 
the amount of peroxide present using a peroxide-value test.283  This method is 
sensitive to alkyl peroxides and can be used for quantitation, although the results in 
this study were near the lower region of the calibration curve.  The results indicate 
the presence of 1.8 peroxide equivalents per one molecule of 52, close to the 
expected peroxide number of 2.0 per molecule of compound 52.  Previous studies 
have also showed the formation of peroxides from phenolic compounds with methyl 
or hydroxyl substitution.305   
The intermediate alkoxyl radical 2a is proposed to be involved in the 
generation of the early-forming oxidation compounds (48 and 52) while the 
phenoxyl radical 2c would lead to the late-forming oxidation compounds (49, 50 and 
51).  It would be anticipated that the phenoxyl radical 2c is more stable than the 
alkoxyl radical 2a.  The results presented here are in agreement with this since the 
majority of the products are derived from the phenoxyl radical pathway and products 
from the alkoxyl radical 2a appear to form more rapidly and/or be converted to 
secondary products faster. 
A reaction pathway can be proposed which fits the experimental data 
reasonably well.  After formation of intermediate 2a, rapid dimerization to form 
compound 48 would occur (Figure 5.2).  Since 48 was shown to be transient in the 
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time-course and AAPH mediated oxidation of 48 lead to the production of 52, 51 
and SECO 2, this suggests that dimerization of 2a to form an aliphatic peroxyl 
linkage is reversible.  The alkoxyl radical 2a from this reversible reaction could 
capture a hydrogen atom from solution to produce SECO 2, which may also explain 
the greater overall yield of phenoxyl radical derived products.  Compound 52 could 
be formed from further oxidation of 2a, in which subsequent formation of a second 
alkoxyl radical (not shown) is followed by oxidation.  The source of the additional 
oxygen atoms in 52 could be either from solvent (H2O) or atmosphere (O2).  Mass 
difference experiments using either H218O or 18O2 may be useful in the future for 
determining the origin of these incorporated oxygen atoms.  The stable product, 51, 
appears to result from formation of 52b, the phenoxyl radical of 52 (Figure 5.3).  
The time course for the oxidation of 48 shows loss of 52 coupled to the appearance 
of 51, which strongly suggests that addition of the AP radical must happen after 
oxidation of SECO 2 to 52 and not as a result of initial formation of 50 and 
subsequent oxidation of the aliphatic alcohols.  This agrees with the observations 
that the aliphatic alcohol radicals seem to form and react faster than the phenoxyl 
radicals. 
 
 
 
 
 
  175
 
5.1a* 
SECO 2a  
 
 
OH
OH
OH
MeO
OMe
OH
OH
O  
OH
MeO
OMe
OH
(CH3)2C
NH2
NH
OH
OH
OH
MeO
OMe
O  
(CH3)2C
NH2
NH
(CH3)2C
NH2
NH
2
2a
o
9
9 '
SECO
o
H transfer
o
o
2c
 
 
Figure 5.1. Proposed reaction scheme for the formation of 2a. 
   *For simplicity, Figure 5.1a shows the reactions by their product numbers. 
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Figure 5.2. Proposed reaction scheme for the formation of compounds 48 and 52 
from SECO 2 via 2a. 
*For simplicity, Figure 5.2a shows the reactions by their product numbers. 
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Compound 50 was determined to be the major product of AAPH 47 mediated SECO 
2 oxidation.  Compound 50 would be derived from the anticipated reaction pathway, 
AP mediated H-atom abstraction from the phenol to yield the resonance stabilized 
phenoxyl radical 2c (Figure 5.4).  The phenoxyl radical 2c would then undergo a 
radical recombination with an AP radical to form the stable product 50 (Figure 5.4).  
This reaction is indicative of a chain-breaking antioxidant and suggests that SECO 2 
likely functions in this way.  Compound 49, a dimer of SECO 2, is also derived from 
the initially formed phenoxyl radical 2c.  Unlike the formation of compound 48 
however, dimerization does not occur via an O-O peroxyl linkage, instead a carbon-
carbon bond is formed between the phenyl rings.  The phenoxyl radical is resonance 
stabilized and one of the resonance contributors would place the unpaired electron 
on the unsubstituted carbon ortho to the phenol OH (Figure 5.5).  Thus, formation of 
49 can be rationalized as a dimerization between two of the carbon-centred 
resonance contributors shown in figure 5.5.  The initial product of dimerization 
would be expected to have a di-keto structure.  The two aromatic rings involved in 
the dimerization however are not present in the keto-form, indicating that 
aromatization drives the equilibrium from the keto to the enol (phenol) form.  It is 
possible that dimerization of 2c to 49 is reversible as is suggested by the time-course 
data, however due to the limited amount of product isolated, an AAPH 47 mediated 
oxidation of 49 could not be performed to confirm this. 
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Figure 5.3. Proposed reaction scheme for the formation of compound 51. 
   *For simplicity, Figure 5.3a shows the reactions by their product numbers. 
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Figure 5.4. Proposed reaction scheme for the formation of compound 50. 
         *For simplicity, Figure 5.4a shows the reactions by their product numbers. 
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Figure 5.5. Proposed reaction scheme for the formation of compound 49. 
         *For simplicity, Figure 5.5a shows the reactions by their product numbers. 
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The data from the oxidation experiments reported here supports the proposed 
reaction mechanism of SECO 2 as a scavenging agent that breaks chain of oxidation 
(Figures 5.6 and 5.7).  In the proposed oxidation pathways, compound 48 is formed 
from dimerization of 2a that subsequently is converted to 52 and then to 51 (Figure 
5.6).  In addition, the final compounds 50 and 51 can trap the carbon-centered AP 
radicals.  Compound 52 also is an intermediate compound of oxidation, which is 
converted to compound 51 with the ability to scavenge the carbon-centered AP 
radical.  It appears that under these conditions, compounds 48 and 52 undergo 
further oxidation to yield compound 51.   
Recently, a similar study was published which examined the AAPH 47 
(referred to as ABAP) mediated oxidation products of SECO 2.152  In that paper, all 
of the products reported in this thesis were not observed.  Only products from the 
phenoxyl radical pathway (49 and 50) were observed, in addition to two other 
products, a dimethyl furanone of SECO 2 and lariciresinol.  The authors suggest that 
the dimethyl furanone is formed from further reaction of compound 50 and that 
lariciresinol is formed via a quinone methide intermediate in which an 
intramolecular cyclization occurs between an alcohol group and the terminal CH 
group of the quinone methide.  In this paper, NMR data was presented only for the 
dimethyl furanone, the only supporting data provided for the other compounds was 
from LCMS.  Therefore, this study is the first to accurately determine the structures 
of the AAPH 47 mediated SECO 2 metabolites. 
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It is important to note that although the work reported in this thesis did not 
observe lariciresinol, it is possible that small amounts may have been formed.  
Lariciresinol is difficult to separate from SECO 2 using reverse phase HPLC and it 
may have co-eluted under the conditions used or been one of several minor products 
that were not characterized due to insufficient product amounts.  Since this thesis 
reports SECO 2 oxidation products resulting from an alkoxyl radical 2a, it is 
possible that lariciresinol in Eklund et al.,152 study was formed through a similar 
alkoxyl radical, although this cannot be proven with the present data.   
There were three major differences in Eklund et al.,152 experimental protocol 
from that used in this thesis which would be expected to influence the reaction 
products observed.152  Eklund et al., used a higher temperature (70ºC), a longer 
incubation time (72 h versus 5 h) and an AAPH 47:SECO 2 ratio of 3:1 versus 10:1 
used in this study.  It was also not clear what their final concentrations of AAPH 47 
and SECO 2 were.  If Eklund et al., used lower concentrations than those used in 
this study, that could explain the need for higher reaction temperatures and longer 
reaction times.   
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Figure 5.6. Proposed reaction scheme for SECO 2:AAPH 47 oxidation from 
hydroxyl groups on C-9 positions. 
*For simplicity, Figure 5.6a shows the reactions by their product numbers. 
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Figure 5.7. Proposed reaction scheme for SECO 2:AAPH 47 oxidation from 
aromatic hydroxyl groups. 
*For simplicity, Figure 5.7a shows the reactions by their product numbers. 
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The dimethyl furanone observed by Eklund et al., would not be expected under the 
less drastic conditions used in this study as they were apparently the result of 
decomposition of 50.  The excess AAPH 47 used in this thesis likely influences the 
formation of the alkoxyl radical-mediated species.  Given the apparent instability of 
the alkoxyl radical derived products (48, 51 and 52) the higher temperature and 
extended reaction time would likely lead to decomposition of these products which 
may explain why Eklund et al., reported a greater loss of material to polymeric 
products than observed in this thesis. 
There are several antioxidant reaction pathways that would be predicted for 
SECO 2, using BHT 17 as a model of phenol antioxidant reactions.  The most likely 
reaction pathways would involve initial loss of a phenolic hydrogen atom to form a 
resonance stabilized phenoxyl radical (2c) followed by radical recombination with 
AP or another radical species at either the phenoxyl oxygen, the C-5 carbon or the 
C-1 carbon.  Ideally, this would result in the removal of two radicals per phenol ring, 
potentially leading to a total of four radicals consumed per molecule of SECO 2.  
The stoichiometry study indicates that SECO 2 consumes substantially less than four 
radicals per molecule (1.5).  There are several possible explanations for this result 
including limited incorporation of SECO 2 into the liposomes and competing 
reactions that would generate radicals or have a net radical consumption of zero.  
The reaction pathway outlined in figure 5.7 demonstrates that formation of an AP-
SECO 2 product, compound 50, does occur and would have a stoichiometric value 
of two associated with it.  Formation of compound 49 would however have a net 
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stoichiometric value of one, since each molecule of SECO 2 donates a hydrogen 
atom to consume one radical and form 2c but the dimerization only consumes 
molecules of 2c and not other radical species.  There is no evidence that oxidation 
occurs on both aromatic rings of SECO 2, as can be seen in both product 49 and 50.  
This is interesting since an intramolecular dimerization of 48 or 49 should proceed 
rapidly, provided the phenoxyl or alkoxyl radicals can be formed.  This suggests that 
only one phenol in SECO 2 is involved in antioxidant reactions, indicating that a 
radical scavenging model based on the number of aromatic hydroxyl groups may not 
apply to this group of compounds.  This observation agrees with a report by Metzler 
in which the radical scavenging ability of SECO 2, as measured using the Ferric 
Reducing/Antioxidant Power assay, was comparable to that of a monophenolic 
analogue, 2-methoxy-p-cresol.306  Further antioxidant studies on selected analogues 
would be necessary to more fully understand this phenomena.  
The products derived from the reaction pathway outlined in figure 5.6 would 
be expected to provide a smaller contribution than those from the reaction pathway 
in figure 5.7 as they are formed in smaller amounts.  Formation of the proposed 
initial alkoxyl radical would result in the consumption of one radical.  It would 
initially appear that dimerization to form 48 would result in a net stoichiometric 
value of one (see 49 above), however since 48 decomposes over time, this 
contribution must be considered in further reactions that occur.  The contribution to 
antioxidant capacity from 51 and 52 is more difficult to rationalize.  Compound 52 is 
proposed to form via the alkoxyl radical 2a and subsequent oxidation.  Oxidation of 
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the second aliphatic alcohol would provide an additional stoichiometric value of 
one, however subsequent oxidation to the peroxyl species would likely involve the 
generation of a radical species therefore negating the radical scavenging effect 
described earlier.  Compound 51 would be anticipated to have a stoichiometric value 
comparable to 50 as a result of the AP-phenoxyl product. 
Since the different oxidative metabolites form at different rates, it is difficult 
to try and add their contributions to arrive at a stoichiometric ratio.  What can be 
stated with some certainty is that two oxidation products (50 and 51) should 
contribute a stoichiometric value of 2, the remaining oxidation products should 
contribute a stoichiometric value of 1 (48, 49 and 52).   
Another point that must be considered is the potential reactivity of the 
alkoxyl radical.  A lipid alkoxyl radical is 104-106 times more reactive towards 
hydrogen atom abstraction than a lipid peroxyl radical, suggesting alkoxyl radical 
formation may be pro-oxidant in nature.307  In this case, 2a would abstract a 
hydrogen atom from a lipid molecule, starting a new chain reaction and contributing 
further to radical propagation.  It may be that oxidation products from 2a cause an 
increase in lipid peroxidation and reduce the antioxidant effect observed from the 
phenoxyl radical pathway.  The antioxidant reactions for 2a may prevent this pro-
oxidant effect, provided their rate of formation is at least comparable to L● 
formation.  It is not unreasonable to speculate that the antioxidant stoichiometry of 
SECO 2 could be higher, but is limited by the competing pro-oxidant reactions of 
SECO 2. 
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The aromatic hydroxyl groups at the C-4 position and the aliphatic hydroxyl 
groups at the C-9 and C9' positions appear to be the preferred oxidation sites for 
AAPH 47.  The contribution of hydroxyl groups in the oxidation of SECO 2 by 
AAPH 47 is in keeping with the previously reported importance of hydroxyl groups 
in radical scavenging and the antioxidative potential of phenolic compounds.302,308  
The formation of dimers like 48 and 49 has been reported previously as products of 
oxidation for other phenolics including (-)-epicatechin in green tea242,266,267 and 
vitamin E. 309-311 
Compounds 48 and 49 had extinction coefficients twice that of SECO 2, 
which would be expected since they are dimers and contain four phenol rings in 
their structures compared with SECO 2 (two phenol rings).  The extinction 
coefficients for compounds 50 and 51 were slightly higher than SECO 2, as a result 
of the AP-substituent, since products from thermal decomposition of AAPH 47 had 
a low absorbance at 280 nm with an extinction coefficient (L mol-1 cm-1) of 586.  It 
was interesting that compound 51 showed a maximum UV absorption at 258 nm, 
which was lower than the UV absorbance for other compounds, and has been 
previously reported for  3,4-dialkoxy substituted lignans.312   
Oxidation compounds of SECO 2 with AAPH 47 showed they were 
scavengers of carbon-centred AP radicals and as a result, may act as antioxidants.  
Previous investigations have shown that flaxseed lignans have antioxidant 
properties.102,151,288,313,314  This study has shown: a time-course for the reaction of 
SECO 2 with AAPH 47, identified the major products derived from the phenoxyl 
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radical 2c by NMR and LCMS and proposed a reaction pathway for their formation, 
and for the first time identified the major products derived from the SECO 2 alkoxyl 
radical 2a by NMR and LCMS and proposed a reaction pathway for their formation.   
In conclusion, the oxidation of AAPH 47 to produce carbon-centred AP 
radicals upon thermal decomposition provides a good model to study the antioxidant 
reactions of SECO 2 in vitro.  The antioxidant mechanisms of SECO 2 would be 
based on the ability of SECO 2 to donate a hydrogen atom and trap free radicals, 
consequently inhibiting oxidative chain reactions.  SECO 2 forms non-radical 
compounds, which do not easily participate in other radical reactions, several of 
which (e.g. 50 and 51) are similar to products observed with other chain breaking 
antioxidants such as BHT 17 and vitamin E.197,215,228  Compounds 50 and 51 are 
non-radical compounds that result from scavenging of an AP radical, which supports 
SECO 2 having a role as a chain-breaking antioxidant in vitro.   The formation of 
alkoxyl radical mediated products was unexpected and it is unknown at this time 
whether the reactions associated with the alkoxyl radical would be antioxidant or 
pro-oxidant in nature. 
  
5.4. SDG 1- antioxidant reaction products from AAPH 47-mediated 
oxidation 
AAPH 47 was also used for the generation of AP radicals to oxidize SDG 1.  
The same initial conditions used for the oxidation of SECO 2 were used for SDG 1, 
except that the incubation time was shortened to 4h.  The results of the SDG 1 
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oxidation indicated that products 55 and 58 are formed early and decompose after 50 
minutes, product 57 forms early and continues to increase throughout the incubation 
and product 56 forms later in the reaction (section 4.6, Figure 4.11).  An AAPH 47 
control reaction helped to distinguish the products of thermal decomposition of 
AAPH 47 from the major SDG 1 oxidation compounds. The identification of SDG 1 
oxidation compounds in this thesis provides the first unambiguous proof that the 
principal site of antioxidant reactions on SDG 1 is the phenol hydroxyl group at 
position 4/4´.  In addition, there was no evidence of any oxidation reactions 
occurring on the glucose groups. 
A reaction pathway can be proposed which fits the experimental data of the 
AAPH 47-mediated SDG 1 oxidation. The first step in the formation of all of the 
isolated SDG 1 oxidation products would be abstraction of a hydrogen atom from 
the phenol by AAPH 47 to yield the intermediate phenoxyl  radical 1a (Figure 5.8).  
This radical would be resonance stabilized and would be anticipated to react at 
several sites including the phenoxyl oxygen (via 1a, figure 5.8), C-5 (via 1b, figure 
5.9) and C-1 (via 1c, figure 5.11).  Intermediate radical 1a would lead directly to the 
generation of the stable, late forming oxidation compound 56 whereas resonance 
contributors 1b and 1c would lead to the formation of the early forming oxidation 
compounds (55 and 58) (Figure 5.9-5.11).  
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Figure 5.8. Proposed reaction scheme for the formation of 1a. 
   *For simplicity, Figure 5.8a shows the reactions by their product numbers. 
 
Compound 55 is a dimer of SDG 1 in which a carbon-carbon bond is formed 
and would be derived from the carbon-centred radical resonance contributor 1b 
(Figure 5.9).  A radical-radical recombination, similar to that proposed for the SECO 
1 dimer 49, would produce 55.  Since the SDG 1 time-course showed a decrease in 
compound 55 over time, a further oxidation of compound 55 with AAPH 47 was 
conducted.  This experiment showed that AAPH 47-mediated oxidation of 
compound 55 resulted in the formation of SDG 1, 56 and 58 indicating relative 
instability of the carbon-carbon bond in 55 that was not observed for 49.  It may be 
that since 49 was a late-forming compound, compared to the early-forming 55, 
significant decomposition of 49 would require a longer incubation time.  The 
appearance of SDG 1 in the oxidation of 55 suggests that 1a can trap a hydrogen 
atom under these conditions.  Compound 55 also appears to isomerize from the keto 
to the enol (phenol) form. 
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Figure 5.9. Proposed reaction scheme for the formation of compound 55. 
   *For simplicity, Figure 5.9a shows the reactions by their product numbers. 
 
The major oxidation product found in this study was compound 56.  
Compound 56 is a stable, non-radical compound formed directly via trapping of an 
AP radical by 1a (Figure 5.10).  This agrees with the observations for the SECO 2 
oxidation in which compound 50, the product of 2c and an AP radical, was the major 
oxidation product. 
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Figure 5.10. Proposed reaction scheme for the formation of compounds 56. 
*For simplicity, Figure 5.10a shows the reactions by their product numbers. 
 
Compound 58 has a dienenone structure in one of the aromatic rings which 
would appear to result from the reaction of HO• or H2O with resonance form 1c, the 
C-1 carbon-centred radical (Figure 5.11). Formation of a dieneone product is 
consistent with the products that would have been predicted from BHT 17 
antioxidant reactions.  Compound 57 is unique because it is the only SDG 1 
oxidation compound in which both phenoxyl groups undergo reaction (Figure 5.12).  
Peroxide-value tests confirmed the presence of a peroxide in compound 57 with a 
total number of 1.7 peroxides per molecule of 52.  This is close to the expected 
peroxide number of 2.0 per molecule of compound 57 with 2 hydroxyl groups.  
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Figure 5.11. Proposed reaction scheme for the formation of compound 58. 
   *For simplicity, Figure 5.11a shows the reactions by their product numbers. 
 
Previous studies also showed the formation of peroxide from phenolic compounds 
with methyl or hydroxyl substitution.305  As stated earlier for the SECO 2 oxidation 
products that had incorporated oxygen atoms, mass difference experiments using 
either H218O or 18O2 may also be useful here for determining the origin of these 
incorporated oxygen atoms.  The maximum UV absorption of compound 57 (269 
nm) demonstrated the greatest change from SDG 1 for all of the SDG 1 oxidation 
products.  It was interesting that the maximum UV absorption of compound 57 was 
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very similar to compound 51 after oxidation of SECO 2 with AAPH 47 (section 4.1, 
Table 4.1) and to those found previously for lignans with a 3,4 dialkoxy 
butyrolactone.312   
The lack of formation of compound 57 from the oxidation of 55 was 
however surprising, as this compound was present throughout the initial incubation 
and the liberation of SDG 1 from 55 should have led to its formation.  This lead to a 
re-analysis of the results from the AAPH 47-mediated oxidation of SDG 1.  
Compound 57 was seen to form rapidly (5 min) and then increase only gradually 
over the remainder of the 4 h incubation.  This suggests several possibilities: 57 is an 
intermediate that forms other products or, 57 is an impurity present in the SDG 1 
sample or forms from an impurity.  Since none of the other major products found 
had undergone oxidation on both aromatic rings, it is unlikely that 57 leads to any of 
the major compounds, although it remains possible that unidentified minor or 
polymeric compounds were derived from 57.  While chromatographic techniques 
work the best for purifying lignans such as SDG 1, it is extremely difficult to 
remove all impurities from SDG 1.  It is reasonable to speculate that compound 57 is 
an impurity or derived from an impurity in the SDG 1 sample.  This is further 
supported by the observation that no other products were found in which oxidation 
had occurred on both aromatic rings. 
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Figure 5.12. Proposed reaction scheme for the formation of compound 57. 
   *For simplicity, Figure 5.12a shows the reactions by their product numbers. 
 
A reaction scheme for AAPH-mediated SDG 1 oxidation which attempts to 
present an overall pathway to all of the oxidation products is shown in figure 5.13.  
An initial, resonance-stabilized phenoxyl radical would be formed and reactions at 
different positions on the aromatic ring would lead to the different products (Figure 
5.13).  1a leads to the formation of 56 as the result of trapping by AP.  As indicated 
previously, it is however likely that 57 is not produced from AAPH 47-mediated 
oxidation of SDG 1, instead coming from a trace impurity in the SDG 1 sample.  1b 
would lead to dimerization between C-5 positions of the aromatic rings to form the 
transient dimer 55, and 1c produces the BHT 17-like dieneone addition product 58.  
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Furthermore, the AAPH 47-mediated SDG 1 oxidation produced a phenoxyl radical-
derived product (58) that was not seen in the SECO 2 experiment.  It is possible that 
formation of this product in the SECO 2 reaction was not observed due to the 
competing reactions at the primary alcohols (early forming products).  If a longer 
incubation time were used, as was done by Eklund et al., analogous compounds to 
58 may have been observed for SECO 2.  Finally, unlike the situation with SECO 2 
oxidation, there were no early forming products derived from alkoxyl radical 
formation and no evidence for oxidation of any of the hydroxyl groups on glucose.  
This suggests that oxidation of the aliphatic hydroxyl groups of SECO 2 is unique. 
Although Eklund et al., study did not include the AAPH 47-mediated 
oxidation of SDG 1, it did include oxidation of matairesinol.152  Although the 
solubility properties would be different, neither compound has free primary alcohol 
groups on the lignan aliphatic chain, so they should undergo similar reactions.  In 
Eklund et al., study matairesinol was found to only form products from oxidation of 
the phenol group (AP adduct, dimethyl furanone, C-5 dimer, quinone methide 
product, hydroxymatairesinol).  While Eklund et al., results seem to agree with the 
results of this study, it remains inconclusive as SECO 2 also produced the same 
reaction products as matairesinol in Eklund et al., study. 
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Figure 5.13. Proposed reaction scheme for SDG 1:AAPH 47 oxidation 
    *For simplicity, Figure 5.13a shows the reactions by their product numbers.
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Using BHT 17 as a model, the antioxidant stoichiometry of SDG 1 could be 
predicted to be as high as four.  As was the case for SECO 2 the actual 
stoichiometric value (1.1-1.2) was much less.  Part of this can be attributed to only 
one phenol ring reacting with AAPH 47, as was also observed for SECO 2, thus 
reducing the maximum stoichiometry to two.  The antioxidant stoichometry of SDG 
1 may be less than SECO 2 for several reasons: decreased lipid solubility and the 
lack of free primary alcohols on the lignan carbon chain to contribute to the 
antioxidant reactions.  Consideration of the antioxidant contributions from the 
different products observed in this study would aid in rationalizing the stoichiometry 
observed.  Compound 55 would be expected to scavenge two radicals per molecule 
and compound 56 would scavenge one radical per molecule.  The stoichiometry for 
the other two products is less straightforward.  Compound 58 is likely to have a 
stoichiometry of two as it is analogous to the reaction observed for BHT 17.  The 
major contribution to antioxidant stoichiometry would be from 56.  Contributions 
from 58 would not decrease the stoichiometry, whereas contributions from 55 would 
decrease the overall stoichiometry.  The contribution from 57 cannot be determined 
due to the uncertainty associated with its origin.  
Compound 56 was the major oxidation reaction product of SDG 1 with an 
ability to scavenge AP radicals during oxidation, thereby confirming SDG 1 as a 
chain-breaking antioxidant.  The same observation was found for compound 50 in 
the SECO 2 oxidation study (section 4.3).  
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This study demonstrated that the flaxseed lignans SECO 2 and SDG 1 act as 
antioxidants in a homogeneous aqueous system.  As well, this data clarifies the 
mechanism by which SECO 2 and SDG 1 scavenge AP radicals.  In addition, this 
report shows that SECO 2 oxidation occurs on the aromatic (4-OH) and aliphatic (9-
OH) hydroxyl protons.  Conversely for SDG 1, only compounds derived from the 
oxidation of aromatic hydroxyl protons were obtained because the 9-OH position is 
glucosylated.  These results are important for better understanding about the 
chemistry behind flaxseed antioxidant activities.  This study provided useful 
evidence that flaxseed lignans can be used as natural antioxidants, and may have 
roles in the prevention of oxidative stress and inhibitory activity against 
tumorigenesis similar to those found for flavonoids.242,244,254 
 
5.5. The influence of the oxidation products on the antioxidant stoichiometry 
(n-value) of SDG 1 and SECO 2 
Two possible antioxidant reaction pathways are shown based on the known 
reactions of BHT 17 (Figure 5.14-5.15).  In the first step, SECO 2/SDG 1 donates 
one hydrogen from a phenol hydroxyl group to a free radical to form the resonance 
stabilized phenoxy radical 2c.  In the second step, the intermediate 2c scavenges a 
free radical to form non-radical compounds.  In figure 5.14, this result in the radical 
adding to the phenol oxygen, in figure 5.15 the radical adds para to the phenol 
oxygen.  The second aromatic hydroxyl group may undergo the same reactions to 
trap two additional free radicals.   
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Figure 5.14. First predicted pathway for biological antioxidant activity of SECO 2 
and SDG 1. 
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Figure 5.15. Second predicted pathway for biological antioxidant activity of
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Compound 50 and compound 56 partially fit the predicted model about how 
SECO 2 and SDG 1 may react as antioxidants.  This study demonstrated that the 
major oxidation products for both SECO 2 and SDG 1 have only one aromatic 
hydroxyl group involved in the oxidation.  SDG 1 displays products that could be 
derived from both pathways, whereas SECO 2 only has products derived from the 
reactions shown in figure 5.14.  Oxidative reactions in only one of the phenol rings 
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clearly decreases the potential stoichiometry for the molecule.  It would seem that 
the oxidation products are resistant to further oxidation.  This could be the result of 
an intramolecular interaction between the oxidized and reduced phenol rings which 
somehow prevents further oxidation, although this would require further 
investigation.  Since no functional groups are introduced near the unreacted phenol, 
inhibition of phenol oxidation is not likely an electronic effect.   
It is not clear why the antioxidant stoichiometry for SDG 1 and SECO 2 in 
this model system is far below the predicted ideal value.  Both lignans tested seem to 
have a stoichiometric ratio of n=1 per two phenol OH groups.  When DDPH 
scavenging was used as a measure of lignan stoichiometry, the stoichiometric factor 
for SECO 2 was 4.5 versus 1.9 for BHT 17, which more closely agrees with the 
predicted stoichiometry for SECO 2.152  Reaction with the stable DPPH radical may 
be a better measure of the total number of easily reduced hydrogen atoms per 
molecule than the present method.   
The results in this study suggest that the difference in antioxidant 
stoichiometry between SDG 1 and SECO 2 is not dependent on the difference in 
solubility but on the participation of the primary alcohol groups on SECO 2 in the 
antioxidant reactions.  There are several lines of evidence to support this hypothesis.  
For example, from Eklund et al. study, the ratio of the stoichiometric results from 
DDPH scavenging for SECO 2 (4.5) as compared to matairesinol (2.9) is 1.55. 152  
This is comparable to the ratio for the stoichiometric ratios found in this thesis for 
SECO 2 and SDG 1 (1.36-1.25).  Matairesinol is more lipophilic than SECO 2, but 
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does not have the two primary alcohol groups present.  The product studies 
performed in this thesis indicate that reactions of the primary alcohol groups on 
SECO 2 lead to oxidation products which have stoichiometric ratios between two 
and one.  Thus, a stoichiometric value of 0.3-0.4 could be assigned to the pair of 
primary alcohols in SECO 2.  Another study of antioxidant activity using the Ferric 
Reducing/ Antioxidant Power assay demonstrated that SECO 2 was better than 
matairesinol (1.2 vs 1.1) and END 12  was better than ENL 13 (0.2 vs 0.1).306  In 
both cases primary alcohols were absent in the weaker antioxidant . 
The only study which contradicts these results is one in which the inhibition 
of lipid peroxidation in a linoleic acid peroxidation assay by 10µM SDG 1, END 12 
and ENL 13 show % inhibition results of 31.3, 20.8 and 31.6%, respectively.151  
That is, the antioxidant activity is less for the compound with free primary alcohols 
(END).  However, the % inhibition at 100µM SDG 1, END 12 and ENL 13 was 
58.7, 55.2 and 39%, respectively, with the most lipophilic compound (ENL), now 
showing the poorest antioxidant capacity and END 12 (free primary alcohols) being 
comparable to SDG 1.  This study also demonstrated that ENL 13 and END 12 were 
superior scavengers of hydroxyl radical compared to SDG 1.  The authors suggested 
that steric hindrance from the glucose groups on SDG 1 may interfere with radical 
scavenging by the phenol hydroxyls, a possibility that cannot be discounted as a 
contributing factor for the results found in this thesis. 
It would be useful to determine how the aliphatic hydroxyl groups on SECO 
2 contribute to antioxidant reactions by blocking the two hydroxyl groups in the 
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aromatic rings.  Under acidic condition, SECO 2 converts to anhydro-SECO via the 
dehydration reaction and the formation of a furan ring.32  Determination of the 
stoichiometric ratio of anhydro-SECO would indicate what role the aliphatic 
hydroxyl groups contribute to the antioxidant activity of SECO 2.  Alternatively, 
protection of the primary alcohols of SECO 2 with methoxy groups could also be 
used to probe the effect of the alcohol groups.  Another analogue of SECO 2, 
dihydroguaiaretic acid (CH3 instead of CH2OH) may also be an appropriate 
compound.  
  
5.6. Estimation of antioxidant capacity (n-value) of SECO 2
 oxidation products 
 The n-value of SECO 2 and SDG 1 oxidation products (as chain breaking 
antioxidants) can be estimated based on the ability to remove a free radical or to 
donate one hydrogen.226  Based on this rule, compounds 50 and 51 would be 
predicted to have n=2 due to first, losing hydrogen (n=1) from SECO 2 molecule 
and second, trapping AP free radical (n=1).  The two dimers 48 and 49 would have 
n=1 due to the lost of one hydrogen form SECO 2 molecule that undergoes 
dimerization.  Compound 52 with peroxide in the structure would estimate to have 
n=0 because it does not lose any hydrogen or trap any AP free radicals.   
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5.7. Estimation of antioxidant capacity (n-value) of SDG 1 oxidation
 products 
Compound 55 would be predicted to have n=1 due to the loss of one 
hydrogen from SDG 1 molecule that undergoes dimerization.  Like compound 50 
from SECO 2 oxidation, compounds 56 from SDG 1 oxidation would have n=2 due 
to losing one hydrogen and trapping an AP radical.  Compound 58 would have n=2 
due to first, losing hydrogen for the formation of a double bond (n=1) and, then, the 
addition of hydrogen (n=1) for the formation of a quinone molecule.   
It would be useful to determine how aliphatic hydroxyl groups contribute to 
oxidation by blocking the two hydroxyl groups in the aromatic rings.  Under acidic 
condition, SECO 2 converts to anhydro-SECO via the dehydration reaction and the 
formation of a furan ring.32  Determination of the stoichiometric ratio of anhydro-
SECO would indicate what role the aliphatic hydroxyl groups contribute to the 
antioxidant activity of SECO 2.  Anhydro-SECO would be expected to exhibit 
similar solubility in a liposomal system. 
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6.0. CONCLUSION 
The major objectives of this study were to investigate the antioxidant 
properties and major oxidative compounds of SECO 2 and SDG 1, using the AAPH 
47 in vitro model of lipid peroxidation.  AAPH 47 produces carbon-centred AP 
radicals upon thermal decomposition and provides a good model to study the 
antioxidant reactions of SECO 2 in vitro. 
SECO 2 and SDG 1 were oxidized at 60°C by AAPH 47 for 5h and 4 h, 
respectively.  The reaction mixtures were subjected to preparative and semi-
preparative HPLC to yield five major oxidation products (48-52) for SECO 2 and 
three to four major oxidation products (55-58) for SDG 1.  The structure of these 
oxidation products have been identified using NMR and ES-MS. 
This study demonstrated that the flaxseed lignans SECO 2 and SDG 1 act as 
chain breaking antioxidants in a homogeneous aqueous system.  The antioxidant 
mechanisms of both SECO 2 and SDG 1 would be based on hydrogen donation 
ability of SECO 2 and SDG 1 to trap AP free radicals and consequently inhibiting 
radical chain propagation.  SECO 2 oxidation occurs on the aromatic (4-OH) and 
aliphatic (9-OH) hydroxyl protons.  Conversely for SDG 1, only compounds derived 
from the oxidation of aromatic hydroxyl protons were obtained because the 9-OH 
position is glucosylated.  After donating a hydrogen atom, SDG 1 forms resonance-
stabilized phenoxyl radicals that form mainly stable non-radical compounds, which 
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do not easily participate in other radical reactions.  The only exception is a dimer, 
which slowly decomposes during oxidation.  SECO 2 also forms resonance-
stabilized phenoxyl radicals that lead to stable, non-radical compounds.  The 
stability of a SECO 2 dimer analogous in structure to the SDG 1 dimer could not be 
determined.  SECO 2 however also forms alkoxyl radicals that appear to form 
mainly stable non-radical compounds.  The one exception is a peroxyl linked dimer 
which decomposes during oxidation, although it appears to lead to the formation of 
the other stable, non-radical products. 
Phenol oxidation products formed in both reactions were generally consistent 
with those observed in a recent report.152  However, SECO 2 forms unique products 
that appear to be the result of alkoxyl radical formation, that were not observed by 
Eklund et al. 
Two oxidation model systems were utilized to determine the potential for 
SECO 2, SDG 1 and SDG polymer 3 to act as antioxidants in oil-based foods.  A 
Rancimat was used for the measurement of inhibition of autoxidation mediated by 
flaxseed lignans in comparison with BHT 17-mediated inhibition of autoxidation of 
canola oil.  This study demonstrated that the lignans could produce a concentration-
dependent inhibition of autoxidation, although none of the lignans was as effective 
as BHT 17.  In addition, SECO 2 was a superior antioxidant to SDG 1 and SDG 
polymer and SDG polymer was at least comparable to SDG 1.  SDG polymer may 
be a good candidate for a food antioxidant due to its lower cost.  Second, a 
stoichiometric ratio measuring the ability of lignans to inhibit AAPH 47-mediated 
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lipid peroxidation in a liposomal system was determined.227  The stoichiometric ratio 
for SECO 2 and SDG 1 were 1.5 and 1.1-1.2, respectively compared to BHT 17 
(2.0), signifying that both SECO 2 and SDG 1 delayed AAPH 47-induced lipid 
autoxidation.  As well, SECO 2 and SDG 1 from flaxseed lignans are chain-breaking 
antioxidants.   
Both model systems showed that as an antioxidant, SECO 2 provides better 
protection than SDG 1.  The observed induction times were consistent with the 
calculated stoichiometric ratio, and illustrative of two appropriate oxidation models.  
The greater antioxidant activity of SECO 2 vs SDG 1 is proposed to be the result of 
the additional contributions to radical scavenging by the alkoxyl radical-derived 
products found for SECO 2.  Most other examples of lignan antioxidant capacity in 
the literature appear to agree with this hypothesis.  In addition, the antioxidant 
stoichiometry is approximately 50% that predicted from the number of phenol OH 
groups per molecule, suggesting that calculating relative antioxidant potential in this 
manner is not appropriate for the lignans. 
Although SECO 2 and SDG 1 are less potent antioxidants compared to BHT 
17, they have potential advantages over BHT 17 in that they are natural antioxidants 
that have potential health benefits associated with their consumption.129,153,277  These 
results provide better understanding of the chemistry behind flaxseed antioxidant 
activities and suggest that flaxseed lignans may be used as natural antioxidants.   
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7.0. FUTURE RESEARCH 
Future biological studies require confirmation of SECO 2 as a chain breaking 
antioxidant in prevention of lipid oxidation, protein oxidation and DNA oxidation 
associated with oxidative stess.  Other in vitro studies with animal and human 
hepatic microsomal preparations could use these compounds to investigate their 
antioxidant actions.  Tissue culture of animal and human cancer cells could be a 
useful way to examine whether these compounds prevent growth of cancer cells.   
Further investigation on the differing antioxidant activities between SECO 2 
and SDG 1 (in vivo study) would be enlightening because most of the glycosides 
would be converted to aglycones by intestinal microorganisms.286  In addition, it 
may be beneficial to treat the flax products in a way that would convert SDG 1 to 
SECO 2 in order to increase its antioxidant capacity.  
This study demonstrated that SECO 2 and SDG 1 act as antioxidants in 
homogeneous solution.  The mechanism by which SECO 2 and SDG 1 scavenges 
AP radicals have been clarified.  However, the details of the behaviour and action of 
SECO 2 and SDG 1 in the membranes remain to be established.  Further areas of 
potential study include: 
 
  211
1.  Determine how the primary aliphatic hydroxyl groups of SECO 2 
contribute to its antioxidant effect.  This could be accomplished by studying 
structural analogues in which the alcohols have been removed. 
2.  Determine whether the mechanism of the inhibition of oxidation by 
SECO 2 and SDG 1 in cell membranes is the same as those in homogeneous 
solutions.  Microsomal lipid peroxidation is one possible method that could 
be used to assess this.  The stable dimers may be useful as potential markers 
of lignan antioxidant activity in these sysytems. 
3.  Phospholipids spontaneously form bilayers called liposomes when 
dispersed in water, and these can serve as good models for real biological 
membranes.  It remains to be determined whether the kinetics and 
mechanisms for the oxidation of lipids in liposomal membranes are the same 
as those of phospholipids and fatty acids in organic solution. 
4.  Further toxicological and safety profiles need to be determined in studies 
of chronic exposure. 
5. Determine whether SECO 2 and SDG 1 can act as preventive antioxidants. 
6. Determine whether SECO 2 and SDG 1 exhibit a synergistic effect in 
vitro. 
7.  Determing the ability of SECO 2 and SDG 1 to act as antioxidants in 
different emulsion food systems (oil in water, water in oil).  
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